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Daniel answered and said, 
Blessed be the name of God for ever and ever, 
for wisdom and might are his; 
and he changeth the times and the seasons, 
he removeth kings, and setteth up kings; 
he giveth wisdom unto the wise 
and knowledge to them that know understanding. 
 
(Dn. 2:20-21)
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RESUMO           
 
O Século XX trouxe consigo uma profunda alteração demográfica nos países 
industrializados impulsionada pelo desequilíbrio entre as taxas de fertilidade e 
mortalidade, levando a um aumento proporcional da população mais idosa que 
continuará pelo século XXI. O envelhecimento populacional observado condiciona 
deste modo o direccionar da descoberta de novos fármacos para novos campos de 
investigação. A demência surge de entre as doenças relacionadas com a idade como 
uma preocupação de saúde pública à escala mundial. Em particular, alguns estudos 
apontam para um crescimento galopante da doença de Alzheimer, a forma mais comum 
de demência irreversível. A doença de Alzheimer é por isso um motivo de crescente 
preocupação dado que não só é baixa a qualidade de vida do portador e de quem cuida 
do doente mas também o investimento por parte do sistema de saúde será cada vez mais 
avultado. Urge assim a necessidade de investigar novas terapêuticas com efeito 
modificador da doença, uma vez que os medicamentos actualmente existentes no 
mercado apenas aliviam sintomas. 
Neste sentido, esta tese de doutoramento sustenta o desenvolvimento de uma 
abordagem biotecnológica com vista à produção de flavonas potencialmente activas 
contra a doença de Alzheimer. Na base deste potencial desempenho terapêutico está a 
evidência de fenómenos inflamatórios característicos da patologia da doença de 
Alzheimer, bem como a actividade anti-inflamatória descrita como propriedade 
farmacológica comum aos compostos pertencentes ao grupo dos flavenóides, como é o 
caso das flavonas. Os compostos biossintetizados poderão constituir a chave para a 
resolução de problemas relacionados com a dificuldade em permear a barreira hemato-
encefálica e deste modo serem direccionados para o cérebro onde poderão actuar contra 
a doença de Alzheimer numa abordagem anti-inflamatória. 
Mais detalhadamente, este trabalho ambiciona a produção respectiva de glucósidos e 
aglíconas, através da desglicosilação enzimática de substratos naturais abundantes como 
os rutinósidos de flavonas: naringina e rutina. A concepção deste bioprocesso faz uso de 
ferramentas chave como sejam a pressão e a imobilização enzimática, entre outras 
condições que incluem: a temperatura, o pH e a utilização de solventes orgânicos e 
líquidos iónicos. A modulação e optimização destas condições, tem como objectivo 
maximizar a eficiência desta abordagem biotecnológica que encerra em si própria os 
seguintes objectivos específicos. (I) Desenvolver um processo biocatalítico, visando a 
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produção dos glucósidos: prunina e isoquercetina, bem como as aglíconas: naringenina 
e quercetina, partindo dos respectivos rutinósidos de flavonas: naringina e rutina, 
utilizando a naringinase; (II) Utilizar a pressão como ferramenta que poderá permitir 
aumentar a eficiência do bioprocesso: quer por aumento da estabilidade do 
biocatalisador a temperaturas elevadas, preservando o seu estado nativo; quer por 
aumento da actividade desse mesmo biocatalisador, acelerando o processo em si. (III) 
Utilizar o processo de imobilização enzimática como meio de facilitar a sua recuperação 
do meio reaccional, permitindo deste modo a sua reutilização. A imobilização da 
naringinase em matrizes de sol-gel visa alcançar uma boa performance do 
biocatalisador, incluindo: rendimento, actividade e estabilidade operacional; um outro 
objectivo da imobilização da naringinase consiste no aumento da sua estabilidade contra 
a inactivação provocada por solventes orgânicos. (IV) Por último, mas não menos 
importante, estudar uma possível utilização vantajosa de glucósidos e aglíconas para 
permear a barreira hemato-encefálica, por oposição aos rutinósidos, com vista a 
direccionar determinadas flavonas para o cérebro. 
Em virtude de um delineamento experimental adequado os objectivos acima descritos 
puderam ser concretizados. Quanto à concepção do bioprocesso em si mesmo, os 
objectivos alcançados dividem-se em três tarefas distintas. 
- A produção das aglíconas: naringenina e quercetina, partindo respectivamente da 
naringina e rutina, por meio da naringinase. Quanto à produção dos glucósidos: prunina 
e isoquercetina, partindo dos rutinósidos referidos foi necessário recorrer a um método 
de desactivação selectiva da -D-glucosidase expressa pela naringinase, através de 
condições optimizadas de temperatura (81.5 ºC) e pH (3.9). Após esta desactivação 
selectiva foi possível produzir os glucósidos em causa utilizando a actividade 
remanescente da -L-ramnosidase. Todos os produtos foram obtidos com elevada 
pureza e com um bom rendimento atendendo ao seu valor económico, sobretudo os 
glucósidos: prunina e isoquercetina. Deste modo foi desenvolvido um método 
potencialmente bastante competitivo sobretudo para a produção destes glucósidos. 
- As condições de pressão estudadas permitiram aumentar a estabilidade de ambas as 
actividades expressas pela naringinase: -D-glucosidase e -L-ramnosidase quando 
sujeitas a temperaturas elevadas. No caso da -L-ramnosidase verificou-se um aumento 
da estabilidade em 32 vezes (250 MPa e 85.0ºC) relativamente à pressão atmosférica, 
enquanto que no caso da -D-glucosidase se verificou um aumento de 30 vezes (200 
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MPa e 75.0 ºC). Este facto é concordante com um diagrama de fase de desnaturação 
proteica, com uma forma elíptica. Este efeito protector da pressão é bastante útil, 
permitindo aumentar a temperatura reaccional o que não só aumenta a velocidade da 
reacção, mas também a solubilidade dos substratos: naringina e rutina, os quais se 
tornam mais solúveis em água com o aumento da temperatura. Quanto à influência da 
pressão sobre a velocidade reaccional, verificou-se que a actividade da -L-ramnosidase 
é favorecida pela pressão (≠V = 7.7 ± 1.5 mL mol1) contrariamente à actividade da 
-D-glucosidase (≠V = 6.5 ± 1.9 mL mol1), ambas expressas pela naringinase. De 
acordo com estes resultados faria supor que as condições de pressão apenas seriam úteis 
no caso da produção de glucósidos a partir de rutinósidos, por meio da actividade da -
L-ramnosidase. Contudo, o estudo da hidrólise da naringina a naringenina sob 
condições de pressão demonstrou que também no caso da produção de aglíconas 
partindo de rutinósidos, a pressão é uma ferramenta adequada para acelerar a reacção 
enzimática (≠V = 20 ± 5.2 mL mol1), que neste caso ocorre em dois passos 
consecutivos. A pressão demonstrou assim ser uma óptima ferramenta para a eficiência 
global do bioprocesso em estudo. 
- A imobilização da naringinase em matrizes de sol-gel foi conseguida com sucesso, 
podendo assim ser recuperada do meio reaccional e reutilizada durante um número 
bastante elevado de ciclos. A imobilização da naringinase em matrizes de sol-gel 
(TMOS/glicerol) apresentou uma elevada performance (89% de rendimento, 72% de 
eficiência e 100% de actividade residual ao fim de 50 reutilizações). A naringinase 
imobilizada nesta matriz demonstrou uma elevada resistência contra a inactivação 
provocada por um vasto portfólio de cossolventes em estudo (aumento do tempo de 
meia-vida superior a 3 vezes). A importância destes resultados incide novamente na 
baixa solubilidade das flavonas utilizadas como substratos, a qual pode ser aumentada 
através da utilização de cossolventes orgânicos. A adição dos líquidos iónicos 
[OMIM][Tf2N] e [C2OHMIM][PF6] à matriz de sol-gel permitiu aumentar a eficiência 
das actividades da -L-ramnosidase e da -D-glucosidase, respectivamente. 
Finalmente, considerando a potencial aplicação dos compostos biossintetizados na 
terapêutica da doença de Alzheimer, estudos preliminares suportam a hipótese da 
utilização do glucósido prunina bem como da aglícona naringenina no sentido de 
permear a barreira hemato-encefálica, que é uma vantagem importantíssima para assim 
poder atingir o local de acção dentro do cérebro, quando comparado com o rutinósido 
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naringina que com base nos resultados disponíveis não parece ser capaz de atravessar a 
barreira hemato-encefálica. 
 
Palavras-chave: Doença de Alzheimer, flavonas, pressão, imobilização, naringinase. 
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ABSTRACT           
 
This thesis sustains a biotechnological approach design for the production of potential 
active flavones against Alzheimer’s disease (AD), based on inflammation evidences 
observed on AD pathology and the common shared anti-inflammatory activity of 
flavonoids. The produced compounds may be the key to circumvent some issues related 
to blood-brain barrier (BBB) permeability, targeting AD through an anti-inflammatory 
approach. 
This work aims to produce the respective glucosides and aglycones of the flavone 
glycosides: naringin and rutin, through enzymatic deglycosylation. The bioprocess 
design makes use of pressure and biocatalyst immobilization as keystone tools among 
other conditions, including: temperature, pH and use of organic solvents and ionic 
liquids. The modulation and optimization of these conditions aims to maximize the 
efficiency of this biotechnological approach. 
In bioprocess design, the achievements are divided into three groups. The first one 
consisted on the production of glucosides and aglycones of naringin and rutin, 
respectively, with naringinase and partially inactivated naringinase at optimized 
conditions of 81.5 ºC and pH 3.9. A second one showed how pressure increased -L-
rhamnosidase activity leading to an activation volume of 7.7 ± 1.5 mL mol1. 
Moreover the stability against heat of -L-rhamnosidase and -d-glucosidase expressed 
by naringinase increased, respectively, 32-fold at 250 MPa and 85.0 ºC, and 30-fold at 
200 MPa and 75.0 ºC, than at 0 MPa. Finally, the third one is related with the high 
performance shown by naringinase entrapped within silica glasses (TMOS/glycerol) 
through sol-gel method (89% yield, 72% efficiency and 100% residual activity). 
Naringinase within this matrix showed a high resistance against cosolvent inactivation 
(half-life time increase, more than 3 fold). The addition of the ionic liquids 
[OMIM][Tf2N] and [C2OHMIM][PF6] to the sol-gel matrices increased the efficiency of 
both -L-rhamnosidase and -D-glucosidase activities, respectively. 
Considering the potential application of the produced drugs on the therapeutics of AD, 
preliminary studies support the hypothesis that prunin and naringenin can cross the 
BBB, which is a striking advantage to target AD comparing to naringin. 
 
Key-words: Alzheimer’s disease, flavone, pressure, immobilization, naringinase. 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SCIENTIFIC BACKGROUND AND OBJECTIVES 
 
Chapter 1 

  CHAPTER 1 
3 
1.1 General introduction 
 
20th century brought deep demographic changes in industrialized countries due to 
fertility and mortality rates imbalance, leading to a proportion increase of the older 
population, which will continue through the 21st century. Not only European but also 
American population projections show that around 2050-2060 up to 25 – 30% of the 
population will be aged 65 years or older (Bustacchini et al., 2009). This demographic 
change is the basis of the increase of age-related diseases incidence and is shifting drug 
research into new fields. Within the group of age-related diseases are included many 
diseases such as: atherosclerosis, hypernatremia, metabolic syndrome, cancer, prostate 
enlargement, osteoporosis, osteoarthritis, insulin resistance, age-related macular 
degeneration, dementia, cognitive dysfunction, Alzheimer’s (AD) and Parkinson’s 
diseases (Baquer et al., 2009; Blagosklonny et al., 2009; Chung et al., 2009). Among 
these, dementia has became a public health concern worldwide (Fothui et al., 2009); not 
only due to the patient clinical and functional status, but also due to the low life quality 
of caregivers, as well as the healthcare costs associated with medical assistance and 
healthcare interventions (Bustacchini et al., 2009). Eliminating AD won’t increase that 
much the maximum human lifespan, due to the existence of so many other diseases 
(Blagosklonny et al., 2009), but at least it will eliminate a very heavy disease 
concerning the patient’s family as well as the healthcare system. 
According to Shineman et al., 2010 is not yet known whether cognitive aging may be 
the beginning of a process that sometimes ends in dementia or if other events are 
needed. Pure dementia cases are only a small percentage that contributes to brain 
atrophy inside a large quantity of genetic and environmental factors such as: 
apolipoprotein E genotype, obesity, diabetes, hypertension, head trauma, systemic 
illnesses and obstructive sleep apnea (Fothui et al., 2009). Simultaneously it is known 
the role played by oxidative stress through oxidative damage and redox imbalance in the 
pathogenesis of neurodegenerative diseases (Chung et al., 2009), particularly 
Alzheimer’s disease (Sultana et al., 2006).  
The “oxidative stress hypothesis” (Yu and Yang, 1996), an upgrade version of the free 
radical theory of aging (Harman, 1956), describes the actual knowledge of the aging 
mechanism, where nucleic acids, proteins and lipids suffer an oxidative damage by 
uncontrolled production of reactive oxygen species (ROS), reactive nitrogen species 
(RNS) and also reactive lipid species. In the case of cell membrane fatty acids and 
CHAPTER 1   
4 
proteins the radical species action leads to permanent function impairment, but in the 
case of DNA damage they can lead to DNA mutations, which may turn to be the basis 
of age-related disorders, among others, such as cancer (Khansari et al., 2009). In 1972, 
Harman found that mitochondria were responsible for the initiation of most of the free 
radical reactions, due to aerobic respiration. Nowadays, several cellular activities are 
known to generate radical species (RS), including: lipoxygenase; cyclooxygenase 
(COX); plasma membrane-associated NADPH oxidase; mitochondrial electron 
transport system; ubiquinone; NADH dehydrogenase; cytochrome P450; cytochrome 
b5; microsomal electron transport; flavoproteins; oxidases in peroxisome and xanthine 
oxidase cytosol (Bodamyali et al., 2000). Besides the RS produced from cellular 
metabolism there is also the contribution of environmental factors, including: physical, 
biological and chemical stressors, where pollution is a major concern contributing to 
systemic oxidative stress (Gomez-Mejiba et al., 2009). In order to fight against 
oxidative damage, the human body possesses an antioxidant defence system that 
includes enzymes, such as: superoxide dismutase (SOD), glutathione peroxidase (GPx), 
glutathione reductase (GSR) and catalase; endogenous non-enzymatic defences: 
glutathione (GSH), bilirubin, thiols, albumin, and uric acid; and nutritional factor 
including vitamins and phenols (Lykkesfeldt et al., 1998; Fusco et al., 2007). 
The basis of the oxidative damage, during aging, is this debility of antioxidant defences 
that triggers a redox imbalance (Chung et al., 2009). Aging is responsible for weaken 
the antioxidant defence, being characterized by a decrease of GSH and GSR levels, one 
of the most abundant and effective anti-oxidative reductant (Cho et al., 2003). 
Specifically concerning brain, the age related neuronal damage is even stressed by other 
factors, such as: high oxygen consumption rate from aerobic metabolism; abundant lipid 
content and low antioxidant enzymes content, when compared to other organs (Baquer 
et al., 2009). Oxidative damage is suggested to mediate mitochondria dysfunction 
which may play a significant role in aging and age-related neurological diseases, 
including: Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis and 
Freidreich ataxia. As a result of the interaction of mutant proteins with mitochondrial 
proteins, the electron transport chain is disrupted and generates ROS that inhibit the 
ATP mitochondrial production, which is a vital energy source for brain cells; further, 
the accumulation of mitochondrial DNA may contribute to mitochondria dysfunction 
during aging (Reddy, 2008). 
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Figure 1.1 shows how oxidative stress may cause a chronic molecular inflammation 
which was found to be the major biological mechanism behind aging process and age-
related diseases (Chang et al., 2006; Khansari et al., 2009). The generated redox 
imbalance enhances upstream signalling pathways such as IB kinase (IKK) and 
mitogen-activated protein kinases (MAPKs) that modulate the activity of the nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-B), a DNA transcription 
factor (Zandi et al., 1997; Karin, 2006). Consecutively NF-B induces the up regulation 
of pro-inflammatory mediators, like: TNF-; interleukins (IL-1, IL-2 and IL-6); 
adhesion molecules (AMs) and enzymes including cyclooxigenase-2 (COX-2) and 
inducible nitric oxide synthase (iNOS) (Brand et al., 1996; Böhrer et al., 1997). In the 
case of chronic diseases, the NK-B activation instead of being short-lived is not well 
controlled (Yu and Yang, 2006), causing a worse scenario once some of the pro-
inflammatory mediators, as: TNF-, IL-1, IL-6 and COX-2 are activators of NF-B, 
creating an auto-activation cycle (Handel et al., 1995; Fischer et al., 1996). In addition 
the consequent tissue damage induced by the inflammatory mediators leads to a vicious 
cycle through the production of more RS, which increases the redox imbalance (Chung 
et al., 2009; Khansari et al., 2009). This molecular inflammation mechanism may in last 
case be a cause or part of disease progression, contributing to the aging process as well 
as to the chronicity of age-related diseases (Chung et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.1 Major pathways involved in the molecular activation mechanism of inflammation, during 
aging and age-related diseases (adapted from Chung et al., 2009).  
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This relation between free radicals and aging related diseases is the basis of antioxidant 
therapy to fight against this kind of diseases (Harman, 2003; Khansari et al., 2009). An 
antioxidant is a substance capable of inhibiting or limiting the oxidation of a certain 
substrate, while present in a very small concentration. Besides endogenous antioxidants 
that belong to body antioxidant defence system there are also exogenous antioxidants 
provided by nutrition. Many of these nutritional oxidants belong to the phenol family 
(Fusco et al., 2007). Polyphenols are a group of chemical compounds containing 
multiple phenolic functionalities, usually referred as natural occurrence, although a wide 
amount of synthetic polyphenols also do exist (Tückmantel et al., 1999). These 
ubiquitous natural compounds, very common in higher plants, come from the plant’s 
secondary metabolism and play several roles related to the plant’s survivability (Joseph 
et al., 2009). Polyphenolic compounds are divided into main groups that are: 
flavonoids, phenolic acids, phenolic alcohols, stilbenes and lignans (Yoshihara, 2010). 
Some polyphenols are specifically found in a particular plant, while others are found in 
most plants and generally occurring in complex mixtures (D’Archivio et al., 2010). 
More than 8,000 polyphenols (Guo et al., 2009) have been identified within fruit, 
vegetables, tea, red wine, coffee, chocolate, olives, herbs, spices, nuts and algae 
(Crozier et al., 2009).  
Epidemiological evidences have shown the benefit of consuming a diet of food 
containing polyphenols (D’Archivio et al., 2010). The majority of these compounds act 
by scavenging radical species, neutralizing in a direct way the free radicals; reducing 
peroxide amount and repairing oxidized membranes; quenching iron that reduces 
oxygen species production; or through lipid metabolism, where oxygen species are 
neutralized by short-chain free fatty acids and cholesteryl esters (Handique and Baruah, 
2002; Berger, 2005). However, some polyphenols under certain circumstances may 
behave as pro-oxidants (Tückmantel et al., 1999). The role of polyphenolic compounds 
ends up being more complex than just antioxidant activity (Masella et al., 2005). They 
may exert other activities including: inhibition of cancer cell proliferation (Noratto et 
al., 2009) and cholesterol uptake (Leifert and Abeywardena, 2008); modulation of 
enzymes such as telomerase (Naasani et al., 2003); anti-inflammatory activity through 
the inhibition of COX-2 (Hussain et al., 2005), lipoxygenase (Sadik et al., 2003) and 
also NF-B, which is a master regulator of infection and inflammation (Guo et al., 
2009); interaction with signal transduction pathways (Kong et al., 2000); prevention of 
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endothelial dysfunctions (Carluccio et al., 2003); and also interfering with caspase 
dependent pathways (Way et al., 2005) and cell cycle regulation (Fischer et al., 2000). 
Following this, acting as free radical scavengers, polyphenols may slow or prevent the 
progression of age-related diseases, in particular AD. Some evidence facts coming from 
food diet have already been published, where the consumption of diets rich in 
antioxidants compounds may provide beneficial effects against aging and preventing or 
delaying cognitive dysfunction (Letenneur et al., 2007), long-term risk of dementia, 
Alzheimer’s disease (Joseph et al., 2009; Devore et al., 2010) and others 
neurodegenerative diseases (Joseph et al., 2009). 
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Figure 1.2 Aloysius Alzheimer 
1.2 Alzheimer’s disease 
 
Aloysius Alzheimer (Figure 1.2), born on the 14th of July 
of 1864, in Marktbreit, Baviera was a famous German 
neurologist known to be the first author who distinguished 
the neurodegenerative disease as a distinct pathologic 
entity, actually called Alzheimer’s disease. AD is an age-
related disease and the most common form of irreversible 
dementia (Citron, 2010). It is generally characterized by a 
slow but inflexible progression of dementia, associated 
with cognitive and memory decline, speech loss and 
personality changes. The memory loss is characteristic of 
AD, firstly a gradual loss of short-period memory occurs, which ultimately is extended 
to the more consolidated memory (Nowak, 2004). As a consequence, AD places a high 
burden not only on patients but also on caregivers. In line with the population aging 
within industrial countries, studies show how in the United States aging will lead to a 
three times increase of AD patients in 2050 comparing to the year 2000, reaching 
around 13.2 millions of people (Herbert et al., 2003). Consequently the annual costs of 
AD are growing up each year, making the healthcare system investments to grow up in 
a scaring way (Citron, 2010). All together, both the devastating socioeconomic impact 
of AD as well as the incidence increase makes AD a disease of major concern. 
Epidemiological studies show evidences of AD as a disease of multifactor causes, 
including: biological, genetic, environmental, behavioral factors and also as a secondary 
consequence of certain health conditions (Citron, 2010). Advanced age is the biological 
and primary risk factor for late-onset AD (Yoshitake et al., 1995). Concerning genetic 
factors, some mutations have been identified in the following genes: amyloid precursor 
protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2), which are related with early-
onset AD; on the other hand the presence of the 4 allele of the apolipoprotein E 
(APOE) is a major risk factor for late-onset AD (Cruts and vanBroeckhoven, 1998). 
Regarding environmental factors, higher education is considered to be a beneficial 
factor against AD. Cigarette smoking is a behavioral risk factor, while physical exercise 
(Yoshitake et al., 1995) and mental activity seem to be beneficial factors (Citron, 2010). 
Finally, certain health conditions are associated with increased risk of AD, including: 
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head injury, high blood pressure, obesity, diabetes and metabolic syndrome (Citron, 
2010). 
 
1.2.1 AD progression mechanisms 
Considering the histopathological post-mortem observation of human brains of AD 
patient’s, two kinds of hallmark lesions can be observed, consisting on both senile 
plaques and neurofibrillary tangles (NFTs) in the brain memory and cognition regions 
(Alzheimer et al., 1995). These senile plaques consist on deposits of extracellular 
amyloid- peptide (A) (Mark et al., 1995), while NFTs are formed by the 
accumulation of abnormal filaments of tau protein (McGeer et al., 2007). Not less 
important is the evidence of inflammatory processes and immune response (McGeer et 
al., 2007). The aim of studying the mechanisms underlying this histopathological 
scenario is to find potential targets to block or delay the progression of AD.  
 
 Formation of amyloid-peptide plaques
The mechanism underlying the formation of Apeptide plaques is called the amyloid 
cascade (Figure 1.3), which starts with the sequential cleavage of the amyloid precursor 
protein (APP), a transmembrane protein, by -secretase (also known as -site APP 
cleaving enzyme 1; BACE1) and -secretase. From the proteolytic fragmentation of 
APP, several isoforms of A peptide are released, among which A42, a very low 
soluble isoform 42 amino acid long. The aggregation of A42 peptide leads to the 
formation of toxic oligomers that deposit in amyloid plaques. Ultimately, the formation 
of oligomers is responsible for the induction of synaptotoxic effects, while the amyloid 
plaques cause an inflammatory response (Walsh and Selkoe, 2007). 
 
 
 
 
 
 
 
 
 
Figure 1.3 The amyloid cascade (adapted from Citron, 2010). 
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The amyloid cascade hypothesis is thought to play an essential role in AD pathogenesis, 
being strongly supported by pathological and genetic evidences. The presence of 
amyloid burden in peripheral amyloidoses is strong pathological evidence; also, both 
the acute synaptic toxicity effects caused by A oligomers and the pro-inflammatory 
effects of amyloid plaque contribute even more for neuronal toxicity. In the case of 
genetic evidences, APOE4 allele is a risk factor not only in AD but also in a number of 
neurological disorders, which suggests a direct effect on neurodegeneration; also APOE 
seems to interfere directly with the amyloid cascade that affects the A peptide 
deposition and clearance (Bu, 2009). Another important fact, concerning genetic 
evidences is that all the mutations behind the familial early onset AD lead to an increase 
of A42 peptide production or at least an increase of A42/A40 ratio, where A40 is an 
isoform less prone to aggregate and finally also these mutations enhance the 
amyloidogenic APP processing (Walsh and Selkoe, 2007). 
 
 Formation of neurofibrillary tangles
NFTs are formed by the accumulation of abnormal filaments of tau. Tau is a soluble 
microtubule-binding protein, which supports axonal transport and cytoskeleton growth, 
by stabilizing microtubules and promoting tubulin assembly into microtubules. Figure 
1.4 shows how the hyperphosphorylation of tau proteins in AD, causes the detachment 
of tau proteins from the microtubule. The soluble tau proteins may then aggregate into 
soluble tau aggregates and insoluble paired helical filaments that ultimately end in the 
formation of NFTs. This microtubule destabilization caused by direct toxic effects of 
both soluble hyperphosphorylated tau and fibrillar tau leads to axonal transport 
impairment causing a progressive loss of neurons (Goedert, 2006). 
 
 
 
 
 
 
 
 Figure 1.4 Tau pathology (adapted from Citron, 2010). 
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Tau pathology may be regarded as consequence rather than a cause of AD due to the 
fact that tau and tangle pathology also occur in other neurological disorders, besides AD 
and also the possibility of being triggered through an upstream mechanism by amyloid 
cascade in AD (Figure 1.3) (Citron, 2010). However, this is not clear, because 
correlations between cognitive dysfunction and tangle load in AD do exist (Thal et al., 
2000). Also tau mutations were found to cause some forms of frontotemporal dementia, 
showing how tau pathology alone causes cell loss and dementia (Hutton et al., 1998). 
 
1.2.1.3 Inflammation 
Inflammation has been shown to be related and significantly contribute to the 
development of dementia that might be relevant for the development of 
neurodegenerative diseases (Chung et al., 2009). Concerning AD, it was suggested that 
inflammatory processes may modulate it contributing to its pathogenesis (Peila and 
Launer, 2006). Moreover an increase concentration of inflammatory markers do occur 
in AD patients including: members of the complement, prostaglandins, cytokines (IL-
1, IL-6, TNF-, TGF-, acute-phase reactive proteins, coagulation factors, reactive 
astrocytes and activated microglia cells (Wyss-Coray and Mucke, 2002; Citron, 2010). 
Also, the levels of nitric oxide synthase enzymes were shown to be increased in the 
frontal, neurons, astroglial cells and blood vessels of post-mortem AD brains (Lüth et 
al., 2002). 
Considering the role of oxidative stress on the inflammatory response, several studies 
were accomplished in order to best understand the inflammatory mechanism underlying 
AD. Evidences show that oxidative damage may be implicated in mechanisms of 
neuronal cell injury (Kolosova et al., 2006), in particular in AD pathogenesis 
(Nunomura et al., 2006). Oxidative stress is thought to influence AD pathogenesis on 
three different levels, by acting on proteins, nucleic acids and lipids. Concerning protein 
damage, an increase nitrative stress was proved to occur in human AD brains, leading to 
increased levels of protein oxidation and nitration (Hensley et al., 1998). Taking into 
account both nuclear and mitochondrial DNA, several oxidized bases and increased 
levels of 8-hydroxy-2-deoxyguanosine do occur in human AD cerebral cortex and 
cerebellum. Finally, increased lipid peroxidation was detected in AD brains, as well as 
increased modification of phosphotidylserine, a key lipid for membrane integrity 
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(Bader-Lange et al., 2008). Noteworthy is the fact that oxidative stress is a common 
mechanism behind major etiologic known factors of AD: 
a) Old age is related with debility of the body antioxidant defence system, which also 
seems to occur in both early and late-onset of AD. The decrease of key antioxidant 
enzyme activities expression such as: SOD, catalase, GPx and GSR is reported to 
trigger the redox imbalance (Sinclair et al., 1998; Galbusera et al., 2004). In 
addition, the Inflammatory Hypothesis of Dementia corroborates the idea that 
brain aging is caused by inflammatory processes (McGeer and McGeer, 1995). 
b) Concerning genetic risk factors, both the presence of APOE4 allele, as well as 
mutations on APP, PS1 and PS2 genes are related to oxidative stress mechanism. 
Interestingly is even a report of a recent study which shows a genetic association 
between inflammation and AD, where the complement receptor 1 gene (CR1) that 
enables the innate immune humoral response was identified as another risk factor 
of AD (Lambert et al., 2009). 
c) Finally, also behavioral factors such as cigarette smoking and certain health 
conditions including diabetes and brain injury are associated with oxidative stress 
(Nunomura et al., 2006). 
Inflammation is undoubtedly the less known mechanism underlying AD. In addition 
oxidative stress seems to be correlated with major etiological known factors. It is 
plausible to draw a hypothesis where certain risk factors may give rise to oxidative 
stress that consequently leads to inflammation and tissue damage, causing AD. 
Inflammation is regarded not only as a consequence of oxidative stress but is also co-
related with it in a cyclical way. Unfortunately, the complexity of studying this 
mechanism is very high and inflammation may ultimately be just a response to a 
damage, caused by something else (Kamat et al., 2008). For instance, some in vivo 
models of AD amyloidosis show antioxidant defence impairment, increased protein 
oxidation and lipid peroxidation (Pratico et al., 2001; Schuessel et al., 2005); also some 
studies show that that A and APP may cause oxidative stress (Mark et al., 1995; Meda 
et al., 1995), and even that the interaction between A with the receptor for advanced 
glycation end products (RAGE) seem to activate NF-B, which may be responsible for 
the inflammatory response (Deane et al., 2004). These facts support the potential role of 
oxidative stress and inflammation on the toxicity mediated by the amyloid mechanism 
of AD. At the same time they also give rise to the doubt of whether oxidative stress and 
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inflammation are a cause or a consequence of AD. Despite inflammation might only be 
a consequence of AD, the fact that it may generate a vicious cycle that produces RS 
(Figure 1.1) turns inflammation into a relevant target for AD targeting in order to avoid 
increased tissue damage. 
 
1.2.2 AD Therapy 
Targeting AD is an audacious task, not only due to the mechanistic complexity of the 
disease but also due to the heterogeneity of the etiologic factors. Actual drugs mainly 
act to improve cognitive function, such as acetylcholinsterase inhibitors: galantamine, 
tacrine, donepezil and rivastigmine, used in mild to moderate AD (Scarpini et al., 
2003); and N-methyl-D-aspartate (NMDA) receptor antagonist, memantine, used in mild 
to severe AD (Sonkusare et al., 2005). In the case of other symptoms, including: mood 
disorder, agitation and psychosis is usually required medication, even though, there isn’t 
a specific indicated drug (Citron, 2010). It’s now more than ever urgent to find new 
therapeutic approaches capable of modifying the progression of the disease. The 
population is getting old in a fast way and the actual market drugs are ineffective to 
target AD progression mechanism. The purpose of developing disease modifying drugs 
relays on the blockage or delay of the disease progression, rather than on a fast 
symptomatic improvement. Concerning AD progression mechanisms, several 
approaches are being studied to target AD. 
 
1.2.2.1 Amyloid cascade approaches 
The amyloid cascade targeting approaches aim to avoid the formation of Apeptide 
plaques, based on the mechanism of the formation of the toxic Aoligomers and 
plaques. Several therapeutic strategies are being researched, including: modulation of 
Aβ production, inhibition of Aβ aggregation, enhancement of Aβ degradation, Aβ 
immunotherapy and APOE-related treatment (Citron, 2010). 
A production can be modulated through the inhibition of -secretase, inhibition of -
secretase or stimulating -secretase, which is an enzyme that competes with -secretase 
for APP substrate and cleaves the A peptide in two. Inhibiting -secretase was found to 
reduce A peptide in mice (Dovey et al., 2001), however these inhibitors have shown to 
cause intestinal metaplasia in adult animals, due to the inhibition of Notch 1 cleavage 
(Milano et al., 2004). New inhibitors seem now to have overcome this issue, and 
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semagacestat from Lilly has entered Phase III studies (Fleisher, 2008). The inhibition of 
-secretase, a transmembrane aspartic protease, has been quite challenging because it 
may cause a possible blockage of remyelination after injury (Citron, 2010), also the 
hydrophilic properties of aspartic protease inhibitors make it hard to penetrate the 
blood-brain barrier (BBB) (Durham et al., 2006). Finally, stimulating -secretase has 
the limitation of the entrance of much more APP to the -secretase than the -secretase 
pathway. No -secretase agonists are reported to be in clinical trials (Citron, 2010). 
The inhibition of A aggregation is based on the development of brain penetrable small-
molecules capable of interfering with A-A peptide interactions (Citron, 2010). A 
cyclohexanol isomer is in phase II trials (McLaurin et al., 2006). 
Considering now the enhancement of A clearance, key enzymes were found to be 
involved in A degradation, such as: neprilysin, insulin-degrading enzyme and plasmin 
(Eckman and Eckman, 2005). Once plasmin cleaves A, one potential therapeutic 
approach consists on the inhibition of plasminogen activator inhibitor (PAI-1), due to 
the fact that this molecule inhibits plasminogen activator that is required to generate 
plasmin from plasminogen. Still within the A clearance approach, two potential other 
targets are the inhibition of RAGE, which mediates A influx into the brain, and the 
activation of the low-density lipoprotein receptor-related protein 1 (LRP-1), which 
mediates the efflux of A from the brain trough the BBB. Phase II trials are being 
undertaken for a RAGE inhibitor (Citron, 2010). 
A immunotherapy is nowadays a very promising area for AD targeting. Actually, there 
are three antibodies against A in Phase III trials: intravenous immunoglobulin G, from 
Baxter, (Tsakanikas et al., 2008); bapineuzumab, from Elan and Wyeth, (Salloway et 
al., 2009); solanezumab, from Eli Lilly(Siemers et al., 2008). Despite the success of 
immunotherapy, some bothering issues related to efficacy and safety shall be regarded 
attentively. A major concern issue is the side effect of intracerebral hemorrhage 
observed in a few plaque-binding antibodies (Citron, 2010). Also a phase I trial, 
consisting on an active immunization against A peptide, where two patients showed 
extensive post-mortem evidence of Aremoval had still progressed to end-stage AD 
(Holmes et al., 2008). This evidence may be critical for the success of amyloid 
therapeutics as an approach for AD targeting.  
In what concerns to the APOE related treatment it is still to answer the question of 
whether the presence of allele 4 is a risk factor due to increased toxic properties 
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relative to the allele 3, or if it has lost the beneficial function of allele 3 against A 
deposition as Fagan et al., 2002 supports. 
 
1.2.2.2 Tau pathology approaches 
The two main treatment strategies concerning tau pathology consist on the inhibition of 
tau aggregation and blockade of tau hyperphosphorylation (Schneider et al., 2008).  
Inhibiting tau aggregation, not only avoids the formation of toxic neurofibrillary tangles 
but also the detrimental activity of tau aggregates (Bulic et al., 2009). This approach is 
however quite challenging. Not only the potential inhibitor must specifically disrupt 
protein-protein interactions of tau aggregates, it also has to be able to cross the BBB 
(Bulic et al., 2009). Only methylthioninium chloride is being studied in Phase II trials, 
after being reported to dissolve tau filaments and to prevent tau aggregation in cell 
models. Preliminary data show evidence, that methylthioninium chloride is capable of 
arresting the disease progression (Wischik et al., 2008). 
Blocking tau hyperphosphorylation can turn to be an even higher challenge. Not only 
it’s not yet known how critical hyperphosphorylation is to tau pathology, a potential 
pathogenic kinase wasn’t yet consensually identified. As both these facts weren’t 
enough, there is even a last big issue, consisting on the development of a safety small 
molecule kinase inhibitor suitable for chronic administration. Safety issues and side 
effects related to chronic inhibition are of major concern, as all marketed kinase 
inhibitor drugs in USA and Europe are used for cancer therapy (Citron, 2010).  
 
1.2.2.3 Anti-inflammatory approaches 
Although some mechanistic uncertainty flies above the inflammation role in AD, some 
evidences place inflammation as a promissory potential for AD disease. For instance the 
use of anti-inflammatory drugs in in vivo studies showed suppression of amyloid plaque 
pathology and A levels, reducing concomitantly pro-inflammatory mediators, reactive 
astrocytes and microglia activation (Lim et al., 2000; Townsend and Pratico, 2005). 
Epidemiological studies with chronic intake of non-steroidal anti-inflammatory drugs 
(NSAIDs) showed more than 50% of risk decrease for AD development (McGeer et al., 
1996). More interesting was the fact that certain NSAIDs showed to modulate -
secretase in such a way that A is reduced and a smaller A42 isoform, less prone to 
aggregate, is increased (Jarrett et al., 1993). In this case, Notch cleavage was not 
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blocked, in opposition to what characterizes some -secretase inhibitors (Weggen et al., 
2001). Other studies proved that the reduction of A wasn’t mediated by COX 
inhibition, or other common targets of NSAIDs, a direct interaction occurred between 
NSAIDs and -secretase or its substrate instead (Leuchtenberger et al., 2006; Kukar et 
al., 2008).  
Inflammation response, while a consequence of oxidative stress, turns antioxidant 
therapy into a powerful tool to prevent not only oxidative stress but also the consecutive 
inflammation response in an upward perspective. Antioxidant strategies may be divided 
into three categories, including: free radical scavengers; preventive antioxidants, which 
include metal chelators, antioxidant enzymes such as GPx and SOD; and de novo and 
repair enzymes such as lipases, proteases and DNA repair enzymes (Nunomura et al., 
2006). A group of nonspecific antioxidants also do exist, including: melatonin (Feng et 
al., 2006), omega-3 polyunsaturated fatty acid (Nunomura et al., 2006), curcumin 
(Yang et al., 2005), ubiquinone (Beal et al., 2004) and α-lipoic acid (Quinn et al., 
2007). 
Some epidemiologic reports have shown that the consumption of high amounts of fruits 
and vegetables, as well as vitamin supplements, lowers AD rates (Fusco et al., 2007). S-
adenosyl methionine is an antioxidant compound found in apple, which was reported to 
be beneficial to improve neuropathological features of AD in mice models (Chan and 
Shea et al., 2006). Other dietary compounds also showed interesting anti-AD activities, 
including: caffeine (Arendash et al., 2006), epigallocatechin-gallate esters from green 
tea (Rezai-Zadeh et al., 2005) and red wine (Wang et al., 2006a). The curry spice, 
curcumin, was found to facilitate disaggregation and reduction of A in AD associated 
neuropathology (Yang et al., 2005). Among the antioxidant compounds most studied in 
order to target AD is Vitamin E. Vitamin E has proved to decrease lipid peroxidation 
susceptibility by 60% in AD patients (Veinbergs et al., 2000). Clinical studies, 
concerning cognitive disorders and AD were developed. While some clinical trials show 
positive effects against cognitive disorders such as: Honolulu-Asia Aging study (3,385 
men) (Masaki et al., 2000); Chicago Health and Aging Project (815 subjects) and 
Nurses’ Health Study (14,986 women) (Grodstein et al., 2003); other studies showed 
negative results that include: Honolulu-Asia Aging study (2459 men) (Peyser et al., 
1995; Luchsinger et al., 2003; Laurin et al., 2004), Washington Heights Study (980 
subjects) and Cache Country Study (4740 subjects) (Zandi et al., 2004). So, although 
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vitamin E has been pointed out to be beneficial against AD, taking into account the 
clinical trials results, its activity against AD is not conclusive. In order to fully 
understand the potential benefits of vitamin E other clinical trials are underway, either 
alone or in combination with several compounds including: memantine, selenium, α-
lipoic acid, vitamin C, coenzyme Q, curcumin, melatonin and lutein (Kamat et al., 
2008). Clioquinol is a metal chelator, included in the preventive antioxidants category, 
which is in Phase II trials for AD (Lannfelt et al., 2008).  
Much like the difficulty found to describe the inflammation mechanism underlying AD 
it is also hard to identify the exact mechanism of action of antioxidants against AD. 
Some agents exert other activities beyond antioxidant functions (Karmat et al., 2008). 
Curcumin for instance, besides its antioxidant activity, has anti-inflammatory effects 
inhibiting both cyclooxygenase and lipoxygenase (Rao, 2007), and also inhibits amyloid 
aggregation (Yang et al., 2005) 
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1.3 Flavones – potential therapeutic drugs against AD 
 
The treatment of AD using flavones, focus on targeting the inflammation process that is 
behind the disease progression. This anti-inflammatory therapeutic approach is based on 
their action to prevent oxidative stress and consequent inflammation, acting as 
antioxidants through free radical scavenging. 
Flavonoids belong to the wide group of polyphenolic compounds and consist on one of 
the largest groups within the known natural products, both in quantity and quality 
(Havsteen, 2002). Flavones are a very large sub-group within the flavonoids to whom 
much attention has been dropped, in order to find compounds of potential 
pharmacological use. As part of flavonoids group, flavones share with them common 
biosynthetic routes, presence in certain plant organs as well as pharmacological 
activities, based on similar mechanisms of action.  
 
1.3.1 Chemical classification 
The biosynthetic process starts by removing the amino group of phenylalanine, leading 
to phenylpyruvate. The thiamine pyrophosphate, from the pyruvate dehydrogenase 
complex, operates the oxidative decarboxylation of two molecules of phenylpyruvic 
acid, producing two active aldehydes molecules, which together with a C1-fragment (-
CHO) in an oxidative step drives to the nucleus of phenyl-γ-pyrone, a synonym of 
chromen-4-one (Figure 1.5) (Havsteen, 2002). Individual flavonoids are then produced 
through multiple hydroxylation in different positions, oxidation/reduction steps and 
derivatization of the hydroxyl groups with methyl groups (Gauthier et al., 1998), 
carbohydrates (Matern et al., 1981) and isoprenoids. Theoretically, considering a 
possible combination of all these sources of variability, more than 2.106 different 
flavonoid compounds can occur (Havsteen et al., 2002). 
 
 
 
 
 
 
 
Figure 1.5 Molecular structures of: phenylalanine amino acid (1.1) and chromen-4-one (1.2). 
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Flavones are derived from the skeleton structure of 2-phenylchromen-4-one (Figure 
1.6), a derivative of the basic nucleus, chromen-4-one (Figure 1.5). Many compounds 
belong to the group of flavones that includes the flavonols: rutin, isoquercetin and 
quercetin as well as the flavanones: naringin, prunin, and naringenin, which are object 
of study within this thesis (Figure 1.7). Concerning these flavones, naringin and rutin 
are two rutinosides that are derived from the disaccharide rutinose (rhamnose + glucose) 
and the respectively aglycones naringenin and quercetin. Prunin and isoquercetin are 
glucosides from both naringenin and quercetin, respectively. In addition, although both 
flavanones and flavonols share the same basic nucleus of flavones, flavanones are 
derived from the 2,3-dihydro-2-phenylchromen-4-one nucleus (Figure 1.6), while 
flavonols are derived from the 3-hydroxy-2-phenylchromen-4-one nucleus (Figure 1.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Molecular structures of 2- phenylchromen-4-one (1.3), 2,3-dihydro-2-phenylchromen-4-one 
(1.4) and 3-hydroxy-2-phenylchromen-4-one (1.5). 
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1.3.2 Pharmacological activity 
A vast number of pharmacological activities are shared by flavonoids. Free-radical 
scavenging, antioxidant and anti-inflammatory activities are the most common, but 
plenty other activities are described, including: anti-tumour, atherosclerosis preventive 
activity, through the protection of human low-density lipoprotein (LDL) against 
oxidation ; hypocholesterolemic activity, through the inhibition of 3-hydroxy-3-methyl-
glutaryl-coenzyme A reductase (HMG-CoA reductase); antithrombotic activity, by 
preventing platelet aggregation; anti-allergic activity; inhibition or killing of many 
bacterial strains; inhibition of viral enzymes; destruction of some pathogenic protozoans 
and even stimulation of some hormones and neurotransmitters (Havsteen, 2002). 
Antioxidant properties relay on the tendency of flavonoids to oxidize from phenols to 
quinones (Havsteen, 2002). Although intimately connected, free-radical scavenging and 
antioxidant properties are distinct, once the first depends on the presence of an unpaired 
electron and the last one depends on the oxidation-reduction potential (Marinov and 
Evtodienko, 1994). Oxidation is however, the basis of the mechanism underlying free-
radical scavenging property. Figure 1.8 shows the general mechanism of flavonoids 
Figure 1.7. Molecular structures of the flavanones: naringin (1.6), prunin (1.7) and naringenin (1.8) and 
the flavonols: rutin (1.9), isoquercetin (1.10) and quercetin (1.11). 
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oxidation, consisting on a first irreversible oxidation step of flavonoids into a 
hydroquinone. The hydroquinone formed is further oxidised into a quinone, producing a 
semiquinone radical intermediate, through a reversible reaction. Ultimately, the quinone 
polymerises into an insoluble substance, which is eliminated afterwards. Figure 1.9 
exemplifies a more complex free-radical mechanism of a compound derived from the 3-
hydroxy-2-phenylchromen-4-one nucleus, from which the flavonols rutin, isoquercetin 
and quercetin are also derived (Havsteen, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OH
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O  
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Figure 1.8 Radical mechanism of hydroquinone (1.12) oxidation through a semiquinone radical 
intermediate (1.13) to the quinine, 1,4-benzoquinone (1.14) (adapted from Havsteen, 2002). 
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Figure 1.9 Radical mechanism of a compound derived from the 3-hydroxy-2-phenylchromen-4-one 
nucleus (adapted from Havsteen, 2002). 
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Several other pharmacological activities may be found in the literature, for the studying 
compounds (Figure 1.7). 
 
1.3.2.1 Naringin 
Naringin is reported to possess in vitro free-radical scavenging activity (Rajadurai et al., 
2007) and in vivo antioxidant (Jeon et al., 2001; Rajadurai et al., 2007) and anti-
inflammatory activity (Amaro et al., 2009). Naringin also shows atherosclerosis 
preventive activity (Lee et al., 2008; Lee et al., 2009), both by hypocholesterolemic 
(Jung et al., 2003; Kim et al., 2006) and antihyperlipidemic activities (Jung et al., 2006; 
Kim et al., 2006; Morikawa et al., 2008). Concerning cancer therapy, naringin can 
potentially be used as antineoplastic agent (Ofer et al., 2005; Schindler et al., 2006; Ali 
et al., 2009; Miller et al., 2008) as well as chemotherapy adjuvant (Jagetia et al., 2003; 
Cariño-Cortés et al., 2010). Diabetes is also a potential field of application, due to its 
hypoglycaemic activity, by increasing hepatic glycolysis and glycogen concentration 
and/or by lowering hepatic gluconeogenesis (Jung et al., 2004; Jung et al., 2006; 
Punithavathi et al., 2008). Other potential target diseases are: osteoporosis (Wong et al., 
2006; Wu et al., 2008; Pang et al., 2010), cerebral ischemia (Gaur et al., 2009), septic 
shock (Kanno et al., 2006) and even anxiety (Fernández et al., 2006). 

1.3.2.2 Prunin 
Concerning prunin, studies report hypocholesterolemic activity and hypoglycaemic 
activity (Choi et al., 1991a, b), antiviral activity (Kaul et al., 1985), antithrombotic 
activity (Itoh et al., 2009), activity as chemotherapy adjuvant (Han et al., 2008). 
 
1.3.2.3 Naringenin 
Naringenin exhibits a higher antioxidant capacity and both hydroxyl and superoxide 
radical scavenger efficiency, than naringin (Cavia-Saiz et al., 2010). Besides anti-
inflammatory activity (Ribeiro et al., 2008b; Amaro et al., 2009; Vafeiadou et al., 
2009), it also has immunomodulatory activity acting against asthma. The 
hypocholesterolemic activity shown in vivo (Jeon et al., 2007) is helpful against 
atherosclerosis disease, while hypoglycaemic activity (Andrade and Burgess, 2007) may 
be useful for diabetes. Concerning cancer, naringenin can be used in adjuvant 
chemotherapy (Fang et al., 2010), or as potential antineoplastic agent in oral 
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carcinogenesis (Miller et al., 2008), in endogenous hormone 17-estradiol-dependent 
cancers (Bulzomi et al., 2010) and malignant melanoma (Lentini et al., 2007). 
Osteoporosis (La et al., 2009) and hepatitis C infection (Nahmias et al., 2008) are other 
potential target diseases. 
 
1.3.2.4 Rutin 
Rutin exhibits free-radical scavenging (Sun et al., 2007) and antioxidant activities 
(Matsunami et al., 2006) as well as antineoplastic activity, where it may leads to the 
inhibition of breast cancer tumour proliferation through the inhibition of vascular 
endothelial growth factor (VEGF) (Schindler et al., 2006). 
 
1.3.2.5 Isoquercetin 
Isoquercetin shows free-radical scavenging activity (Matsunami et al., 2006), higher 
antioxidant activity than rutin (Sun et al., 2007; Soundararajan et al., 2008) and in vivo 
anti-inflammatory activity (Rogerio et al., 2007). It may be highly useful in the 
treatment of asthma (Fernandez et al., 2005; Rogerio et al., 2007), diabetes (Paulo et al., 
2008) and obesity through the inhibition of the glucose transport across intestinal cells, 
via glucose transporter-2 (GLUT2), while rutin does not (Kwon et al., 2007). 
 
1.3.2.6 Quercetin 
Quercetin shows free-radical scavenging activity, however may show a deleterious pro-
oxidant instead of antioxidant activity in high concentrations (Johnson and Loo, 2000). 
As isoquercetin, it exhibits potential activity against obesity through the inhibition of 
glucose and fructose transport by GLUT2 (Kwon et al., 2007). Concerning this property 
it is running a phase II clinical trial, started at July 2003, for the therapeutic use of 
quercetin with the following title: “Investigating the Use of Quercetin on Glucose 
Absorption in Obesity, and Obesity With Type 2 Diabetes” 
(http://clinicaltrials.gov/ct2/show/NCT00065676, 09/12/2010). Quercetin is also active 
against cancer, as a tyrosine kinase inhibitor (Ferry et al., 1996), asthma and 
hypertension (Emura et al., 2007). 
 
Free-radical scavenging is a common property within these flavones, which makes them 
potential useful against AD, by stopping the mechanism of redox imbalance, oxidative 
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stress and chronic inflammation. Naringin and naringenin are also reported to inhibit 
NF-B which is responsible for triggering pro-inflammatory molecules (Kanno et al., 
2006; Shi et al., 2009). Naringenin is seen as a potential chemopreventive agent against 
AD, by reducing the micromolecular A-induced oxidative cell stress (Heo et al., 
2004). In vitro studies showed that quercetin inhibits A aggregation and destabilizes 
pre-formed A fibrils (Ono et al., 2003), showing also protective effects of neuronal 
cells from oxidative stress-induced by A peptide (Ansari et al., 2009) and even more 
interestingly, inhibiting -secretase (Shimmyo et al., 2008). Finally, Tedechi et al. 
(2010) found a possible molecular basis to explain the neuroprotective effect of 
flavonoids, including: rutin, quercetin, naringin and naringenin, consisting on a 
flavonoid-dependent rigidifying effect on the cellular membrane that hinders the 
permeabilization of A into the bilayer, protecting the cell death induced by aggregated 
A.  
The apparent low toxicity of flavonoids turns them very promising for radical 
scavenging in biological systems, being also included in the normal human nutrition. 
Quercetin, for instance, had however been pointed out as being genotoxic. Several in 
vitro studies, including bacterial test systems and also eukaryotic cells support this idea, 
but conversely, studies examining genotoxic endpoints in mice and rats showed 
consistently that quercetin does not exert mutagenic or genotoxic properties in vivo 
(Utesh et al., 2008). 
 
1.3.3 Antioxidant therapy drawbacks in AD treatment 
Some drawbacks concerning antioxidant therapy to treat AD have occurred. Several 
antioxidants including vitamin C and E, only offer symptomatic treatment without 
changing the neurodegenerative and pathological course of the disease (Kamat et al., 
2008). In order to find explanations to these drawbacks, several hypothesis come out, 
including: possible insufficient exposure time; eventual need of combined effects 
between antioxidants in order to achieve the desired effect; difficult translation of 
animal results to humans; the relationship between pro-oxidant and oxidant factor; 
clinical trial addressed at a very late disease state; therapeutic window issues and even 
inappropriate animal model, which is not homologous to human AD (Fusco et al., 2007; 
Kamat et al., 2008). Moreover drug pharmacokinetics must have played a decisive role. 
This lack of antioxidant therapy efficacy against AD may be related with the 
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distribution into the brain through the BBB or even earlier, during absorption. 
Concerning vitamin E, it was found to have a low brain bioavailability (Sung et al., 
2003). In the case of curcumin for instance, even 3 – 8 g/day was not enough to achieve 
therapeutic circulating levels in humans (Hsu and Cheng, 2007). According to these 
statements one major issue concerning the use of flavones to target AD must be the drug 
passage across the BBB, which also occurs in the cases of -secretase inhibitors and tau 
aggregation inhibitors. 
Not only AD, but targeting any disease within the central nervous system (CNS) is 
challenging due to the BBB, which is formed by a layer of endothelial cells connected 
with tight junctions, expressing several efflux transporters and drug-metabolizing 
enzymes (Pardridge, 1997; Tamai and Tsuji, 2000). Both brain tissue binding and 
permeability of BBB play an important role on the disposition of drugs to target CNS 
(Summerfield et al., 2007). The influence of brain tissue binding is higher in the case of 
lipophilic drugs, where it may act as sink to help maintaining the diffusion gradient 
across the BBB (Summerfield et al., 2007). On the other hand, drug permeation across 
BBB is dependent not only on the physicochemical properties of the molecule, but also 
on the potential to interact with transport systems at the BBB (Summerfield et al., 
2007). Concerning these physicochemical properties, it has been suggested that 300 to 
400 Da is the ideal molecular mass for passage though BBB (Fischer et al., 1998); with 
a low polar surface area (Clark, 1999) and low hydrogen-bonding ability (Young et al., 
1988). The interaction with transport systems at the BBB may turn to be decisive not 
only for the entrance into the CNS, through receptors recognition, but also for its exit 
through BBB efflux pumps (Summerfield et al., 2006). 
 
1.3.4 The role of the glycosidic residue 
Flavonoids, depending on their content of glycosides, isoprenoids and aliphatic ethers, 
can acquire almost any polarity (Havsteen, 2002). Particularly, the glycosidic residue of 
certain compounds influences not only its pharmacokinetics but also its 
pharmacodynamics (Kren and Martinkova, 2001). From a pharmacokinetic point of 
view, the glycosidic residue may play very distinct roles, allowing or restricting the 
passage through the cell membrane. The glycosidic residue is responsible for turning the 
compound more hydrophilic, which reduces the solubility within the cell membrane and 
consequently makes it harder to get into the cell. On other side, a possible recognition of 
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the glycosidic residue by a certain cell membrane receptor, such as the glucose 
transporter, may turn it easier to get into the cell. Concerning pharmacodynamics, the 
biological activity of compound with or without the glycosidic residue can differ 
substantially, depending on the global molecular structure (Kren and Martinkova, 
2001). These facts are undoubtedly interesting in order to find a molecule with the 
proper polarity to target CNS or eventually being recognized by certain receptors of the 
BBB, also taking into account the activity against AD. 
In line with the above statements and comparing the respective rutinosides, glucosides 
and aglycones (Figure 1.7) may perform better than rutinosides in order to cross the 
BBB. Flavone aglycones are more hydrophobic than the respective rutinosides, which 
makes them more suitable for passive diffusion across the BBB, due to their lower polar 
surface area (Clark, 1999). For instance, Youdim et al. (2004) showed that the 
aglycone, quercetin can pass through the BBB. On the other hand, flavone glucosides 
have an exposed glucose moiety, while rutinosides have a rhamnose. The glucose 
moiety of glucosides may be recognized by specific receptors, including glucose 
receptors and being transported into the brain (Summerfield et al., 2006). Some studies 
show that the sodium dependent glucose transporter (SLGT1) may actively transport the 
glucoside isoquercetin (Hollman et al., 1999; Walgren et al., 2000; Wolffram et al., 
2002; Walle and Walle, 2003). SLGT1 is not only present in the BBB, but also in 
intestine, kidney and endothelium. 
 
1.3.5 Enzymatic deglycosylation of flavone glycosides 
Although all compounds shown on Figure 1.7 occur in nature, the glucosides: prunin 
and isoquercetin and the aglycones: naringenin and quercetin are scarcer than the 
rutinosides: naringin and rutin. Naringin occurs abundantly in the internal epidermis of 
citrus fruits, mostly in orange and grapefruit and is responsible for a bitter flavour 
(Caccamese et al., 2003). Rutin also occurs in citrus fruits (Wood, 2005) and some 
plants such as: Fagopyrum esculentum Moench (Kreft et al., 1999), Asparagus 
officinalis L. (Wang et al., 2003) and Dimorphandra mollis Benth (Féres et al., 2006). 
The scarcity of prunin, isoquercetin, naringenin and quercetin makes them very 
expensive to isolate, especially in the case of the glucosides prunin and isoquercetin. 
Additionally, flavonoid family compounds are very difficult to separate due to its 
structural resemblance and easy decomposition (Havsteen, 2002). As consequence, the 
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market price of isoquercetin is very much higher than rutin, the rutinoside that may 
generate isoquercetin through the hydrolysis of a rhamnose molecule. The same 
happens also in the case of prunin when comparing with naringin. 
The enzymatic deglycosylation of both naringin and rutin comes out as a suitable 
process in order to produce the respective glucosides and aglycones (Figure 1.10), due 
to the specificity and mild conditions of enzymatic reactions, avoiding additional 
purification steps and preserving unstable products. Hydrolases are the enzymes that 
catalyze hydrolytic reactions, namely the hydrolysis of a glycosidic bond (Metzler, 
2001; Buckow, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.5.1 Naringinase 
Naringinase is a hydrolase consisting on a multi-enzyme complex obtained from 
Penicillium sp. or Aspergillus sp. (Yalim et al., 2004), which provides both -L-
rhamnosidase (EC 3.2.1.40) and -D-glucosidase (EC 3.2.1.21) activities. In this work, 
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Figure 1.10 Scheme of the production of flavonoid glucosides and aglycones starting form its rutinosides 
precursores using na enzymatic aproach (-L-rhamnosidase and -D-glucosidase). 
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it is used a naringinase from Penicillium decumbens. Mamma et al., 2005 purified the 
naringinase from Penicillium decumbens and identified a -L-rhamnosidase with a 
molecular mass of 58 kDa and a -D-glucosidase assembled in a tetramer with 
monomers of 120 kDa. Naringinase is a very attractive hydrolase in the commercial 
point of view and possesses several applications within the pharmaceutical and food 
industry (Puri and Banarjee, 2000). Among these applications, naringinase can be used 
to hydrolyze both naringin and rutin into prunin and isoquercetin, respectively, with α-
L-rhamnosidase activity and consecutively to the aglycones, naringenin and quercetin, 
respectively, by means of β-D-glucosidase activity (Figure 1.10). A rhamnose is 
released in the first step and a glucose molecule in the second one. 
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1.4 Enzymatic biocatalysis 
 
Enzymes are catalysts used to accelerate chemical reactions, which in other way would 
occur in a very slow way. They cause the decrease of the activation energy, which 
favors the reaction occurrence; and are not destroyed by the reaction and don’t shift the 
chemical equilibrium either. Their specificity for a certain type of reactions and 
substrates makes them unique when comparing with a chemical catalyst. In addition, 
their lability against temperature, pH and other denaturing agents is related with their 
own nature while proteins (Metzler, 2001). 
 
1.4.1 Structure of enzymes 
The functional properties of enzymes are determined by their tridimensional structure. 
Their structure folds spontaneously from a unique amino acid sequence, a polypeptide 
chain, under physiological conditions. Usually there is only one conformation where the 
enzyme remains active, which is called the native conformation. Enzymes possess a 
primary, secondary, tertiary and also a quaternary structure in the case of the association 
of two or more polypeptide chains (Figure 1.11) (Lehninger et al., 2005). 
 
 
 
 
 
 
 
 
 
 
The primary structure consists on aminoacids linked through peptide bonds. The 
aminoacids sequence on the primary structure is responsible for the chemical and 
biological properties of the enzyme, defining the next levels of structural organization. 
The secondary structure defines the spatial arrangement of the polypeptide chain. It is 
established through hydrogen bridges between the carbonyl and the amine group of 
another amino acid. Hydrogen bridges are an intermediate type of interactions, between 
Primary 
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Figure 1.11 Tridimensional structures of proteins (adapted from Lehninger et al., 2005). 
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covalent bond and electrostatic bonds. This kind of interaction plays a decisive role in 
order support the secondary structure (Lehninger et al., 2005; Scharnagl et al., 2005). 
The tertiary structure is the product of structural arrangements of the polypeptide chain 
at the secondary structure and the interactions between the lateral chains of 
geometrically and spatial closed amino acids. The structure and stability of the tertiary 
structure of the enzymes is dependent on several interactions, including disulfide 
bridges, electrostatic interactions, van der Walls forces, hydrogen bridges and 
hydrophobic interactions. Disulfide bridges are established between cysteine amino 
acids, and as covalent bonds are extremely important to support the tertiary structure. 
Electrostatic interactions are settled by close charges present in the lateral chain of 
certain amino acids, but their contribution to the enzyme structure is low. In the case of 
Van der Walls forces, an electrostatic type of interaction established between non-
charged polar groups, despite the low energy of these interactions, their importance for 
the enzyme structure is high due to the high number of these interactions. Hydrophobic 
interactions are established between close hydrophobic residues and play an important 
role whenever the enzyme is solubilized in a polar solvent. The hydrophobic groups 
have tendency to hide inside the enzyme, interacting with each other and repelling the 
solvent (Metzler, 2001; Lehninger et al., 2005). 
Finally, the quaternary structure consists on the spatial arrangement of two or more 
subunits of the enzyme. This structure is only present in multimeric enzymes, which 
consist of two or more associated polypeptide chains (Scharnagl et al., 2005). 
 
1.3.2 Enzymatic kinetics 
The reaction rates of enzymatic catalyzed reactions are, generally, proportional to the 
first potential of the enzyme concentration, while the dependence with the substrate 
concentration is not that linear. A reversible complex formation between enzyme and 
substrate has been shown to be the first step in enzymatic catalysis. This enzyme-
substrate complex (ES) can either lead to the formation of products and free enzyme or 
break up into substrate and free enzyme again. In order to describe this system 
Michaelis and Menten (1913) proposed the following scheme: 
 
 
 
E + S               ES               E + P 
k1                kcat 
k1               
  CHAPTER 1 
31 
where E is the free enzyme, S is the substrate and k1, k1 and kcat are rate constants. The 
following approximations are also considered (Metzler, 2001):  
a) the reversible reaction for the formation of the enzyme-substrate complex starting 
from free enzyme and product can be omitted during the study of the initial rate 
period, when the product concentration is low; 
b) the combination of free enzyme and substrate leads instantaneously to the enzyme-
substrate complex. This step is fast and reversible; 
c) the substrate concentration is in large excess comparing with enzyme 
concentration, where for a certain short time during rate measurement the 
concentration of the enzyme-substrate complex is constant (steady-state 
approximation); 
d) the conversion of the enzyme-substrate complex into product and free enzyme is 
slow and doesn’t change the equilibrium between enzyme plus substrate and the 
enzyme-substrate complex (kcat « k1). 
 
Michaelis and Menten (1913), proposed the following equation (Equation 1.1): 
 
 
 
where v is the initial reaction rate, vmax is the maximum initial reaction rate and KM is 
the Michaelis-Menten constant. This model can be reduced to a first order equation 
relative to the substrate concentration, whenever de substrate concentration is much 
smaller than the Michaelis-Menten constant ([S] « KM), (Equation 1.2): 
 
 
 
On the other hand, when the substrate concentration is much higher than the Michaelis-
Menten constant ([S] » KM), this model is reduced to a zero order equation relative to 
the substrate concentration (Equation 1.3). Under these conditions all the enzyme is 
saturated and converted into enzyme-substrate complex. vmax is a numerical constant 
that represents the maximum velocity obtained when E is completely converted to ES 
(Michaelis and Menten, 1931). 
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1.4.2.1 Kinetic parameters 
The Michaelis-Menten kinetics is also referred as a hyperbolic kinetics because a plot of 
v against [S] has the shape of a rectangular hyperbola through the origin, having two 
asymptotes (v = vmax and [S] = KM). According to this model the initial reaction rate 
tends asymptotically to the maximum reaction rate. In these conditions neither the KM 
nor the vmax can be determined reliably. In order to determine these kinetic parameters is 
useful to linearize the Michaelis-Menten equation using the Lineweaver-Burk 
representation (double reciprocal plot) (Equation 1.4), which is obtained from the direct 
inversion of the Michaelis-Equation terms. Through the representation of 1/v against 
1/[S] it is obtained a straight line with a slope corresponding to KM.vmax1 and an 
ordinate origin equal to vmax1. Following this, the experimental kinetic parameters can 
be determined through linear regression fit of the obtained experimental data 
(Lineweaver and Burk, 1934). 
 
 
 
Despite the generalized use of the double reciprocal plot, their estimates are both biased 
and imprecise (Ritchie and Prvan, 1996). This method gives excessive emphasis on 
enzyme rates at low substrate concentration, where also the relative errors of the 
experimental data are higher. In this thesis, to avoid these limitations, the kinetic 
parameters were determined by non-linear least-squares regression, using the Michaelis-
Menten equation. The parameters obtained by the double reciprocal plot were used only 
as initial values of the non-linear regression parameters. 
 
Michaelis-Menten constant 
In many cases kcat is much smaller than k1, so in these cases the Michaelis-Menten 
constant equals the dissociation constant for the breakdown of the enzyme-substrate 
complex into free enzyme and substrate. Thus, Michaelis-Menten expresses an inverse 
relationship to the strength of substrate binding to the enzyme. It is a characteristic of 
each enzyme-substrate system at a certain temperature and pH and measures the affinity 
of the enzyme in relation to the substrate. A small Michaelis-Menten constant indicates 
high affinity for the substrate and in this case the maximum initial reaction rate will be 
approached more quickly. In addition, Michaelis-Menten constant represents the 
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substrate concentration at which the reaction rate reaches half of its maximum value 
(Metzler, 2001). 
 
Catalytic constant 
The catalytic constant (kcat) is a kinetic constant of first order for the conversion of the 
enzyme-substrate complex into product plus free enzyme. This constant is related with 
the reaction properties of the enzyme-substrate, enzyme-intermedium compound and 
enzyme-product complexes and can be determined according to Equation 1.5: 
 
 
 
where Et is the total enzyme amount (Equation 1.6): 
 
 
Specificity constant 
The enzyme specificity is observed not only in binding but also in the rate that converts 
the enzyme-substrate complex into products, following this, the kcat.KM1 ratio shows up 
as a specificity constant besides being an apparent kinetic constant of second order. This 
ratio expresses the specificity for substrates that are in competition for the enzyme 
active site (Metzler, 2001). 
 
1.4.3 Thermodynamic parameters 
The transition state theory (TST) was developed through Pelzer and Wigner (1932), 
Eyring (1935), Wynne-Jones and Eyring (1935), and Evans and Polanyi (1935, 1937) 
work. This theory allows the description of a chemical reaction concerning its physical 
behavior, correlating both kinetic and thermodynamic parameters. It was primarily used 
as a qualitative basis to achieve mechanistic information on chemical reactions (Truhlar 
et al., 1996). Accurate experimental data on rate constants can be used to successful 
calculate thermodynamic functions of activation (TFA) and show some insights on 
catalysis, at a macroscopic level. TST supports its mathematical formulation on the 
following assumptions (Ritchie, 1990): 
(1.5)  t
max
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a) Within each reactional mechanism step of a certain chemical reaction, the 
transition of reactants into products, or reverse, follows an intermediate state, 
called the transition state. 
b) The Quasi-Equilibrium assumption states the existence of quasi-equilibrium 
between the reactants and the activated complexes, which precedes the 
thermodynamic equilibrium between reactants and products, according to the 
following scheme: 
 
 
where K≠ is the equilibrium constant of the quasi-equilibrium between 
reactants and the activated complex. 
c) The kinetic theory calculates the conversion rate of activated complexes into 
products, which is a directly proportional to the concentration of the 
configurations present within the transition state multiplied by the frequency 
(kBT/h); where kB is the Boltzmann constant, h is the Planck constant and T is the 
absolute temperature. 
Assuming the existence of the quasi-equilibrium, which is governed by an equilibrium 
constant it’s possible to define thermodynamic functions in a similar way to the 
functions determined from usual equilibrium constants. Following this and according to 
the formulated assumptions, it is possible to establish the fundamental equation of TST 
(Equation 1.7): 
 
 
 
where the standard reaction rate constant (kº) is related to the change of the standard 
Gibbs free energy of activation (≠Gº); R is the gas constant. 
By other way, through Equation 1.8: 
 
 
where ≠Hº and ≠Sº represent, respectively, the change of the standard activation 
enthalpy and the change of the standard activation entropy, between the initial and the 
transition states, Equation 1.7 can adopt another look, leading to Equation 1.9: 
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Considering both Equations 1.7 and 1.9, it is possible to determine TFA, through the 
derivatization of kº in respect to independent variables. TFA reflect physical interactions 
and represent the properties differences between the initial state and the structure of the 
transition state. Following this, they have been quite useful to analyse the structure and 
mechanism of reactional systems. 
 
1.4.3.1 Temperature dependence at constant pressure 
The effect of temperature gives information concerning energy aspects of the reactional 
process. The thermodynamic activation functions at constant pressure are obtained from 
their isobaric variation with temperature: 
 
Standard Gibbs energy of activation 
The reason why enzymes accelerate reactions is because they reduce the standard Gibbs 
energy of activation, when compared with non-catalyzed reactions, by stabilizing the 
transition state. The standard Gibbs energy of activation (Equation 1.10) is a function of 
rigorous determination that gives similar information to the reaction rate coefficient. 
Due to the enthalpy-entropy compensation, this parameter is low sensitive to changes 
between initial and transition states (Segurado, 1989; Pinheiro, 1999). For instance an 
effect that lowers enthalpy, due to a higher linkage degree between two molecules also 
lowers entropy, due to movement freedom restriction of those two molecules (Boots and 
Bokx, 1989). Nevertheless, a decrease of the standard Gibbs energy of activation of a 
certain reaction caused by the presence of an enzyme may be driven by a decrease of the 
standard activation enthalpy and/or by an increase of the standard activation entropy 
(Cabral, 2003). 
 
 
 
Standard activation enthalpy 
The standard activation enthalpy (Equation 1.11) is a function that gives information 
concerning the intrinsic energy associated with linkages formation and rupture within 
the transition state, as well as the intrinsic energy associated with solvation of both 
initial and transition states (Segurado, 1989). The enzyme shall provide a structure with 
ideally positioned groups in order to interact with substrate in the activated complex. 


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Standard activation entropy 
The standard activation entropy (Equation 1.12) is a function that gives information 
concerning the molecular structure of reactional species, activation complex and 
mechanism. It includes contributions inherent to the freedom of translation, vibration 
and rotation movements; entropic electrostatic factors, linked to the electrostriction 
effect; and changes related to solvation entropy, between the initial and the transition 
states. Negative values of ∆≠Sº mean a more organized transition state than the initial 
state (Segurado, 1989; Pinheiro, 1999). In the case of enzymatic catalyzed reactions the 
substrate binds to the enzyme to form the activated complex and is maintained in a 
favorable geometry for the reaction to proceed. On the other side, in the case of non-
catalyzed reactions the substrate needs to find an eventual other substrate in order to 
form the activated complex, which involves a high entropy loss. This proximity effect 
caused by the enzyme turns activation entropy more favorable (Cabral, 2003). 
 
 
 
 
TFA at constant pressure can be determined after choosing the mathematical model that 
best fits to the experimental data of k against T. Several mathematical models have been 
proposed to describe the dependency of k with temperature, but only the two simpler 
models were studied: 
 
Arrhenius model 
It is a well known experimental fact that k is temperature dependent, and the empirical 
Arrhenius equation still constitutes the main mathematical relation used to describe it. 
This equation, a first order polynomial describing ln k as function of T1, can be written 
as Equation 1.13: 
 
 
 
(1.13) 
T
BAk ln 
PPP
T
T
k
RT
T
T
k
R
T
T
G
H
















































ln
1
ln
1
º
º 2 (1.11) 
(1.12) 
P
P
T
T
kT
R
k
hR
T
GS







































ln
lnºº
B
  CHAPTER 1 
37 
where A and B are empirical parameters related to TFA and temperature independent. 
With respect to Arrhenius model (Arrhenius, 1887), and considering both Equation 1.13 
and TST, ≠Hº and ≠Sº are determined, respectively, from the experimental kinetic 
data using Equations 1.14 and 1.15: 
 
 
 
 
Standard Gibbs energy of activation can be calculated directly from the k value through 
Equation 1.16. 
 
 
 
Wold and Ahlberg model 
In case of enzymatic biocatalysis, often is found that the former relation frequently does 
not fit satisfactorily to experimental data, probably because proteins are not rigid 
structures. A second order polynomial relation known as the Wold and Ahlberg 
equation (Equation 1.17) can be considered to determine TFA values; in this equation 
besides A and B, C is also an empirical parameter (Wold and Ahlberg, 1970). 
 
 
 
With respect to Wold and Ahlberg model (Wold and Ahlberg, 1970), and considering 
both Equation 1.17 and TST, ≠Hº and ≠Sº are determined, respectively, from the 
experimental kinetic data using Equations 1.18 and 1.19: 
 
 
 
 
 
 
Standard Gibbs energy of activation can be calculated from Equation 1.16. 
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1.4.3.2 Pressure dependence at constant temperature 
The effect of pressure gives information concerning volumetric aspects of the reactional 
process. The thermodynamic activation functions at constant temperature are obtained 
from their isothermal variation with pressure: 
 
Standard Gibbs energy of activation 
The standard Gibbs free energy of activation at constant temperature is determined in a 
direct way from the reaction rate values, from the experimental kinetic assays under 
pressure, according to Equation 1.10. Its meaning has already been discussed on 1.4.3.1. 
 
Standard activation volume  
The standard activation volume (≠V0) (Equation 1.20) is a function that measures the 
volume change between the activation complex and reactants (Van Eldik et al., 1989). It 
is a very important function in order to study the structure and properties of the 
transition state as well as the reaction mechanisms. ≠Vº shows a very discriminative 
character concerning the solvent involvement, even though is sensible to a less number 
of factors, when compared with ≠Sº. Pressure accelerates processes where the initial 
state occupies a larger volume than the transition state. The rate constant increases with 
pressure as long as the activation volume change is negative. 
 
 
 
Activation volume has been interpreted in a molecular way according to intrinsic and 
solvent contributions (Mozhaev et al., 1996). The intrinsic contributions depend on the 
molecular packing density and to the breaking or formation of covalent bonds. The 
volume change corresponding to covalent bond formation is around 10 mL mol1, 
while in the case of angles bond variation and packing density is practically null 
(Mozhaev et al., 1996). Following this, except in the cases of breaking or formation of 
covalent bonds, the solvent contribution is of most importance concerning volume 
change. The solvent contribution comes from weak interactions hydration, including: 
electrostatic interactions, hydrogen bonds and hydrophobic interactions. Concerning 
electrostatic interactions, the formation of ionic charges is associated with a volume 
decrease due to electrostriction effect, consisting on the compression of the dipoles 
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generated by water molecules surrounding the ion electric field. The hydrogen bonds 
are stabilized with pressure due to the lowering of the inter-atomic distance, although 
the volume change associated with hydrogen bridges is small. On other side the 
formation of hydrophobic interactions are associated with a volume increase, which 
turns its formation disfavoured with pressure (Mozhaev et al., 1996; Balny, 2004). 
 
Standard isothermal compression of activation 
The standard isothermal compression of activation (Equation 1.21) is an activation 
function that represents the dependence of the activation volume in respect to pressure 
(Viana and Reis, 1996). It measures the compressibility change between the activation 
complex and the reactants. Its magnitude depends on the physical and chemical 
properties of the solvent, particularly its action on the activation process (Segurado, 
1989). 
 
 
 
TFA at constant temperature can be determined after choosing the mathematical model 
that best fits to the experimental data k vs. P. Several mathematical models have been 
proposed to describe the dependency of k with P. As in the case of TFA at constant 
pressure, where the experimental data have an average accuracy, only the more 
simplistic models were studied. 
 
Burris and Laidler model 
The Burris and Laidler mathematical model (Equation 1.22) (Burris and Laidler, 1955) 
is the more simple dependence between ln k vs. P: 
 
 
 
where A and B are empirical parameters independent from pressure. This equation 
supports an independence of the activation volume in respect to pressure, leading to a 
null isothermal compression of activation. The change of the standard activation volume 
is determined through Equation 1.23. 
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Golinkin, Laidlaw and Hyne model 
The Golinkin, Laidlaw and Hyne mathematical model (Equation 1.24) (Golinkin et al., 
1966) describes a second order polynomial dependence between ln k vs. P: 
 
 
where besides A and B, C is an empirical parameter independent from pressure. ≠Vº 
can be calculated from the fitting of Equation 1.24 to experimental data and is given by 
Equation 1.25. In addition, this model implies a constant value for the standard 
isothermal compression of activation change, which is given by Equation 1.26. 
 
 
 
 
Generalized polynomial equations model 
The generalized polynomial equations model, suggested by Walling and Tanner (1963), 
make use of a potencies series in respect to pressure (Equation 1.27), to describe the 
dependence between ln k vs. P: 
 
 
where A0, A1, A2, A3 … An are empirical parameters independent from pressure. The 
essential empirical behaviour of this model, as well as Burris and Laidler model and 
Golinkin, Laidlaw and Hyne model, which are particular cases of this general 
polynomial equation doesn’t allow finding relevant conclusions. On other side, these 
models have a vast applicability once they don’t impose a certain reactional model 
(Segurado, 1989). ≠Vº can be calculated from Equation 1.28 and ≠º is given by 
Equation 1.29: 
 
 
 
 
Baliga and Whalley model 
Baliga and Whalley model is represented by Equation 1.30 (Baliga and Whalley, 1970): 
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According to this model, ≠Vº can be calculated from Equation 1.31 and ≠º is given 
by Equation 1.32 
 
 
 
 
 
Despite not being an activation function, the standard reaction volume is a very useful 
thermodynamic parameter, which is determined through an isothermal variation with 
pressure: 
 
Standard reaction volume 
The standard reaction volume (Vºreac) (Equation 1.33) is an important thermodynamic 
function to be determined whenever the effect of pressure is studied, giving information 
about volumetric changes between the reactants and products. Pressure favours 
processes where products occupy a smaller volume than reactants according to Le 
Chatelier principle. The reaction equilibrium constant (K) increases with pressure as 
long as the reactional volume change is negative (Van Eldik et al., 1989). 
 
 
 
The interpretation of the molecular events underlying the standard reaction volume is 
analogous to the standard volume of activation. In the case of the activation volume it 
measures the volumetric changes between the transition state and the reactants, while in 
the case of the reaction volume what is measured is the volumetric change between 
products and reactants (Van Eldik et al., 1989). 
The determination of the standard reaction volume can also be done using analogous 
models used for the determination of the standard volume of activation. In the case of 
the activation volume, its determination is based on a dependence of the reaction rate 
constant with pressure, while in the case of the reaction volume it is determined through 
an equilibrium constant dependence with pressure. From ln K dependence with pressure 
is estimated the reaction volume. Following this, in order to determine the reaction 
volume the reaction rate, k, shall be substituted by the equilibrium constant, K in the 
models describing the dependency of k with P (Calado, 1986; Van Eldik et al., 1989). 
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1.4.4 Enzymatic stability 
The enzyme stability is crucial for an entire biotechnological process, once the enzyme 
activity is dependent on the integrity of its native state, in order to maximize the process 
productivity. While protein, the enzyme stability can be defined through a simplistic 
approach of a 2-state model: native and denatured state (Cooper, 1999). The native state 
compromises all states where enzyme remains active, while the states where the enzyme 
completely loses its activity are included in the denatured state. Considering the folding-
denaturing transition as phase transition (Hawley, 1971), a Gibbs energy change (G) 
can be established between the denatured (GD) and the native state (GN), according to 
Equation 1.34: 
 
 
The magnitude of the Gibbs energy change measures how easily an enzyme may suffer 
denaturation (Scharnagl et al., 2005). A large Gibbs energy change is consistent with a 
very stable enzyme, which is dependent on the enthalpic/entropic compensation ruled 
by Equation 1.35, where H is the enthalpy change and S is the entropy change 
(Scharnagl et al., 2005). 
 
 
Several variables influence the enzyme stability and G assumes a multidimensional 
function of all these parameters (Equation 1.36), including: temperature (T), pressure 
(P), cosolvent type and concentration (cx), pH, ionic activity (ay), etc (Jurado et al., 
2004):  
 
 
1.4.4.1 Temperature 
The influence of temperature on the reaction rate of enzyme catalysed reactions is 
similar to chemical reactions, but the proteic nature of enzymes may turn it a bit more 
complex. Bellow optimal temperature, the enzymatic reaction rate increases with 
temperature, but above the optimal temperature value the inactivation caused by heat 
leads to a reaction rate decrease. On the basis of inactivation is the structural change of 
protein that occurs under these conditions. As temperature is raised the enthalpy change 
between the native and the denatured state starts to increase as well as the entropy 
(1.34) ND GGG 
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change, due to the destruction of the ordered water structures around the protein. Above 
the temperature value where entropy compensates enthalpy the denatured state is 
favored, corresponding to a negative Gibbs energy change (Cabral et al., 2003; 
Scharnagl et al., 2005). During the temperature-induced denaturing transition the 
protein native structure is destroyed into a random-coil structure, where the 
hydrophobic aminoacids initially impelled into the inside of the protein through 
hydrophobic interaction are exposed to the outside, contacting with water (Scharnagl et 
al., 2005). 
 
1.4.4.2 Pressure 
The protein stability against pressure can be divided into a high and a low pressure 
range values, considering two distinct transitions between the native and the denatured 
states. No matter the pressure magnitude, hydrostatic pressure induces protein 
denaturation following the principle of Le Chatelier, favoring the smaller volume state.  
Concerning a high pressure range, above some threshold pressure value, which depends 
on the enzyme in study, the volume change (V) between the native (VN) and the 
denatured state (VD) is negative, as rule (Equation 1.37): 
 
 
Underlying this fact is the presence of voids, eventually in the protein pockets, that are 
squeezed. Therefore, the denatured state is favored under high pressure range once 
pressure favours the state that occupies a smaller volume. Denaturation occurs after 
crossing a certain pressure value where G is null.  
The low pressure range, it is limited not only to low pressure but also to high 
temperature, once it would be necessary negative pressures to study the denaturation at 
a large temperature range. Within these two boundaries (low-pressure/high-temperature) 
the pressure decrease may lead to denaturation. In this case the volume change is 
positive, by contrast with the high pressure range. During pressure decrease the 
denatured state is favoured once it occupies a larger volume than the native state, 
leading to a positive volume change (Scharnagl et al., 2005). 
The effect of pressure on the biocatalyst structure is a major issue in pressure 
biocatalysis. The primary structure established through peptide bonds is not affected by 
pressure, while in the case of the hydrogen bridges of the secondary structure a pressure 
ND VVV  (1.37) 
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magnitude ranging from 300 to 700 MPa is needed to disturb them. The destruction of 
the secondary structure leads to the enzyme denaturation and consequent loss of 
catalytic activity (Mozhaev et al., 1996; Buckow, 2006). In order to influence the 
tertiary structure is needed a pressure magnitude around 200 MPa, which is similar to 
the pressure magnitude needed to dissociate a quaternary structure, which is around 150 
MPa (Mozhaev et al., 1996; Buckow, 2006). It is on the tertiary and quaternary 
structure level that pressure may exert influence on the protein conformation. The 
presence of small cavities within the proteins allows the adoption of different 
conformations that are dependent on weak interactions between polypeptide chains 
(Mozhaev et al., 1996; Lullien-Pellerin and Balny, 2002; Balny, 2004; Buckow, 2006). 
 
Enzymatic stability against temperature under pressure 
As a phase transition, the folding-denaturing of proteins under both pressure and 
temperature conditions draws an elliptical line in a P-T plane (Figure 1.12) (Hawley, 
1971), where G is null, delimiting a closed range, where the protein adopts a stable 
native state (G > 0). Crossing the boundary of that region, the native conformation 
loses its stability and the protein unfolds. As this transition is characterized by a latent 
heat of first order, the phase boundary slope can be determined according to the 
Clausius-Clapeyron equation (Equation 1.38) (Hawley, 1971; Heremans and Smeller, 
1998; Smeller, 2002; Scharnagl et al., 2005; Wiedersich et al., 2008): 
 
 

The boundaries of the stability phase diagram can be determined from a solution of 
Clausius-Clapeyron equation, assuming that the specific heat capacity (CP), the 
compressibility factor () and the thermal expansion factor () are independent on both 
pressure and temperature. The integration of Clausius-Clapeyron equation leads to 
Equation 1.39 (Hawley, 1971; Smeller, 2002): 
 
 
 
Equation 1.39 is a second order curve in the P-T plane, being a general mathematical 
equation for a conic section that can adopt an elliptic, hyperbolic or parabolic shape 
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(Wiedersich et al., 2008). T0 and P0 are arbitrarily chosen reference values for pressure 
and temperature, known as standard conditions. It was found that in the case of proteins 
this equation adopts an elliptic shape due to a mathematical constraint (Inequation 1.40) 
(Smeller, 2002), which happens to be satisfied by the different signs of CP and  in 
first studies by Hawley (1971), involving chymotrypsinogen and ribonuclease.  
 
 
 
It shall be stressed that the phase transition approach has its on limits, concerning not 
only the approximations made but also differences between proteins, which strongly 
disperses it (Scharnagl et al., 2005). Nevertheless, this approach seems to describe well 
many proteins fold-denaturing thermodynamics (Scharnagl et al., 2005). The elliptic 
phase protein denaturing diagram (Figure 1.12) is the base of a potential use of pressure 
to avoid biocatalyst inactivation caused by heat. Considering the grey region that 
bounds the native state, a temperature increment from (a) to (b) (Figure 1.12) leads to 
the protein unfolding. If, coupled to temperature increment pressure is raised, from (a) 
to (c), the enzyme native state is preserved. This stated antagonistic effect between 
pressure and temperature is the basis of pressure stabilization of the enzyme native state 
at high temperatures (Balny, 2004; Scharnagl et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1.40) 
0
P2
T
C 


 > 
Figure 1.12 Elliptic phase protein denaturing diagram. 
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Sharnagl et al. (2005) proposed a hypothesis to explain this effect, based on the 
behaviour of protein stability under pressure. The use of pressure as a tool to avoid the 
biocatalyst heat denaturation is based on the fact that at a high pressure range the 
induced denatured state has a different structure than at a low pressure range. At a high 
pressure range the denatured state is still a kind of globular state where protein shrinks 
due to the squeezing of voids, so that VD < VN. On the other hand at a low pressure 
range and at sufficiently high temperature the volume change is positive VD > VN. At 
these conditions unfolding to a random-coil structure is still possible, which occupies a 
larger volume than the native state, due to the exposure of hydrophobic aminoacids to 
the solvent. As pressure favours the state that occupies a smaller volume, native state is 
favoured in detriment of denatured state, at high temperature within a low pressure 
range.  
The protecting effect of pressure against heat inactivation has its own boundaries and 
two distinct modes of action may occur according to the pressure magnitude. These two 
modes of action are separated by a critical pressure value, which is specific for each 
enzyme, where the volume change associated with denaturation is null. Above this 
critical pressure value, the volume change associated with denaturation happens to be 
negative; meaning that in this case pressure will favour the denatured state which is the 
smallest volume state. On the opposite, bellow this critical pressure value the volume 
change associated with denaturation is positive, so in this case pressure favours the 
native state of the enzyme. Following this, pressure magnitude is critical for the 
stabilization of the enzyme native state under high temperature. Of course that a critical 
temperature value also do exist, which bounds the maximum temperature where 
pressure is still able to antagonize the denaturing effect of heat. It is bellow this critical 
temperature and pressure values that pressure can turn to be a very helpful favouring the 
native state, which corresponds in this case to the smaller volume state (Scharnagl et al., 
2005).  
 
1.4.4.3 Cosolvents 
Water is the solvent where enzymes exist and work in a natural way. By this way the 
dynamic of the water molecules present within the protein hydration shell are directly 
associated with the enzyme stability. Then, any cosolvent that interferes with this 
hydration shell leads to enzyme inactivation. The possible mechanisms underlying the 
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enzyme denaturation caused by organic cosolvents can be divided into: direct contact 
between the cosolvent molecules and enzyme; indirect interaction, which is caused by a 
disturbance of the water molecules dynamic that constitute the hydration shell of 
enzymes; or through the combination of both mechanisms (Scharnagl et al., 2005). 
Cosolvents can be classified into: compatible if they don’t disturb the protein 
functionality; non-compatible if they induce protein structure disruption; and 
compensatory cosolvents, which stabilize the folded structure against external stresses 
(Scharnagl et al., 2005). The stability of the enzyme native state depends greatly on the 
hydrophobic effect, which comes from the tetrahedral structure that characterizes the 
water molecules. Any solvent that is not compatible with the tetrahedral arrangement of 
water molecules ends up weakening the hydrophobic effect, leading to enzymatic 
denaturation. The denaturation caused by the presence of cosolvents is similar to heat 
denaturation, where hydrophobic amino acids are exposed to the involving water 
(Scharnagl et al., 2005). 
 
1.4.4.4 pH 
The pH value influences the ionization of the aminoacids that constitute the enzyme, 
according to their specific pKa values. The aminoacids charges determine the three-
dimensional enzyme structure. Also when the substrate has electrical charges, the 
approximation to the enzyme active centre depends on the charge of the residues 
involved in the bonding process. Therefore, an optimal pH value at which the enzyme 
activity is maximal can be fixed using an adequate buffer system (Cabral et al., 2003; 
Jurado et al., 2004; Scharnagl et al., 2005). 
The influence of pH on enzymatic activity can be analysed according to a kinetic model 
in which the enzyme is subjected to successive deprotonation according to the following 
equilibrium: 
 
 
where EH2+ is the inactive protonated enzyme; EH is the active enzyme; E is the 
inactive deprotonated enzyme; K1 is the first equilibrium constant and K2 is the second 
equilibrium constant (Jurado et al., 2004) that can be expressed, respectively, according 
to Equations 1.41 and 1.42: 
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Making an overall balance (Equation 1.43), the influence of pH on the enzymatic 
specific activity (A) can be described by Equation 1.44, where Amax is the maximum 
enzyme specific activity.  
 
 
 
 
 
Optimum pH values (pHopt) can be determined from Equation 1.45: 
 
 
 
The deduction of Equations 1.44 and 1.45 can be found in annex 1. 
 
1.4.4.5 Ionic activity 
The presence of certain ions may influence the enzyme native state. In some cases, the 
enzyme inactivation occurs mostly when the ions diameter is small, penetrating the 
enzyme native structure and inducing conformational changes; others can increase the 
resistance against heat inactivation due to the reduction of polypeptide chain flexibility 
(Scharnagl et al., 2005). 
 
1.4.5 Enzymatic inactivation models 
The study of the influence of the above-mentioned conditions over the stability of 
enzymes requires the use of mathematical models. Henley and Sadana (1985), proposed 
a series-type enzyme inactivation sequence involving a first-order inactivation sequence 
and an active intermediate according to the following scheme: 
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where k1 and k2 are the first and second inactivation rate constants, respectively. A0, A1 
and A2 are specific activities of the initial active enzyme, enzyme intermediate and final 
enzyme state, respectively. This model is described by Equation 1.46. 1 and 2 are the 
specific activities ratio A1.A01 and A2.A01, respectively and Ar is the enzyme residual 
activity (Henley and Sadana, 1985). 
 
 
 
In cases of biphasic inactivation Equation 1.46 leads to Equation 1.47, where the final 
state is totally inactivated (2 = 0) (Henley and Sadana, 1985). 
 
 
 
This model also includes the cases described by a single-step first-order inactivation 
process, according to Equation 1.48, where both 1 and 2 are equal to zero (Henley and 
Sadana, 1985). 
 
 
In addition, the inactivation kinetics half-life time (t1/2), i.e., the time needed to reduce 
its original activity to 50 %, in the case of a first order kinetic can determined according 
to Equation 1.49: 
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1.5 Enzymatic immobilization 
 
The immobilization of enzymes is a very common technique used in biotechnology, 
consisting on confining the enzyme within a restricted area and retaining simultaneously 
the enzymatic catalytic activity (Cabral et al., 2003). The success of this methodology 
depends on the compensation of a large range of advantages over eventual limitations 
that shall be minimized. 
The general advantages of enzymatic immobilization include: the retention of the 
enzyme inside a reactor; achieving high concentration of enzyme; modulation of the 
enzyme micro-environment and easy separation of product and enzyme, which 
facilitates downstream processing. More specifically, the retention of the enzyme inside 
a reactor allows not only repeated but also continuous utilization. A high concentration 
of enzyme is important whenever a fast bioconversion is needed due to unstable 
substrates. In the case of modulation of the enzyme microenvironment, several 
advantages may arise, including: increased catalytic activity, modulation of enzymatic 
specificity; tuning the partition characteristics of the matrix and increasing the enzyme 
stability against temperature, pH and organic solvents (Tischer and Kasche, 1999; 
Cabral et al., 2003). 
The enzymatic immobilization process has however some limitations mainly regarding 
the loss of catalytic activity and the empiricism of the process, which requires a case by 
case process optimization. The activity loss may occur during the immobilization or 
bioconversion step or eventually being a direct cause of the immobilization matrix. 
Before choosing a certain immobilization procedure it is important to study the 
adequacy between the studying enzyme and certain immobilization conditions such as 
pH, ionic strength and temperature conditions as well as the presence of toxic agents 
required for the immobilization step. Concerning the micro-environment it is important 
to avoid the exclusion of macromolecules as well as restriction transfer effects and 
stereochemical restriction to the enzyme active centre. Local pH variations are also an 
important issue to avoid the enzyme activity loss caused by the immobilization matrix. 
Finally, the enzymatic activity can be lost during the bioconversion process, due to 
several main issues including: enzyme loss; chemical or physical susceptibility of the 
immobilization matrix; pore diameter heterogeneity; accumulation of inhibitors inside 
the matrix and matrix retention of small solid particles in suspension (Tischer and 
Kasche, 1999; Cabral et al., 2003). 
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In order to obtain useful bioimmobilizates, some requirements must be fulfilled, such 
as: high biocatalyst activity, long-term stability, good accessibility to substrates, 
resistance to leaching, resistance against denaturation and avoiding biocatalyst loss 
during immobilization. An eventual decrease on the rate and extension of the reaction 
must be overcome by the repeated use of the immobilized enzyme (Tischer and Kasche, 
1999; Jin and Brennan, 2002). 
 
1.5.1 Methods 
The immobilization methods can de classified according to the combination of the 
nature of the support and the kind of interaction that is responsible for immobilization. 
The immobilization methods can be divided into binding methods and physical 
retention methods (Cabral et al., 2003). The selection of an adequate method relies on 
the advantages and disadvantages that are inherent to each method (Tischer and Kasche, 
1999). 
The binding methods include: immobilization by reticulation and immobilization by 
carrier binding method. In the case of immobilization by reticulation, bifunctional 
reagents are used in order to do the cross-link of enzymes through covalent bonds. The 
carrier binding method includes: immobilization by covalent binding, ionic binding, 
physical adsorption and chelation. The strength of the interaction established between 
the enzyme and the support is a very important issue in the case of binding methods. 
The strength of the interaction increases from adsorption binding methods, passing by 
ionic methods till covalent binding methods. Weak interactions may lead to the enzyme 
release from the support under certain reactional conditions, including; pH, temperature, 
ionic strength and dielectric constant. On the other hand a strong interaction such as 
covalent binding may involve a complex immobilization method and catalytic activity 
loss (Cabral et al., 2003). 
The physical retention methods are divided into: immobilization by occlusion, 
immobilization using membranes and microencapsulation. The immobilization by 
occlusion consists on entrapping the enzyme inside a gel. This immobilization method 
is described in more detail in 1.5.1.1. The immobilization using membranes consist on 
arresting the enzyme using a selective porous membrane. The advantages of using this 
method consist on neither changing the enzyme structure nor its microenvironment, but 
some other issues rise, including: adsorption of enzyme, products or substrates; enzyme 
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loss through pores and low biotransformation rate due to high mass transfer resistance 
effects caused by the membrane. The microencapsulation method includes both 
microcapsules and inverted micelles. Microencapsulation consists on immobilizing the 
enzyme inside a semi permeable membrane. Microcapsules lead to lower mass transfer 
effects than gels produced by occlusion method, but on the other hand the aggressive 
conditions of the formation of membranes may lead to catalytic activity loss. Inverted 
micelles are aggregates in which the polar groups are concentrated in the interior and 
the apolar groups constitute the external layer extend outward into the solvent. They 
have been used in the bioconversion of substrates with low water solubility, using 
organic solvents, but one major disadvantage is the recovery of the enzyme and 
products, after the bioconversion process (Cabral et al., 2003). 
 
1.5.1.1 Occlusion method 
The immobilization by occlusion consists on entrapping the enzyme inside a gel, which 
is insoluble in water. There are two main methods concerning the occlusion 
methodology that includes reticulation of a polymeric solution and reticulation of 
monomers. The reticulation of polymeric solutions may occur through ionic binding, 
precipitation and polymerization, while the reticulation of monomers needs an inductor 
agent of the formation of crossed-bridges (Cabral et al., 2003). 
In the case of simple inclusion no additional link steps are required, which is 
advantageous once the enzyme activity is preserved without the need to derivatize it, 
nor establishing contact forces between the enzyme and other surfaces (Tischer and 
Kasche, 1999). Also the occlusion method helps preserving the catalytic activity against 
external agents, as in the case of the presence of organic cosolvents. The occlusion of an 
enzyme within a porous matrix may allow the exclusion of aggressive or inhibitory 
compounds by modulating the support hydrophobicity and porosity, which also allows 
the optimization of the partition characteristics and mass transfer effects. In order to 
minimize the diffusional restriction of mass transfer, the support particle size shall be as 
small as possible (Cabral et al., 2003). 
Some drawbacks may arise from immobilization by inclusion caused by mass transfer 
limitations or eventually limited access to the active centre of the enzymatic biocatalyst 
caused by steric hindrance (Tischer and Kasche, 1999). Internal mass-transfer effects 
may occur due to partition effects and porous diffusion, while external mass transfer 
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effects depend on the thickness of the diffusion layer outside the carrier (Mateo et al., 
2007). Also, during the immobilization process an eventual exposure of the enzyme to 
temperature changes, pH, or chemical aggressive agents may lead to some inactivation 
(Cabral et al., 2003). 
 
1.5.2 Immobilization support 
The choice of the immobilization support is crucial for the success of the global 
immobilization process. In fact it must be chosen in accordance to the enzyme, 
immobilization method, process conditions and characteristics of the support. Supports 
can be divided into organic and inorganic, concerning a chemical based classification; 
or eventually into porous and non-porous supports, concerning their morphology. On 
the selection of a certain support, some aspects related to their characteristics must be 
considered including: the presence of functional reactive groups; the definition of the 
hydrophobic/hydrophilic character; the chemical, mechanical and biological resistance; 
the geometry; the cost/availability ratio and its porosity (Cabral et al., 2003). 
Concerning the presence of functional groups, organic supports are compatible with 
reticulation techniques and are more biocompatible than inorganic supports; in addition 
there is a large range of techniques for surface activation for organic supports when 
compared with inorganic supports. The definition of the hydrophobic/hydrophilic 
character is mainly accomplished in the case of synthetic organic supports. The 
chemical, mechanical and biological resistance is particular high, in the case of 
inorganic supports. Inorganic supports have increased stability against pH, ionic 
strength, organic solvents, temperature and hydrostatic or hydrodynamic extreme 
conditions. The support geometry is better defined in the case of synthetic rather than 
natural supports, but in terms of the cost/availability ratio the synthetic supports are less 
suitable than the natural occurring supports (Cabral et al., 2003). 
Organic polymers can be used for carrier binding immobilization and by occlusion 
methods. It’s easy to add functional reactive groups at the surface of organic polymers 
for the enzyme binding, although its mechanical and chemical resistance is low. 
Synthetic polymers have the advantage of reduced microbial growth over natural 
polymers; they also have a low variation of porosity degree and high chemical 
composition range by combining different monomers. Inorganic supports have the 
advantage of being chemically inert and have a good mechanical and thermal stability. 
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Unfortunately, inorganic compounds have some limitations concerning the presence of 
functional groups for the enzyme covalent binding; also there are few techniques to do 
the activation of the support (Cabral et al., 2003). 
Finally, porosity enables the protection of the enzyme against an adverse macro-
environment; a high surface area/mass ratio allows a high load of enzyme. On the other 
side, porosity leads to significant diffusional restrictions and the compatibility with 
macromolecular substrates is reduced. Small pores avoid the loss of enzyme, but lead to 
diffusional restrictions for product and substrate, which may reduce the global process 
productivity. Large pores lead to low diffusional restriction effects, but the enzyme may 
easily get out of the matrix. The ideal pore size results from a process optimization; in 
addition matrices with controlled pore size are more expensive (Cabral et al., 2003; 
Ribeiro, 1994). 
 
1.5.3 Immobilization within silica glasses through sol-gel method 
Silica has been regarded as a very interesting material to be used as a carrier 
immobilization material due to several characteristics such as: mechanical strength, 
chemical stability, shape flexibility, non-toxicity and biological inertia. Another 
advantage is the capability of not swelling in aqueous or organic solvents which 
prevents leaching of entrapped biomolecules, such as: proteins, nucleic acids, organelles 
and cells (Livage et al., 2001). Despite all these advantages a major limitation to the 
bio-encapsulation within inorganic materials, such as glasses or ceramics, relied on their 
synthetic procedure that traditionally involved high temperature processes. A method 
that could combine tough materials, with fragile biomolecules, retaining much of its 
physicochemical characteristics was found, the so called sol-gel process (Avnir, 1995). 
First reports on encapsulation of enzymes using silica glasses were published by Dickey 
(1955) and Johnson et al. (1971), although only in the 90s a real development has 
started (Braun et al., 1990).  
The application of sol-gel for the entrapment of biomolecules started to be generalized 
and nowadays a wide variety of biological species have been entrapped including: 
enzymes, antibodies, regulatory proteins, membrane-bound proteins, nucleic acids and 
even whole cells (Livage et al., 2001; Jin and Brennan, 2002). The bioactivity coupled 
with the intrinsic characteristics of silica turned these new hybrid materials very 
attractive for several applications, including: biosynthesis, medicine, environmental 
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technology, sensors and photonics (Livage et al., 2001). Biosynthesis is a wide field for 
sol-gel glasses applications such as biocatalyst bioencapsulation. 
Sol-gel method is an inclusion immobilization method, consisting on the formation of 
mineral phases starting from soluble precursors, which suffer an inorganic 
polymerization reaction. The so called hybrid materials rise from the incorporation of 
biomolecules within the inorganic hosts, only possible due to the soft reaction 
conditions that take place at room temperature, in water or organic solvents and in a 
wide range of pH and ionic strength conditions (Coradin et al., 2006). The sol-gel bio-
immobilizates are generally prepared following three main steps: sol preparation, gel 
formation and aging. The sol preparation includes hydrolysis of a specific precursor 
followed by condensation and polycondensation, as outlined on Figure 1.13, which 
illustrates a complete hydrolysis of a tetra-alkoxysilane. After the production of a silica 
colloid the gel is obtained through pH change (Jin and Brennan, 2002), by the addition 
of a buffer solution containing the biomolecule. The aging step is a drying process, 
where the solvent is removed coupled with continuous condensation reactions leading to 
the xerogel (Coradin et al., 2006; Jin and Brennan, 2002). While the initial gels are soft 
and have high water content and large pores (up to 200 nm diameter), the aged gels, 
called xerogels have a pore diameter ranging from 220 nm due to an overall matrix 
shrinkage during interstitial water loss (Jin and Brennan, 2002). Xerogels suffer 
additional cross-linking and densification during aging comparing to hydrogels, which 
makes them more mechanical and chemical resistant than hydrogels (Gil, 2001). On the 
other hand, the smaller pore size observed in xerogels can be a disadvantage when 
compared to hydrogels due to possible diffusional limitations, also enzymes such as can 
denature with complete dehydration that occurs in xerogels by contrast with hydrogels 
(Gil, 2001). 
The major advantages of sol-gel derived silicate materials for enzymes immobilization 
are: the optical transparency, which allows absorbance or fluorescence signal reading; 
the variety of possible chemical modifications through addition of organically modified 
silanes (Ormosils), polymers and several kind of fillers; tuneable pore size and 
distribution, which allows small substrate molecules to diffuse into the matrix, avoiding 
the leaching of the enzyme (Jin and Brennan, 2002). However, some limitations shall be 
regarded: materials can crack; enzymes can denature during immobilization due to 
alcohol release, pH conditions or ionic strength; the pore size can be too small and turn 
difficult the diffusion of small substrate molecules into the matrix or eventually be too 
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large to prevent enzyme leaching; enzyme-silica and substrate-silica interactions may 
lead to enzyme denaturation or difficult substrate approaching to the gel.  
Taking into account the potential of sol-gel derived silicate materials, several sol-gel 
precursors and additives are in continuous research in order to fight against the above 
limitations (Jin and Brennan, 2002). According to the precursors and additives 
employed in the formation of the material several gels can be prepared, including: 
inorganic sol-gels, Ormosils, organic-inorganic nanocomposite sol-gels and templated 
sol-gels. 
 
 
 
 
 
 
 
 
 
 
 
1.5.3.1 Inorganic sol-gels 
Inorganic sol-gels are generally derived from alkoxide-based sol-gel processes, mostly 
using tetramethylortosilicate (TMOS) or tetraethylortosilicate (TEOS); other inorganic 
sol-gels can also be made from sodium silicate and silica mixed with metal oxides, 
including: aluminium, titanium, zirconium, vanadium, and molybdenum (Gil, 2001). 
The use of sodium silicates is even older than alkoxides (Iler, 1979), but some 
disinterest has risen due to the reactivity of silicates, which is harder to control than 
alkoxides (Jolivet, 2000). The use of metal oxides is limited due to their brittleness and 
limited porosity (Gil, 2001).  
The sol-gel process studied on this thesis is an alkoxide-based sol-gel process, using 
TMOS as precursor. Silicone alkoxides are very convenient for bio-encapsulation for 
several reasons, including: the ability to control the pore size through changing the 
hydrolysis pH, where acidic conditions lead to dense microporous (pore size < 2 nm) 
network and alkaline conditions to mesoporous gels (2 nm < pore size < 50 nm) 
 
hydrolysis 
Si(OH)3-O-Si(OH)2-O-Si(OH)2-O-Si(OH)3                            Si(OH)3-O-Si(OH)3 
 
 Si(OR)4                                     Si(OH)4 
 
H20 
H20 
Si(OH)3-O-Si(OH)3 
  H20 
 Si(OH)4 
 
   ROH 
 
  condensation 
polycondensation 
Figure 1.13 Sol preparation: complete hydrolysis of a tetra-alkoxysilane, followed by condensation and 
polycondensation.  
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(Coradin et al., 2006); ready synthesis; physicochemical robustness and optical 
transparency (Gill, 2001). On the other hand, some disadvantages may occur, including: 
high shrinkage degree that leads small pore diameters (210 nm), causing diffusional 
limitations; enzyme inactivation due to alcohol release, during alkoxide hydrolysis; lack 
of modifiable chemical functionality; electrostatic interactions between silica and 
substrate or with the entrapped enzyme, due to the high proportion of deprotonated 
silanol groups (Jin and Brennan, 2002).  
Some of the above disadvantages can however be overcome. The small pore diameters 
of the xerogels can be circumvented by the use of hydrogel, and eventually control the 
aging conditions in order to find a matrix with intermediate pore size diameter between 
hydrogel and xerogel. The potential inactivation of the enzyme due to methanol release, 
during TMOS hydrolysis can be avoided by the use of a glycerated silane precursor 
(Gill and Ballesteros, 1998). Finally, the lack of modifiable chemical functionality and 
the electrostatic interactions of inorganic silica can be modified by the addition of 
ormosils, which can also be used to tune the pore size diameter (Coradin et al., 2006). 
All these strategies, to avoid alkoxide disadvantages were studied on 4.3.1. 
 
1.5.3.2 Organically modified silicates (Ormosils) 
Ormosils are produced starting from precursor silanes with organic groups attached by 
hydrolytically stable Si-C bonds, constituting alkyl-alkoxysilanes, allowing the 
formation of poly-(organosiloxanes) with an inorganic siloxane backbone and free 
organic moieties. The organic group can vary from a simple alkyl linear chain to 
complex chains with multiple functionalities, a major advantage comparing to silicone 
alkoxides once hydrophilic, hydrophobic, ionic, and H-bonding properties can be tuned; 
they also display good porosities (Keeling-Tucker and Brennan, 2001). These properties 
can be useful to change the partition coefficient of a substrate in order to increase its 
affinity for the matrix or eventually increasing the stability of the immobilized enzyme 
(Jin and Brennan, 2002). On the other hand these materials have limited transparency 
and are more fragile than inorganic matrices, once the alkyl group reduces the cross-
linking (Gil, 2001); also only a limited percentage of the precursor can be added before 
reaching a solubility limit (Pierre, 2004). Two kinds of alkyl-alkoxysilanes were used 
towards naringinase immobilization (4.3.1). The purpose of using 3-
aminopropyltrimethoxysilane (APS) was to change the ionic environment to increase 
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wettability leading to an extended gel biocompatibility (Gill and Ballesteros, 1998; 
Venton et al., 1984). Methyltrimethoxysilane (MTS) was used to increase the 
hydrophobic gel properties, which could be interesting to increase the affinity of the gel 
matrices for the flavanone substrates (Gill and Ballesteros, 2000). In addition, both 
these alky-alkoxysilanes aimed to tune the pore size diameter of the hydrogel. 
 
1.5.3.3 Organic-inorganic nanocomposite sol-gels 
Organic-inorganic nanocomposite sol-gels consist on a combination of an inorganic or 
organic silicate precursor with several kinds of additives including hydrophobic and 
hydrophilic polymers, silicones, surfactants, sugars, dyes, redox species and even fillers 
that improve mechanical properties, such as graphite, cellulose, fumed silica or clays 
(Gill, 2001; Jin and Brennan, 2002). Polymers such as: poly(ethylene glycol), 
poly(vinylimidazole) or poly(ethyleneimine) can not only reduce adsorption of proteins 
and analytes onto the silica increasing the overall activity (Heller and Heller, 1998; 
Keeling-Tucker et al., 2000; Keeling-Tucker and Brennan, 2001), but also reduce the 
material shrinkage by sterically preventing the pore collapse (Wambolt and Saavedra, 
1996; Baker et al., 1998). Many other polymers can also be used, such as alginate, 
carrageenan, gelatin, agar, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(glyceryl 
methacrylate), poly(hydroxyethyl acrylate), poly(acrylamide) and polyurethane (Gil, 
2001). 
The advantage of these sol-gels comparing to inorganic gels and ormosils rely on a wide 
rigidity spectrum and hydrophilic/hydrophobic properties, tuneable pore sizes, large and 
ordered pores, improved mechanical stability and better biocompatibility (Gill, 2001; 
Jin and Brennan, 2002). 
 
1.5.3.4 Templated sol-gels 
Within the group of templated sol-gels are all the sol-gel matrices produced with 
structure-directing and pore-forming agents. These agents include polyols such as 
glycerol, hydroxyacids, PEG, surfactants and ionic liquids (ILs). These compounds may 
modify the sol-gel structure through the formation of several systems including: 
microemulsions and macroemulsions, vesicular or liquid-crystalline phases, foams or H-
bonded aggregates (Gil, 2001). Beck and Vartuli (1996) at Mobil Research and 
Development Corporation, during their research on mesoporous materials, mixed silicon 
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alkoxides with surfactants, demonstrating that molecular systems can be used as 
structuring agents, or templates, to control the structure and morphology of inorganic 
phases. 
Comparing templated sol-gels with organic-inorganic nanocomposite sol-gels some 
similarities do exist, such as the reduction of the gel shrinkage by sterically preventing 
pore collapse as well as the availability of biocompatible templating agents; in 
opposition, templates are removed after aging. Meso to macroporous materials are 
produced, making templating agents a great promise to produce highly ordered and 
porous biodoped sol-gels (Gill and Ballesteros, 1998; Wei et al., 2000). 
Glycerol was a templating agent used along the immobilization studies (chapter 4), 
acting simultaneously in the reduction of the material shrinkage and preventing the pore 
collapse and also as drying-control additive, during it slow release from the gel (Gill 
and Ballesteros, 2000). 
Ionic liquids were also studied (4.3.3) as templates for nanostructured gels. Ionic liquids 
are compounds, comprised entirely of ions: cations and anions that have a melting point 
below 100 ºC. They are versatile compounds due to the possibility to tune the desired 
property such as polarity, conductivity, thermal and chemical stability, density, 
viscosity, melting point, and their solvent capacity just by combining different anions 
and cations. Indeed, depending on the anion and alkyl group of the cation, ILs can 
solubilize carbonyl compounds, alcohols, alkyl halides, supercritical CO2, and also 
transition metal complexes. In addition to this, they can have low miscibility with 
dialkyl ethers, alkanes, water and may be insoluble in supercritical CO2. ILs have been 
recognized as “greener” solvents compared with classic organic solvents mainly due to 
their negligible vapor pressure, high thermal and chemical stability and possibility of 
reutilization (Welton, 1999; Wasserscheid and Keim, 2000; Dupont et al., 2002; 
Martins et al., 2008).  
Regarding the properties of ILs there are some important features which should be 
mentioned. In terms of solubility, ILs containing the alcohol group in the side chain are 
generally miscible with water whereas more hydrophobic side chains on the cationic 
unit tend to reduce this miscibility. Regarding the anion effect, more hydrophobic 
groups such as PF6 or the bis-triflimide increase the immiscibility with water and the 
IL viscosity while the BF4 anion improves the solubility in water affording less viscous 
ILs. Halides, dicyanoamide (DCA), trifluoroacetate (TFA), trifluoro methane sulfonate 
(TfO) are more polar anions which result in ILs with an increased affinity towards water 
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(Welton, 1999; Wasserscheid and Keim, 2000; Dupont et al., 2002; Greaves and 
Drummond, 2008). 
These vast tunable properties of ILs makes them a potential alternative reaction media 
for biocatalysis, increasing reactivity, selectivity and stability of enzymes (Park and 
Kazlauskas, 2003), but also as sol-gel additives, acting as templating agents enhancing 
the immobilized biocatalysts activity and stability (Liu et al., 2005a, b; Lee et al., 
2007a, b). 
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1.6 Objectives 
 
The work that sustains this thesis emerged within the multidisciplinary field of 
pharmaceutical sciences, where the convergence of distinct knowledge areas may give 
rise to innovation. This thesis focuses on a biotechnological approach to produce 
potential active drugs against AD. On the basis of this approach is the optimization of 
the enzymatic deglycosylation conditions of natural flavone glycosides, including 
naringin and rutin. The bioprocess optimization is carried out in order to maximize the 
efficiency of this bioprocessing approach, making use of pressure and biocatalyst 
immobilization as cornerstone tools among other conditions including: temperature, pH 
and use of organic solvents. The purpose of this thesis comprises the following specific 
goals: 
 
a) Development of a biocatalytic process to produce the flavone glucosides: prunin 
and isoquercetin; and the aglycones: naringenin and quercetin; starting from the 
natural glycosylated flavones: naringin and rutin, using naringinase as biocatalyst. 
Inherent to this goal is the study of a selective inactivation of -D-glucosidase 
from naringinase, remaining the -L-rhamnosidase activity, which is needed to 
obtain the flavone glucosides: prunin and isoquercetin. 
b) Use of pressure as a tool to increase the overall bioprocess efficiency, through 
modeling the stability and activity of the biocatalyst. The increased stabilization of 
the biocatalyst against temperature as well as the acceleration of the biocatalytic 
reaction is the two main goals, concerning pressure application. In one hand the 
use of pressure aims to increase the stability of both -L-rhamnosidase and -D-
glucosidase from naringinase, under high temperature conditions. These high 
temperature conditions not only increase the reaction rate but are also 
simultaneous desirable for an increased solubility of the natural flavone substrates. 
On other hand, pressure aims to increase the reaction rate constants and 
maintaining simultaneously high equilibrium constants. 
c) Use of naringinase immobilization in order to its easy separation from the reaction 
media and re-use. Naringinase immobilization within sol-gel matrices through sol-
gel method aims to achieve a good performance of the bio-immobilizate including 
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immobilization yield, activity and operational stability. Moreover, ionic liquids 
may be useful to improve the activity of immobilized naringinase. A secondary 
goal of naringinase immobilization is to increase its stability against organic 
solvents, which can be used to solubilize the flavone substrates. 
d) Study the anti-inflammatory activity of naringin and naringenin on a CNS cell 
model and show the advantage of using aglycones and glucosides to cross the 
BBB, instead of rutinosides, in order to treat AD. 
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1.8 Thesis design 
 
The work that sustains this thesis is structured into seven chapters, where chapter 1 and 
7, respectively, consist on the introduction and conclusion of this thesis, while the main 
work is briefly approached on the remaining chapters. 
a) Chapter 2 describes the production of the flavone glucosides: prunin and 
isoquercetin; and the aglycones: naringenin and quercetin; starting from the 
glycosylated flavones: naringin and rutin, with naringinase. Also within chapter 
2 the Response Surface Methodology (RSM) is used to determine the optimized 
combination of pH and temperature conditions to selective inactivate -D-
glucosidase from naringinase, remaining a high residual activity of -L-
rhamnosidase. 
b) Chapter 3 focus on to the use of naringinase under pressure. Pressure is used to 
increase the stability of both -L-rhamnosidase and -D-glucosidase activities, 
expressed by naringinase, against inactivation caused by heat. In addition 
pressure is used to enhance its activity. 
c) Chapter 4 is related to the use of sol-gel method to entrap naringinase within 
silica glasses. On this chapter is described an optimization of naringinase 
bioencapsulation and an improved stability of immobilized naringinase in 
cosolvent systems. Moreover, this chapter focus on the use of ionic liquids to 
improve the activity of immobilized naringinase. 
d) On Chapter 5, naringin and naringenin were studied in an anti-inflammatory cell 
culture model. Moreover, an animal model was used to investigate the potential 
of naringin, prunin and naringenin to cross the BBB and reach brain. 
e) Finally, Chapter 6 consists on a general discussion about this thesis. 
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2.1 Introduction 
 
The development of a biocatalytic process to obtain the flavone aglycones: naringenin 
and quercetin, starting respectively from the natural flavone rutinosides naringin and 
rutin is quite straightforward. More difficult to obtain are the very expensive flavone 
glucosides: prunin and isoquercetin, starting respectively from naringin and rutin. 
Behind this issue is the fact that naringinase from Penicillium decumbens provides 
simultaneously both -L-rhamnosidase and -D-glucosidase activities, turning it 
difficult to obtain the intermediate glucosides products, which are immediately 
hydrolyzed by -D-glucosidase into the respective aglycones (Figure 1.10). 
In order to circumvent this issue some authors propose chromatographic separation 
methods to purify -L-rhamnosidase from naringinase (Mamma et al., 2005), while 
others suggest the use of selective inhibitors of -D-glucosidase (Chang and Muir, 
2003). In this work, to circumvent this problem and also the use of expensive processes, 
another approach is suggested, consisting on the study of the susceptibility of both -L-
rhamnosidase and -D-glucosidase of naringinase against several pH-temperature 
conditions in order to selectively inactivate -D-glucosidase. 
Statistical design of experiments is a useful tool to provide experimental schemes where 
the parameters under study are combined at different levels to determine the influence 
of a particular factor on the response. Moreover, by choosing a particular experimental 
design, individual effects can be determined as well as interactions between factors. 
Response surface methodology (RSM) is an efficient statistical technique for the 
modeling and optimization of multiple variables in order to predict the best performance 
conditions considering a minimum number of experiments (Giovanni, 1983). It consists 
on a group of mathematical and statistical procedures that can be used to study 
relationships between one or more responses and a number of independent variables. 
RSM defines the effect of the independent variables, alone or in combination, on the 
process. In addition, to analyze the effects of independent variables, this experimental 
methodology generates a mathematical model that accurately describes the overall 
process. This method finds it major application when the effect of one variable is 
affected by the setting of another one. Such interactions between variables are difficult 
to detect by a traditional experimental setup where one variable is changed at a time. 
These experiments are set up so that the coefficients of the mathematical model (usually 
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a polynomial equation) representing the variations of the experimental response of 
interest may be evaluated with the best possible precision. In addition, RSM has the 
advantage of being less expensive and time-consuming than the classical methods. RSM 
is a non-conventional approach that has been successfully used for the optimization of 
enzymatic reactions conditions (Ribeiro et al., 2003; Marques et al., 2007; Amaro et al., 
2009) and medium composition (Ribeiro et al., 2006; Vásquez et al., 2006). 
In this work, a central composite rotatable design (CCRD) and RSM were used to 
evaluate the combined effects of temperature and pH in order to selectively inactivate -
D-glucosidase expressed by naringinase and produce the glucosides: prunin and 
isoquercetin, starting respectively from naringin and rutin. 
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2.2 Material and Methods 
 
2.2.1 Chemicals 
p-Nitrophenyl α-L-rhamnopyranoside (4-NRP), p-Nitrophenyl β-D-glucopyranoside (4-
NGP), naringin, naringenin and rutin were from Sigma-Aldrich. All other chemicals 
were of analytical grade and obtained from various sources. 
 
2.2.2 Enzyme solution 
Naringinase (CAS nº. 9068-31-9, cat. nº. 1385) from Penicillium decumbens was 
obtained from Sigma-Aldrich and stored at 20ºC. The lyophilized naringinase powder 
was dissolved in an appropriate buffer solution 24 hours before experiments and kept at 
4 ºC. 
 
2.2.3 Analytical methods 
The concentration of p-nitrophenol produced after the hydrolysis of 4-NRP and 4-NGP 
was evaluated using the Zenith 3100 spectrofluorimeter, at  = 340 nm, using a 96 flat 
well plate. A calibration curve was built for each compound. 
The flavone rutinosides, glucosides and aglycones were eluted running a thin layer 
chromatography (TLC) on a RP-18 silica-gel plate with methanol, water and acetic acid 
(50:44:6, v/v/v) (Gocan and Cimpan, 2004). The spot visualization was done under UV 
light at 254 nm, followed by spraying with a freshly prepared solution of acetic acid, 
sulphuric acid concentrated and p-anisaldehyde (100:2:1, v/v/v) and by heating at  
150 ºC for 5 min (Pekin et al., 2005). 
The HPLC-DAD-ESI-MS/MS experiments used to identify the produced compounds 
(prunin, naringenin, isoquercetin, quercetin) were performed with a liquid 
chromatograph (Alliance, Waters 2695 Separation Module) system with a photodiode 
array detector (DAD, Waters 2996) set at 280 nm (for monitoring) in tandem with a 
mass spectrometer (Micromass Quattro Micro API) with a Triple Quadrupole (TQ) and 
an electrospray ion source (ESI) operating in negative mode. Chromatographic 
conditions were as follow: column C18 (Synergi, Phenomenex) 100 mm  2.0 mm, 2.5 
m; eluent (A) water-formic acid (99.5:0.5, v/v), (B) acetonitrile (LC-MS grade, 
Merck). The linear gradient was at initial time 95 % eluent A, at 30 min 60 % eluent A, 
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at 45 min 10 % eluent A. The flow rate was 0.25 mL/min and the column temperature 
35 ºC. Mass range was measured from 100-1000 amu. The ESI source conditions were 
adjusted as follows: source capillary operating at 2.5 kV and the extraction cone at 30 
V: the source temperature was 150 ºC and the desolvation temperature was 350 ºC. 
 
2.2.4 Activity measurement 
4-NRP and 4-NGP were used as specific substrates of α-L-rhamnosidase and β-D-
glucosidase activities, in order to discriminate the enzymatic activities, expressed by 
naringinase (Mamma et al., 2005). Therefore, both enzymatic activities were followed 
and easily measured without the need of a previous subunit protein separation and 
purifying procedures. In both reactions 1 mol of substrate led to 1 mol of product. 
The activities of -L-rhamnosidase and β-D-glucosidase were evaluated using 0.20 mM 
of substrate in 20 mM citrate buffer at pH 3.4. A naringinase concentration of 50 mg L-1 
was used in these experiments. The enzymatic hydrolysis was followed 
spectrophotometrically. The absorbance was measured every 1 min during 30 min, 30.0 
ºC. The enzyme specific activity of -L-rhamnosidase and -D-glucosidase expressed 
by naringinase was calculated by linear regression on the first data-points during the 
initial 30 min reaction time. 
 
2.2.5 pH profile 
The pH profiles of the enzymatic activity were obtained through non-linear regression 
by minimising the residual sum of squares between the experimental data points of the 
specific activity vs. pH and those estimated by the model (Equation 1.44), using Solver 
add-in from Microsoft Excel 2003 for Windows XP and considering the following 
options: Newton method; 100 iterations, precision of 106, 5 % of tolerance and 104 
convergence. The experimental optimum pH values were used as initial parameters of 
the non-linear regression and no constraints were used. Optimum pH values were then 
determined using Equation 1.45. 
 
2.2.6 Inactivation kinetics 
A temperature range of 75 – 85 ºC and a pH range of 3.2 – 6.0 were used in order to 
study -D-glucosidase and -L-rhamnosidase inactivation kinetics. Naringinase thermal 
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inactivation was carried out in Eppendorf tubes (1.5 mL), at isothermal conditions (± 
0.1 ºC) using a thermostatic water bath (Julabo Hc/F18). The inactivation period ranged 
from 2.5 to 160 min according to the temperature used. After removing the enzyme 
samples from the water bath they were cooled on ice for 5 min to stop the thermal 
inactivation. Enzyme activity was measured, in triplicate, immediately as well as one 
day after thermal inactivation, without occurring reactivation. A0 is the specific activity 
of the control, i.e. the enzyme sample without being submitted to inactivation. To 
describe the inactivation kinetics the residual activity (Ar) was defined as the ratio 
between the specific activity after each inactivation period (At) and the specific activity 
of the control. 
First-order inactivation rate constants and  parameters were determined by non-linear 
regression, minimizing the residual sum of squares between the experimental data 
points of the residual activity vs. inactivation time and those estimated by the models 
described on 1.4.5. The Solver add-in from Microsoft Excel 2003 for Windows XP was 
used with the following options: Newton method; 100 iterations, precision of 106, 5 % 
tolerance and convergence of 1104. The first-order inactivation rate constant obtained 
from linear regression of ln Ar vs. t was used as the initial value of the k1 parameter for 
the non-linear regression. The non-linear regression parameters were restricted to 
positive numbers. In addition was restricted to values lower than 1. 
t0.01% was the time needed to achieve a specific activity of -D-glucosidase which is 
0.01% of the specific activity of -L-rhamnosidase. At this time (t0.01%) the -D-
glucosidase was considered completely inactivated. These t values were determined 
through extrapolation of the kinetic inactivation profiles obtained under different 
conditions of pH and temperature. The residual activity of -L-rhamnosidase at this 
period values (t) was determined for each specific condition of pH and temperature.  
 
2.2.7 Experimental design 
The optimized temperature and pH inactivation conditions of -D-glucosidase from 
naringinase were established through the Response Surface Methodology (RSM). Using 
this methodology two variables were tested simultaneously with a minimum number of 
trials, according to adequate experimental designs, which enables to find interactions 
between variables (Montgomery and Myers, 2002). The experimental design 
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methodology makes use of statistical tools for selecting a minimum set of experiments 
adequately distributed in the experimental region (experimental matrix).  
In this study, -D-glucosidase inactivation was carried out following a central 
composite rotatable design (CCRD). A total of 11 experiments were carried out in the 
CCRD: four factorial points (coded levels as (+1) and (-1)); four star points (coded as 
(+√2) and (√2) and three centre points (coded as 0) (Table 2.1). The choice of 
experimental domains resulted from preliminary studies. The response variable was the 
-L-rhamnosidase residual activity, after -D-glucosidase inactivation. The studying 
factors were pH and temperature. The experiments were performed in random order and 
in triplicate at all design points. 
 
 
 
 
 
 
 
2.2.8 Statistical analysis 
Making use of CCRD, 5 levels for each factor were used which enabled to fit second-
order polynomials to the experimental data points. The results of each CCRD were 
analyzed using the software "StatisticaTM", version 6, from Statsoft, USA. Both linear 
and quadratic effects of the two variables under study, as well as their interactions, on 
the -L-rhamnosidase residual activity were calculated. Their significance was 
evaluated by analysis of variance.  
Experimental data were fitted to a second-order polynomial model and the regression 
coefficients obtained. The generalized second-order polynomial model used in the 
response surface analysis was as follows (Equation 2.1): 
 
 
 
where 0, 1, 2, 1, 2, and 12 are the regression coefficients for intercept, linear, 
quadratic and interaction terms, respectively, and x1, and x2 are the independent 
CCRD pH Temperature (ºC) 
-√2 3.2 75.0 
-1 3.6 76.5 
0 4.6 80.0 
+1 5.6 83.5 
+√2 6.0 85.0 
Table 2.1 Coded and decoded levels of the experimental factors used in experimental design. 
2112
2
222
2
11122110 xxxxxxy   (2.1) 
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variables, temperature (1) and pH (2). The fit of the models was evaluated by the 
determination coefficients (R2) and adjusted R2 (R2adj). 
 
2.2.9 Verification experiments 
After finding the optimal conditions for the selective inactivation of -D-glucosidase 
activity expressed by naringinase, verification experiments were carried out. The 
experimental and predicted values determined by RSM were compared in order to 
validate the model.  
 
2.2.10 Production and purification methods 
Prunin was obtained through the hydrolysis of a 10 mM naringin solution, using  
50 mg L-1 of naringinase, with its-D-glucosidase selectively inactivated, in 20 mM 
citrate buffer, pH 3.4, 60.0 ºC for 6 hours. Prunin precipitated after 12 hours at 4 ºC and 
was recovered through vacuum filtration. Afterwards it was dissolved in hot water and 
was filtered. Prunin was obtained through recrystallization from water. 
Naringenin was obtained through the hydrolysis of a 10 mM naringin solution, using  
50 mg L-1 of naringinase in 20 mM acetate buffer, pH 4.0, 60.0 ºC for 6 hours. 
Naringenin precipitated after 12 hours at 4 ºC and was recovered through vacuum 
filtration. Afterwards it was dissolved in hot ethanol and was filtered. Naringenin was 
obtained through recrystallization from ethanol and water. 
Isoquercetin was obtained through the hydrolysis of a 5 mM rutin solution, using  
50 mg L-1 of naringinase, with its -D-glucosidase selectively inactivated, in 20 mM 
citrate buffer, pH 3.4, 60.0 ºC for 6 hours. Isoquercetin precipitated after 12 hours at  
4 ºC and was recovered through vacuum filtration. Afterwards it was dissolved in hot 
ethanol and was filtered. Isoquercetin was obtained through recrystallization from 
ethanol and water. 
Quercetin was obtained through the hydrolysis of a 5 mM rutin solution, using  
50 mg L-1 of naringinase in 20 mM acetate buffer, pH 4.0, 60.0 ºC for 6 hours. 
Quercetin precipitated after 12 hours at 4 ºC and was recovered through vacuum 
filtration. Afterwards it was dissolved in hot ethanol and was filtered. Quercetin was 
obtained through recrystallization from ethanol and water. 
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2.3 Results and discussion 
 
2.3.1 pH profile 
The pH profile of both -L-rhamnosidase and -D-glucosidase activities, expressed by 
naringinase was studied, between 2.5 and 5.8 in citrate buffer, hydrolysing the specific 
substrates, 4-NRP and 4-NGP, respectively. The pH profile was studied. Figure 2.1 
shows the distinct activity pH profiles of -L-rhamnosidase and -D-glucosidase 
expressed by naringinase. From these studies and adjusting the model of Equation 1.44, 
the optimum pH was found to be 3.4 and 4.1, with maximum specific activities of 0.181 
and 0.060 mol mg1 min1, respectively, for -L-rhamnosidase and -D-glucosidase 
(Table 2.2). Jurado et al. (2004) adjusted a similar model to the experimental data of -
galactosidase activity vs. pH.  
In previous work, the specific activity of -D-glucosidase in 20 mM acetate buffer (pH 
4.0) was found to be 0.086 mol min-1 mg-1, while in this work using 20 mM citrate a 
specific activity decrease of 30 % occurs. Also, Norouzian et al. (2000) observed a 
naringinase activity inhibition with 20 mM citric acid buffer. In line with these results, 
citrate buffer was used in further studies instead of acetate, concerning the selective -
D-glucosidase inactivation of naringinase.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 pH profiles of -D-glucosidase and -L-rhamnosidase (mean value ± SE). 
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2.3.2 Inactivation kinetics 
Naringinase was inactivated using combined temperature and pH conditions, 
respectively between 75.0 – 85.0 ºC and 3.2 – 6.0. The influence of temperature and pH 
on the stability of -D-glucosidase and -L-rhamnosidase were evaluated on a 
minimum set of optimal selected experiments.  
The inactivation behaviour of -D-glucosidase and -L-rhamnosidase expressed by 
naringinase was distinct from each other under the same temperature and pH conditions 
(Figure 2.2). Table 2.3 shows the inactivation parameters determined at different 
temperature and pH conditions for both -D-glucosidase and -L-rhamnosidase. In 
some cases -D-glucosidase showed a first inactivation step that was followed by a 
second one with the existence of an enzymatic intermediate with a lower specific 
activity than the initial enzyme native state (1 < 1) (Table 2.3); and a final state where 
the enzyme is completely inactivated (2 = 0) (Henley and Sadana, 1985). On the other 
hand, -L-rhamnosidase inactivation as well as the inactivation of -D-glucosidase, 
under the temperature conditions higher than 80.0 ºC, occurred according to the 
classical first-order inactivation model (Figure 2.2) (Equation 1.48). 
Tsen et al., (1989) and Ellenrieder and Daz (1996) reported naringinase (from 
Penicillium decumbens) inactivation profiles at pH 3.5–3.7. -Rhamnosidase from 
Aspergillus terreus (Gallego et al. 2001) and Aspergillus nidulans (Manzanares et al. 
2000) when incubated at pH values lower than 4.0 rapidly lost activity, whereas 
Aspergillus aculeatus (Mutter et al. 1994) showed to be insensitive to pH in a 3 – 8 
range. Comparing our results with available stability data of purified fungal α-
rhamnosidases referred by different authors (Manzanares et al. 2000; Manzanares et al. 
2001; Gallego et al. 2001; Soria and Ellenrieder, 2002), it can be pointed out that our 
developed method, which avoids -L-rhamnosidase purification, through the 
inactivation of -D-glucosidase, is an effective and cheap method. 
 
Activity pHopt Non-linear parameters R2 
-D-glucosidase 4.1 Amax = 0.060, pK1 = 2.6, pK2 = 5.5 0.892 
-L-rhamnosidase 3.4 Amax = 0.181, pK1 = 1.3, pK2 = 5.6 0.984 
Table 2.2. Optimum pH values of -D-glucosidase and -L-rhamnosidase. 
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2.3.3 RSM  
In this study a central composite design and response surface methodology (RSM) were 
applied in order to find the best pH-temperature conditions to selectively inactivate -
D-glucosidase expression from naringinase, retaining the highest -L-rhamnosidase 
activity. The experiments were carried out according to a full factorial design 22 and a 
CCRD, as a function of both temperature and pH. The residual activity values of -L-
-D-glucosidase -L-rhamnosidase 
T (ºC) pH 
1 k1 (h1) k2               R2  k1 (h1) R2 
Ar (-L-
rhamnosidase) 
75.0 4.6 0.376 0.283 0.017 0.999 0.0023 0.990 0.33 
76.5 3.6 0.327 0.990 0.084 0.997 0.0062 0.994 0.57 
76.5 5.6 0.226 0.486 0.093 0.999 0.0073 0.980 0.56 
80.0 3.2 - 0.579 - 0.971 0.0323 0.989 0.73 
80.0 4.6 - 0.428 - 0.980 0.0154 0.979 0.74 
80.0 4.6 - 0.434 - 0.990 0.0149 0.991 0.75 
80.0 4.6 - 0.431 - 0.992 0.0149 0.996 0.75 
80.0 6.0 - 0.547 - 0.953 0.0375 0.995 0.71 
83.5 3.6 - 0.869 - 0.987 0.0589 0.989 0.71 
83.5 5.6 - 0.838 - 0.953 0.0711 0.991 0.65 
85.0 4.6 - 0.868 - 0.997 0.0646 0.979 0.68 
Figure 2.2 Thermal inactivation of -D-glucosidase (a) and -L-rhamnosidase (b), under combined 
temperature and pH conditions. 
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a) b) 
Table 2.3 Thermal inactivation parameters of -D-glucosidase and -L-rhamnosidase, under combined 
temperature and pH conditions. 
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rhamnosidase determined after -D-glucosidase inactivation were used to calculate the 
significant effects, either linear or quadratic. 
Experimental data showed that -L-rhamnosidase residual activity after -D-
glucosidase inactivation was affected by pH and temperature individually and 
interactively. On Table 2.4 are presented the effects and respective significance levels 
(p) of the temperature, pH and interaction between both on the -L-rhamnosidase 
residual activity. Therefore, negative effects of the factors temperature, pH or from their 
interaction indicate that the response decreased with the increase in these factors. Linear 
and quadratic terms of temperature were high significant (p < 0.001); also the linear and 
quadratic terms of pH were significant (p < 0.05) for -L-rhamnosidase residual 
activity. A negative interaction between the variables tested (T x pH) on -L-
rhamnosidase residual activity, indicated that higher activities are obtained at higher 
temperatures and lower pH values within the experimental domain.  
 
 
 
 
 
 
 
 
A least squares technique was used to fit quadratic polynomial model and obtain 
multiple regression coefficients for -L-rhamnosidase residual activity that is 
summarized on Table 2.5. Examination of these coefficients using the t-test indicated 
that, both linear and quadratic terms of temperature effects on -L-rhamnosidase 
residual activity were highly significant, p < 0.001 (Table 2.5). The linear and quadratic 
terms of pH were significant on -L-rhamnosidase residual activity (p < 0.05) (Table 
2.5). 
Therefore a curved surface was fitted to the experimental data (Figure 2.3). Partial 
differentiation of these polynomial equations was used to find the optimum points, i.e. 
the stationary points. The least-square estimates of the coefficients of the model were 
calculated from the values of the response for each experiment in the chosen 
experimental matrix. The relationship between independent and dependent variables in 
Variable Ar (-L-rhamnosidase) 
T (linear term) 18.1467*** 
T (quadratic term) ─ 23.8667*** 
pH (linear term) ─ 2.5064* 
pH (quadratic term) ─ 2.4592* 
T x pH ─ 2.3500 
Table 2.4 Effects and respective significance levels (p) of temperature (T) and pH on -L-rhamnosidase 
residual activity (Ar). 
* p < 0.05, *** p < 0.001 
CHAPTER 2   
78 
the three-dimensional representation is a convex surface (Figure 2.3). The obtained 
response surface (Figure 2.3) was described by second-order polynomial equations to 
the experimental data points, as a function of temperature and pH (Table 2.5).  
The high values of R2 and R2adj of the model (Table 2.5) showed a close agreement 
between the experimental results and the theoretical values predicted by the model 
(Vuataz, 1986). The adjusted coefficient of determination for -L-rhamnosidase 
residual activity (R2adj = 0.872) implied that 87.2 % of the variations could be explained 
by the fitted model. 
The ANOVA for the two response variables (temperature and pH) indicated that the 
model developed for -L-rhamnosidase residual activity was adequate with the linear 
and the quadratic term with high statistical significance (p < 0.05) (data not showed). 
The regression models allowed the prediction of the effects of the two parameters, 
temperature and pH on -L-rhamnosidase residual activity and concomitant -D-
glucosidase inactivation. These optimal conditions found were at 81.5 ºC and pH of 3.9, 
remaining a -L-rhamnosidase residual activity of 0.77. Once tested, the model may be 
used to predict the value of the response(s) under any conditions within the 
experimental region. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coefficient Ar (-L-rhamnosidase)  p 
o 63.6717 0.0004 
Linear   
1 1.5645 0.0004 
2 0.3661 0.0322 
Quadratic   
11 0.0095 0.0004 
22 0.0123 0.0355 
Cross product   
12 0.0033 0.0530 
   
R2 0.936 - 
R2adj 0.872 - 
Table 2.5 Second-order model equations for the response surfaces fitted to the experimental data 
points of -L-rhamnosidase residual activity (Ar), as a function of temperature (T) and pH, and 
respective R2 and R2 adj. 
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2.3.4 Verification of the optimal temperature and pH inactivation conditions 
The optimal conditions of temperature and pH found, using RSM, were tested in order 
to support the predicted results. Figure 2.4 shows the inactivation profiles of both -D-
glucosidase and -L-rhamnosidase under 81.5 ºC and pH 3.9. Moreover, the 
verification experiments proved that the predicted values for -L-rhamnosidase residual 
Figure 2.3 Response surface fitted to the experimental data points, corresponding to -L-rhamnosidase 
residual activity, as a function of temperature (T) and pH. 
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activity (0.77) for the model was satisfactorily achieved within more than 95 % 
confidence interval. The time needed for -D-glucosidase activity reach 0.01% of -L-
rhamnosidase activity was determined through extrapolation of -D-glucosidase 
inactivation and corresponded to 16 minutes. At this time the -L-rhamnosidase 
residual activity found was 0.78 which is quite similar to value predicted with RSM 
(0.77). 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.5 Compounds production and identification 
Once -D-glucosidase of naringinase was selectively inactivated, the -L-rhamnosidase 
activity was used for the production of flavone glucosides starting from rutinosides 
(Table 2.6 and Figure 2.5). Adequate purification procedures were used and compounds 
identification was carried out through HPLC-MS/MS analysis. Compounds purity was 
higher than 95%. 
 
 
 
 
 
 
 
 Figure 2.5 TLC of naringin (a), prunin (b), naringenin (c), rutin (d), isoquercetin (e) and quercetin (f). 
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Figure 2.4 Inactivation kinetics of-D-glucosidase and -L-rhamnosidase, at 81.5ºC and pH 3.9. 
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Naringin enzymatic hydrolysis led to prunin, while isoquercetin was obtained from rutin 
(Figure 1.10). A production yield of 30% and 61% was obtained, respectively, for both 
prunin and isoquercetin. The aglycones were also produced from rutinosides using 
native naringinase, expressing both -L-rhamnosidase and -D-glucosidase (Figure 
1.10). Naringenin was obtained with a production yield of 49% from naringin, while 
quercetin was obtained from rutin (Figure 1.10) in a yield of 86%.The sequential 
removal of the sugar moiety from the rutinosides into the glucoside and finally into the 
aglycone decreased the molecule polarity, as shown in Figure 2.5. These outcomes 
showed the high potential of the developed method on the production of the flavone 
glucosides and aglycones, as well. 
Compounds Rf Visible light UV light (254 nm) 
Acid revelation + 
heating (150 ºC) 
Naringin 0.62 invisible visible orange 
Prunin 0.58 invisible visible orange 
Naringenin 0.30 invisible visible orange 
Rutin 0.55 yellow visible yellow 
Isoquercetin 0.53 yellow visible yellow 
Quercetin 0.30 yellow visible yellow 
Table 2.6 Results of TLC analysis of naringin (a), prunin (b), naringenin (c), rutin (d), isoquercetin (e) 
and quercetin (f). 
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2.4. Conclusions 
 
In the current study it was found the best combinations of temperature and pH to 
selectively inactivate -D-glucosidase from naringinase. This achievement comprises 
simultaneously a high remaining -L-rhamnosidase activity. This -L-rhamnosidase 
residual activity, expressed by naringinase, was affected by pH and temperature 
individually and interactively. The residual activity could be described by a response 
surface that enabled the fit of second-order polynomial equation. A closed agreement 
between the experimental -L-rhamnosidase residual activity (0.78) and the predicted 
value by the model (0.77) reflects the good fitness of RSM as a tool to accomplish this 
study. The optimum temperature and pH conditions to selectively inactivate -D-
glucosidase, remaining the highest -L-rhamnosidase residual activity occur at 81.5ºC, 
pH 3.9 for 16 minutes.  
Starting from the natural occurring flavone substrates, naringin and rutin, the flavone 
glucosides, prunin and isoquercetin, were produced with a production yield of 
respectively 30% and 61%, while the flavone aglycones, naringenin and quercetin were 
obtained with a final yield of 49% and 86% respectively. 
Naringinase with -D-glucosidase activity selectively inactivated allowed the 
production of two very expensive flavone glucosides, prunin and isoquercetin, in an 
easy and cheap bioprocess starting from naringin and rutin, respectively. This method 
could also be generalized for obtaining others also expensive flavone glucosides starting 
from their rutinosides. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENZYMATIC BIOCATALYSIS USING NARINGINASE UNDER 
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3.1 Introduction 
 
Pressure is a very promising tool concerning enzymatic biocatalysis. Its influence on 
enzyme stability is directly dependent on the enzyme tridimensional structure that can 
be modulated according to the pressure magnitude. On the other hand, it may influence 
the enzyme activity by changing the reaction limiting step. These two approaches may 
be used to increase the productivity of a biocatalytic process. Accordingly, the 
biocatalytic study of naringinase under pressure focuses on two main issues: stability 
and activity. Therefore the stability of both -L-rhamnosidase and -D-glucosidase 
activities expressed by naringinase was evaluated against temperature inactivation under 
pressure, as well as the influence of pressure on the activity of these both enzymatic 
activities. 
On the basis of the stability studies against temperature is the importance of this 
parameter to modulate the reaction rate as well as the solubility of certain substrates 
such as naringin and rutin (Pulley, 1936; Zi et al., 2007). The low water solubility of 
these substrates is a limitation to attain higher hydrolysis reaction rates with naringinase 
in aqueous media, as higher substrate concentrations are required to achieve better 
reaction rates. Temperature raise favours substrates solubility as well as the reaction rate 
but only till optimum temperature is reached, excessive high temperature may be 
deleterious to naringinase native state, which is crucial for its activity. 
Pressure can be used in a way to hinder naringinase denaturation under high 
temperature conditions, as stated on 1.4.4.2. This protecting effect of pressure against 
heat inactivation is bounded by a critical pressure value, where the volume change 
associated with denaturation is null and above which turns to be negative (Weemaes et 
al., 1998; Scharnagl et al., 2005; Buckow et al., 2007). Even though this study focuses 
on high temperature values, the protective effect of pressure is also bounded by a 
critical temperature value bellow which this effect exists and can be studied. Both these 
critical pressure and temperature values are dependent on each specific studied protein, 
comprising an interesting biotechnological field in order to increase the efficiency of 
biocatalytic processes. 
Beyond the influence of temperature and pressure on the enzyme structure, the 
enzymatic reaction rate and chemical equilibrium dependence on these two variables is 
a matter of major biotechnological interest. As stated on 1.4.3, the functional 
dependence of enzymes activity on the binomial temperature and pressure can be used 
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to modulate it, in order to attain improved results (Pedro et al., 2007; Hay et al., 2007; 
Eisenmenger and Reyes-De-Corcuera, 2009). Beyond temperature, pressure has been 
used to accelerate biocatalytic reactions and even to shift chemical equilibriums 
according to TST and the Le Chatelier’s principle, respectively. The determination of 
the thermodynamic parameters: Vreac, ≠V, ≠H, ≠S and ≠G are of major importance 
in order to understand the enzymatic reaction dependence on both pressure and 
temperature. 
This work aims to study a potential increased stability of both -L-rhamnosidase and -
D-glucosidase from naringinase, under pressure, against high temperature conditions, 
concerning the stated behaviour of proteins against pressure and temperature (Figure 
1.12). Also, optimum pressure conditions under high temperature ought to be found, 
under which the pressure protecting effect is maximum. Focusing on enzyme activity, 
the aim is to study the effect of both pressure and temperature over the reaction rate 
constants of both -L-rhamnosidase and -D-glucosidase expressed by naringinase. 
Also the influence of pressure on the equilibrium constant of both -L-rhamnosidase 
and -D-glucosidase will be studied. Finally, another aim of this study consists on 
studying the hydrolysis of the flavone rutinoside naringin into naringenin by 
naringinase.  
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3.2 Material and Methods 
 
3.2.1 Chemicals 
Naringin, 4-NRP and 4-NGP were from Sigma-Aldrich; 3,5-dinitrosalicylic acid (DNS) 
and glucose were from Merck; all other chemicals were of analytical grade and obtained 
from various sources. 
 
3.2.2 Enzyme solution 
Naringinase (CAS nº. 9068-31-9, cat. nº. 1385) from Penicillium decumbens was 
obtained from Sigma-Aldrich and stored at 20ºC. The lyophilized naringinase powder 
was dissolved in 20.0 mM acetate buffer pH 4.0, at 200 g.L-1 concentration. The 
enzyme stock solution was kept at 4 ºC for a month, during the experimental period. 
 
3.2.3 High-pressure equipment 
Experiments under pressure were carried out in a stainless-steel vessel immersed in a 
thermostatic water bath (Julabo Hc / F18) according to the sketch in Figure 3.1 
assuming isobaric and isothermal conditions (Vila-Real et al., 2007).  
A particular concern when working with pressure equipments was the temperature 
increase whenever pressure was build-up due to adiabatic heat. According to 
Albuquerque (1979), the temperature increase is dependent on the compression rate but 
is independent of the temperature value. This overheating may reach 15 ºC at 250 MPa 
when the compression rate is 50 MPa min1 (Albuquerque, 1979). After reaching the 
desired pressure, a maximum temperature was reached followed by a temperature 
decrease till the working temperature. In order to avoid the possible overheating during 
pressure build-up due to adiabatic heat, a simple method was developed that consisted 
on the compensation of the heat of compression with the heat loss during 
decompression. Previously, the reaction vessel was pressurized at the working pressure 
waiting till thermal equilibrium was attained. The assay starts with the vessel 
decompression, following opening and closing to insert the samples and finally a 
compression of the same magnitude. The temperature inside the reaction vessel was 
determined by measuring the conductance of a 0.01 mM potassium chloride aqueous 
solution and fitting a linear dependence between conductivity and temperature. The 
thermostat was regulated for 30.0 ºC. The compression rate was standardized in a way 
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to minimize the overheating (Table 3.1). Figure 3.2 shows the temperature variation 
inside the reaction vessel along time. The overheating was maximal after 10 minutes 
and didn’t exceed 2.0 ºC even at the higher pressure (Table 3.1). Only pressure values 
of 150, 200 and 250 MPa were studied since at lower pressure the overheating is low. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pressure values  
(MPa) 
Pressure range 
(MPa) 
Compression rate 
(MPa min1) 
ΔT 
(ºC) 
0 – 125 125  
125 – 140 15 0.9 ± 0.0 
150 
140 – 150 3  
0 – 150 150  
150 – 190 40 1.5 ± 0.1 
200 
190 – 200 3  
0 – 150 150  
150 – 200 50 1.7± 0.1 
250 
200 – 250 13  
Figure 3.1 Pressure apparatus. Vessel (1); steel pipe (2); valve (3); pressure gauge (4); manual pump (5); 
vessel cap (6); thermostatic bath (7). 
Mean value ± SE, n = 3. 
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Figure 3.2 Temperature change inside the reaction vessel along time, during depressurization followed by 
pressurization till the desired pressure (150, 200 and 250 MPa) (thermostatic bath set at 30.0 ºC). 
Table 3.1 Correspondence between the temperature overheating and the attained pressure values of 150, 
200 and 250 MPa and respective compression rates. 
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3.2.4 Analytical methods 
The concentration of the reducing sugars was determined using the DNS assay (Miller, 
1959). In this work the DNS macroassay was modified into a microassay procedure 
using a microtiter plate, having the advantages of higher repeatability, speed, large 
sample analysis number and sample volume reduction. The microassay developed 
consisted on the addition of DNS reagent (85 L) to an equal sample volume in a 96 
well microtiter plate. The microplate is heated for 5 minutes at 100 ºC and then cooled 
in a water bath at room temperature. Absorbance is read at 575 nm (Hitachi 2000, UV-
visible spectrophotometer). The concentration of the reducing sugars was determined 
against a glucose calibration curve. 
The concentration of p-nitrophenol released after the hydrolysis of 4-NRP and 4-NGP 
was evaluated spectrophotometrically (Hitachi 2000, UV-visible spectrophotometer 
coupled to a Julado F25 thermostat) at 340 nm, using a calibration curve of each 
compound. 
 
3.2.5 Activity measurement 
3.2.5.1 Inactivation kinetics 
0.20 mM of 4-NRP and 4-NGP, in 20 mM acetate buffer at pH 4.0, were respectively 
used as substrates to determine α-L-rhamnosidase and β-D-glucosidase activities, 
expressed by naringinase. The naringinase concentration used in the assays was 100 mg 
L1. There was a linear correlation between enzyme concentration and enzyme activity, 
from 0 to 300 mg L1 naringinase concentration. The enzyme residual activity was 
measured spectrophotometrically, throughout the addition of equal volumes of enzyme 
and substrate solutions. Absorption was measured every 30 s, during 10 min, at 30.0 ºC, 
at atmospheric pressure. The enzyme activity was determined by linear regression on 
the first data-points during the initial reaction time. 
 
3.2.5.2 Reaction thermodynamic functions 
0.20 mM of 4-NRP and 4-NGP, in 20 mM acetate buffer at pH 4.0, were respectively 
used as substrates to determine α-L-rhamnosidase and β-D-glucosidase activities, 
expressed by naringinase. 
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In the studies of temperature dependence assays the naringinase concentration used was 
100 mg L1. The enzyme activity was measured spectrophotometrically, throughout the 
addition of equal volumes of enzyme and substrate solutions. Absorption was measured 
every 30 s, during 10 min, at atmospheric pressure, within a temperature range of 20.0  
45.0 ºC. The enzyme activity was determined by linear regression on the first data-
points during the initial reaction time. 
In the case of the determination of the activation volume within pressure dependence 
assays, a naringinase concentration of 5 mg L1 was used to study the α-L-rhamnosidase 
activity and 10 mg L1 was used to study the -D-glucosidase activity. The absorption 
was measured every 15 min, during 90 min, at 40.0 ºC, at atmospheric pressure after 
removing the samples from the high-pressure equipment, within a pressure range of 0  
200 MPa. Each data point required a new experiment due to the depressurization needed 
at the end of the incubation period. The enzyme activity was determined by linear 
regression on the first data-points during the initial reaction time. 
 
Naringin bioconversion studies were performed in 20 mM acetate buffer at pH 4.0, with 
naringinase. Naringin was hydrolyzed into prunin and rhamnose followed by the 
hydrolysis of prunin into naringin and glucose. 
In the studies of temperature dependence it was used 0.2 mM of naringin and a 
naringinase concentration of 50 mg L1. Initial reaction rate was evaluated within a 2 
hours period, using a continuous sampling method every 10 minutes, along the catalytic 
reaction. The reaction occurred at atmospheric pressure in a thermostatic water bath 
(Julabo HC/F18) within a temperature range of 25.0 – 45.0 ºC. The reaction was 
stopped by cooling the samples on ice. The reducing sugars content was measured 
spectrophotometrically, using DNS assay. The enzyme activity was determined by 
linear regression on the first data-points during the initial reaction time. 
In the case of the determination of the activation volume within pressure dependence 
assays, it was used a pressure equipment coupled to a UV-visible spectrophotometer 
(these experiments were carried out in the lab of Prof. Dr. Phillips). It was used a 0.1 
mM of naringin and a naringinase concentration of 50 mg L1. The absorption was 
measured every 10 s, during 60 min, at 40.0 ºC, within a pressure range of 0  250 MPa. 
The naringenin absorbance was measured spectrophotometrically at 309 nm. The 
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enzyme activity was determined by linear regression on the first data-points during the 
initial reaction time. 
 
3.2.5.3 Naringin bioconversion: combined effects of pressure and temperature 
Naringin bioconversion studies were carried out in standard solutions of naringin in 20 
mM acetate buffer at pH 4.0 and at atmospheric pressure (0 MPa), as well as, under the 
pressure of 150 MPa. During this bioconversion, naringin is hydrolyzed into prunin and 
rhamnose followed by the hydrolysis of prunin into naringin and glucose. 
At atmospheric, pressure kinetic measurements ranged from 25.0 to 80.0 ºC. In the high 
pressure catalytic reaction studies, each data point required a new experiment due to the 
depressurization needed at the end of the incubation period. The reaction was 
immediately stopped, lowering the temperature of solutions below 0 ºC and the samples 
were frozen (20 ºC) until the enzymatic activity assays were carried out. The 
naringinase concentrations ranged from 5 – 75 mg mL1, according to the experimental 
temperature, in order to obtain a straight linear progression during the first 80 minutes, 
using a continuous sampling method every 10 minutes, along the catalytic reaction. The 
reducing sugars content was measured spectrophotometrically, using DNS assay. The 
enzyme activity was determined by linear regression on the first data-points during the 
initial reaction time. 
 
3.2.6 Inactivation conditions 
3.2.6.1 Atmospheric pressure 
The thermal inactivation kinetics of α-L-rhamnosidase and β-D-glucosidase was studied 
at 55 – 85 ºC. The thermal inactivation at atmospheric pressure occurred at isothermal 
conditions (± 0.1 ºC) using a thermostatic water bath (Julabo Hc/F18). The enzyme 
solution was kept in Eppendorf tubes (1.5 mL) during the thermal inactivation. After 
removing the enzyme samples from the water bath they were cooled on ice for 5 min to 
stop the thermal inactivation. The inactivation time ranged from 180 to 6 min according 
to the temperature used. Enzyme activity was measured, in triplicate, immediately after 
inactivation, as well as one day after. A0 is the specific activity of a control non-heated 
enzyme sample. 
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3.2.6.2 Pressurized conditions 
The study of naringinase inactivation under pressure was performed at 0 – 250 MPa, at 
a certain temperature value. Only one temperature condition was studied for each 
activity of -L-rhamnosidase (85.0 ºC) and -D-glucosidase (75.0 ºC). The temperature 
conditions chosen were the highest temperature to cause a fast enzymatic inactivation, 
so eventual protecting effects of pressure from inactivation could be easily measured. 
The enzyme solution was kept in closed Eppendorf tubes (1.5 mL) during inactivation 
under pressure. After removing the enzyme samples from the water bath they were 
cooled on ice for 5 min to stop the thermal inactivation. The inactivation time ranged 
from 180 to 90 min according to the pressure used. A0 was the specific activity of a 
control non-pressurized and non-heated enzyme sample.  
 
3.2.7 Parameters estimation 
3.2.7.1 Inactivation rate constants 
First-order inactivation rate constants (k1 and k2) as well as the α1 parameter could be 
determined by non-linear regression by minimizing the residual sum of squares of the 
experimental data points for the residual activity vs. treatment time and those estimated 
by the model, using Solver add-in from Microsoft Excel 2003 for Windows XP, 
considering the following options: Newton method; 100 iterations, precision of 106, 5 
% of tolerance and 104 convergence. The first-order inactivation rate constant obtained 
from linear regression of ln Ar vs. t was used as the initial value for the non-linear 
regression k1 parameter. The non-linear regression parameters were restricted to positive 
numbers.  
In the case of the kinetics obeying to Equation 1.47, t1/2 was determined through either 
interpolation or extrapolation. Concerning the first-order inactivation kinetics, t1/2 was 
calculated using Equation 1.49. 
 
3.2.7.2 Reaction thermodynamic parameters 
The reaction thermodynamic parameters could be determined after fitting an adequate 
model described on 1.4.3 to experimental data of equilibrium constants and reaction rate 
constants, through linear regression. In the case of Baliga and Whalley model (Equation 
1.30) the fit to experimental data was carried out using a non-linear curve-fit program in 
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Excel for Windows, version 8.0 SR2, by minimizing the residual sum of squares 
between the experimental data points and the estimated values by the model. 
 
3.2.7.3 Enzymatic kinetic parameters 
The fit of the Michaelis-Menten model (Equation 1.1) to experimental data was carried 
out using a non-linear curve-fit program in Excel for Windows, version 8.0 SR2, by 
minimizing the residual sum of squares between the experimental data points and the 
estimated values by the model. The kinetic parameters estimated by linear regression 
using the Lineweaver-Burk equation (Equation 1.4), which results from the linearization 
of the Michaelis-Menten equation, were used as initial values of the non-linear 
regression parameters. The non-linear regression parameters were constricted to positive 
numbers. The catalytic constant was determined according to Equation 1.5. 
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3.3 Results and Discussion 
 
3.3.1 Inactivation kinetics 
3.3.1.1 Thermal inactivation of -L-rhamnosidase and -D-glucosidase, at atmospheric 
pressure 
The effect of temperature on the stability of -L-rhamnosidase and -D-glucosidase, 
expressed by naringinase was studied between 55 – 75 ºC, and 70 – 85 ºC, respectively 
(Figure 3.3). Enzyme activity was measured, immediately after, as well as one day after, 
without occurring reactivation. 
In the case of β-D-glucosidase, biphasic inactivation kinetics (Equation 1.47) was 
observed (Figure 3.3a). This inactivation kinetics, considering a first inactivation step 
followed by a second one, were in agreement with the existence of an enzymatic 
intermediate with a lower specific activity than the initial enzyme native state, and a 
final state where the enzyme was completely inactivated (Henley and Sadana, 1985). 
The inactivation of α-L-rhamnosidase occurred according to the classical first-order 
inactivation model (Equation 1.48) (Figure 3.3b). 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 shows the two inactivation constants calculated for β-D-glucosidase, as well 
as the α1 parameter determined for each working temperature. In case of α-L-
rhamnosidase a single inactivation constant was determined for all temperature 
conditions studied (Table 3.2). The half-life parameter of α-L-rhamnosidase (Table 3.2) 
seemed to be more resistant against inactivation caused by heat than β-D-glucosidase. In 
fact, at 75.0 ºC, β-D-glucosidase exhibited a half-life of 5 min, while the α-L-
Figure 3.3 Thermal inactivation kinetics of β-D-glucosidase (a) and α-L-rhamnosidase (b), at 0 MPa 
(mean value ± SE). 
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rhamnosidase half-life (279 min) was more than 50 fold higher. Almost complete 
inactivation of β-D-glucosidase and α-L-rhamnosidase occurred at 75.0 ºC and 85.0 ºC, 
respectively, within a 1 hour period. 
 
 
 
The Arrhenius model (Equation 1.13) fitted the experimental data, and the inactivation 
constants of β-D-glucosidase and α-L-rhamnosidase clearly showed a linear temperature 
dependence (Figure 3.4), allowing the accurate calculation of thermodynamic 
parameters. Therefore, the activation enthalpy, entropy and Gibbs energy were 
determined and are presented in Table 3.3. The positive activation enthalpy is in 
agreement with bond disruption occurring during denaturation. In the case of β-D-
glucosidase where a biphasic inactivation kinetics was observed (Figure 3.3a), the 
activation enthalpy almost triplicates from inactivation step 1 (104 kJ mol1) to step 2 
(285 kJ mol1). In fact the activation enthalpy of the first inactivation step was lower 
than the second, which was consistent with a first small bond disruption where the 
intermediate enzyme still had some activity followed by a second inactivation step with 
higher bond disruption. 
Both enzymes showed positive activation entropy (Table 3.3), which was consistent 
with the melting away of the ordered solvent structures. Denaturation occurred when 
entropy compensated enthalpy turning negative the Gibbs free energy of activation 
(Table 3.3). The denatured state caused by high temperature led to a random coil-like 
structure with exposure of hydrophobic groups of amino acids to the aqueous solution. 
T (ºC) 1 k1.103 (min1) k2.103 (min1) t1/2 (min) R
2 
-D-glucosidase      
55.0 0.88 ± 0.04   46 ± 40 0.13 ± 0.22 2211 ± 2500 0.999 
60.0 0.87 ± 0.03   34 ± 11 0.26 ± 0.22 3065 ± 1641 0.965 
65.0 0.77 ± 0.04   53 ± 22 1.20 ± 0.33   388 ± 56 0.995 
70.0 0.54 ± 0.02   84 ± 13 3.08 ± 0.27     42 ± 1 0.998 
75.0 0.17 ± 0.06 184 ± 57 27.5 ± 4.6    5.2 ± 1.3 0.999 
-L-rhamnosidase      
70.0 -   0.9 ± 0.1 - 761 ± 89 0.829 
75.0 -   2.5 ± 0.1 - 279 ± 14 0.972 
77.5 -   3.9 ± 0.2 - 179 ± 11 0.966 
80.0 -   7.5 ± 0.1 -   92 ± 1 0.966 
82.5 - 16.3 ± 0.6 -   42 ± 2 0.978 
85.0 - 46.2 ± 1.0 -   15 ± 0 0.977 
Mean value ± SD, n = 3. 
 
Table 3.2 Thermal inactivation parameters of  β̀-D-glucosidase and α-L-rhamnosidase, at 0 MPa. 
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This process was driven by solvent and enzyme entropy increase mainly due to the 
greater freedom of the side chains of the amino acids as well as the enzyme backbone 
(Scharnagl et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.1.2 Thermal inactivation of -L-rhamnosidase and -D-glucosidase, under pressure 
The study of the inactivation of β-D-glucosidase and α-L-rhamnosidase under pressure 
(0 – 250 MPa) was carried out respectively at the temperature conditions of 75.0 and 
85.0 ºC (Figure 3.5). 
 ≠H (KJ mol1) ≠ S (J mol1 K1) ≠G (KJ mol1) R2 
-D-glucosidase     
(1st inactivation) 104 ± 12 37 ± 35 12.3   (60 ºC) 
12.5   (65 ºC) 
12.7   (70 ºC) 
12.8   (75 ºC) 
0.98 
(2nd inactivation) 285 ± 34 539 ± 99 179    (60 ºC) 
182    (65 ºC) 
185    (70 ºC) 
188    (75 ºC) 
0.97 
     
-L-rhamnosidase 256 ± 24 441 ± 67 153    (75 ºC) 
154    (77.5 ºC) 
155    (80 ºC) 
157    (82.5 ºC) 
158    (85 ºC) 
0.97 
Table 3.3 Thermodynamic parameters of the thermal inactivation of β-D-glucosidase and α-L-
rhamnosidase, at 0 MPa. 
Mean value ± SD, n = 3. 
Figure 3.4 Temperature dependence of the inactivation constants of β-D-glucosidase and α-L-
rhamnosidase, at 0 MPa. 
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Similar to thermal inactivation kinetics, β-D-glucosidase showed a biphasic inactivation 
kinetics under pressure (Figure 3.5a) and two inactivation constants (k1 and k2) were 
determined as well as the α1 parameter. On the other hand α-L-rhamnosidase showed 
first-order inactivation kinetics (Figure 3.5b) with an inactivation constant reported on 
Table 3.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P (MPa) 1 k1.103 (min1) k2.103 (min1) t1/2  (min) R2 
-D-glucosidase      
0 0.17 ± 0.06 190 ± 62 27.9 ± 4.8     5 ± 1 0.99 
25 0.48 ± 0.03 166 ± 21 17.8 ± 2.8   12 ± 1 0.99 
50 0.53 ± 0.00 126 ± 16   6.6 ± 0.4   23 ± 2 0.99 
100 0.65 ± 0.01 293 ± 250   3.2 ± 0.3   88 ± 8 0.99 
150 0.70 ± 0.05 147 ± 30   2.6 ± 0.4 133 ± 6 0.99 
200 0.70 ± 0.06 136 ± 100   2.3 ± 0.4 154 ± 16 0.99 
250 0.76 ± 0.08 482 ± 544   3.6 ± 0.8 118 ± 4 0.99 
-L-rhamnosidase      
0 - 46.3 ± 1.2 -   15 ± 0 0.97 
25 - 17.5 ± 0.7 -   40 ± 2 0.96 
50 - 10.7 ± 0.5 -   65 ± 3 0.98 
100 -   4.7 ± 0.0 - 147 ± 3 0.97 
150 -   2.7 ± 0.3 - 263 ± 27 0.98 
200 -   1.9 ± 0.1 - 362 ± 15 0.93 
250 -   1.4 ± 0.1 - 487 ± 57 0.88 
 
In the case of β-D-glucosidase, as pressure was increased from 0 to 200 MPa the second 
inactivation constant decreased, while for the first inactivation constant no tendency 
could be established. This first inactivation rate exhibited a large error reflected on the 
Figure 3.5 Inactivation kinetics of β-D-glucosidase at 75.0 ºC (a) and α-L-rhamnosidase at 85.0 ºC (b), 
under several pressure conditions (mean value ± SE). 
 
0.00
0.25
0.50
0.75
1.00
0 50 100 150 200 250
t  (min)
A
r 0 MPa
25 MPa
50 MPa
100 MPa
150 MPa
200 MPa
250 MPa
0.00
0.25
0.50
0.75
1.00
0 50 100 150 200 250
t  (min)
A
r
0 MPa
25 MPa
50 MPa
100 MPa
150 MPa
200 MPa
250 MPa
a) b) 
Table 3.4 Inactivation kinetics parameters of β-D-glucosidase at 75.0 ºC and α-L-rhamnosidase at 85.0 ºC, 
under several pressure conditions. 
 
Mean value ± SD, n = 3. 
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large standard errors (Table 3.4). Nevertheless, as expected, the half-life time of β-D-
glucosidase increased with pressure from 5 minutes at atmospheric pressure up to a 
maximum of 154 minutes at 200 MPa (Table 3.4). At 75°C and under a pressure 
condition of 200 MPa, -D-glucosidase was 30 fold more resistant against inactivation 
than at atmospheric pressure. Indeed, the biphasic kinetics observed in Figure 3.5a 
shows that the first inactivation constant was higher than the second inactivation 
constant, which means that β-D-glucosidase initially was inactivated more rapidly 
before reaching the time value of the half-life and afterwards more slowly (Table 3.4), 
which also occurs in thermal inactivation, at atmospheric pressure. 
In the case of α-L-rhamnosidase, the inactivation constant also decreased with pressure, 
which is in agreement with an increase of its half-life from 15 minutes at atmospheric 
pressure up to a maximum of 487 minutes at 250 MPa (Table 3.4). In fact, this observed 
maximum value may be even greater under higher pressure conditions, which could not 
be tested due to experimental device limitations. α-L-rhamnosidase was 32-fold more 
resistant against inactivation at 250 MPa and 85 ºC than at atmospheric pressure.  
Figure 3.6 highlights the inactivation constant dependence with pressure, showing how 
both the second inactivation constant of β-D-glucosidase and the inactivation constant 
of α-L-rhamnosidase decreased with pressure. These data are well fitted to the Golinkin 
Laidlaw and Hyne equation (Equation 1.24), allowing the activation volume 
determination at atmospheric pressure (Table 3.5). A compressibility coefficient of 
activation (≠) was also determined according to Equation 1.26 (Table 3.5), originated 
by an activation volume change with pressure. The large and positive activation volume 
obtained (Table 3.5) is consistent with a high volume increase between the reactant state 
and the transition state. As pressure favors the smaller volume, which is the volume of 
reactants, pressure led to the stabilization of the native state of both subunits of 
naringinase. In addition, for each naringinase subunit, this stabilization under pressure 
was also dependent on the pressure magnitude (Table 3.5). The positive value of the 
compressibility coefficient of activation is in agreement with a minor effect of pressure 
over the activation volume until a minimum was reached, corresponding to a null 
activation volume. The β-D-glucosidase minimum observed in Figure 3.6 corresponded 
to an optimum pressure value of 173 ± 9 MPa which is the zero of the first derivative of 
Equation 1.24 In the case of α-L-rhamnosidase, a minimum may be achieved at higher 
pressures (Figure 3.6), which we were not able to test due to experimental device 
limitations.  
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These results corroborate the antagonism between pressure and temperature at high 
temperature conditions, concerning the stability of proteins. It is also interesting to 
notice that a temperature increase can be done without compromising an enzyme 
inactivation increase by means of pressure, when comparing to atmospheric pressure 
conditions. This comparison can be done through the half-lives of both thermal 
inactivation at atmospheric pressure and under pressure conditions (Table 3.2 and 3.4). 
The highest β-D-glucosidase half-life time under pressure is 154 minutes (for 2nd 
inactivation), at 200 MPa and 75.0 ºC (Table 3.4), which is between the inactivation 
half-lives at 65.0 ºC (388 minutes) and 70.0 ºC (44 minutes), at atmospheric pressure 
(Table 3.2). These data support that β-D-glucosidase, under 200 MPa at 75.0ºC, showed 
the same inactivation half-life of a reaction carried between 65.0ºC and 70.0ºC 
temperature conditions, at atmospheric pressure; which corresponds to a 5 to 10ºC 
temperature magnitude increment. In an analogous way, α-L-rhamnosidase, which 
showed an half-life time of 487 minutes, at 250 MPa and 85.0 ºC (Table 3.4), had an 
inactivation half-time which was comprised between the half-lives time of 70.0 ºC (761 
minutes) and 75.0 ºC (279 minutes), of a reaction carried at atmospheric pressure (Table 
3.2); which corresponds to a 10 to 15ºC temperature magnitude increment. Altogether 
these data suggest that pressure may allow a reaction temperature increment ranging 
from 5 to 15ºC, according to certain reaction conditions as well as to the naringinase 
activities, without compromising an enzyme inactivation increase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Pressure dependence of the inactivation constant of β-D-glucosidase (k2) at 75.0 ºC and α-L-
rhamnosidase at 85.0 ºC. 
-4.00
-3.00
-2.00
-1.00
0.00
0 100 200 300
P  (MPa)
ln
(k
P.k
at
m
-
1 )
Glucosidase
Rhamnosidase
,k 2
CHAPTER 3   
100 
 
 
 
 
 
 
 
 
3.3.2 Reaction thermodynamic functions 
3.3.2.1 Pressure dependence 
The effect of pressure, from atmospheric pressure (0 MPa) to 200 MPa, at 40 ºC, was 
assessed for both -D-glucosidase and-L-rhamnosidase activities expressed by 
naringinase. These experiments allowed the determination of equilibrium constants and 
reaction volumes as well reaction rate constants and the activation volumes for both 
enzymatic reactions as shown below. In addition the activation volume associated with 
the bioconversion of naringin by naringinase was also determined. 
 
Reaction volume 
On Figure 3.7 is shown the pressure dependence of the equilibrium constants of the 
specific substrates 4-NRP and 4-NGP hydrolyzed by -L-rhamnosidase and -D-
glucosidase. Lower equilibrium constants of both substrates were obtained as pressure 
increased. 
Pressure effects on equilibrium constants were quantified fitting the experimental data 
to first, second and third order polynomial equations, respectively described by the 
models of Burris and Laidler (Equation 1.22) (Burris and Laidler, 1955), Golinkin, 
Laidlaw and Hyne (Equation 1.24) (Golinkin et al., 1966) and Walling and Tanner 
(Equation 1.27) (Walling and Tanner, 1963); and also by Baliga and Whalley model 
(Equation 1.30) (Baliga and Whalley, 1970). The F-test (Fisher-Snedecor test) (Table 
3.6) was used to choose the model that fitted better to the experimental results. Baliga 
and Whalley model was the best to describe the equilibrium constants dependence with 
pressure, allowing the calculation of reaction volumes (Table 3.6). Positive reaction 
volumes of 64 and 93 mL mol1 were obtained, respectively for 4-NGP and 4-NRP, 
hydrolysis by -L-rhamnosidase and -D-glucosidase. 
The decrease in hydrolysis equilibrium constants for both 4-NGP and 4-NRP with 
pressure (Figure 3.7) was in agreement with the positive reaction volumes. These results 
 ≠V (mL mol1) ≠mL mol1 MPa1) R2 
-D-glucosidase 87 ± 8 0.50 ± 0.06 0.98 
-L-rhamnosidase 79 ± 7 0.32 ± 0.06 0.99 
Table 3.5 Thermodynamic parameters of the inactivation kinetics of β-D-glucosidase at 75.0 ºC and α-L-
rhamnosidase at 85.0ºC (0 250 MPa). 
Mean value ± SD, n = 3. 
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indicate that the volume of the system increased when the reaction proceeds from 
substrate (S) to the products (P). Therefore, as pressure gets higher the equilibrium is 
directed back to the substrates that occupy together a smaller volume. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-D-glucosidase -L-rhamnosidase 
F-test F-test Models 
F Fc 
Vreac 
(mL mol1 )
 
F Fc 
Vreac  
(mL mol1) 
Golinkin, Laidlaw and Hyne  2.1 10.1 - 3.5 10.1 - 
Walling and Tanner 8.9 19 - 8.0 19 - 
Whalley and Baliga 14.3 10.1 64 ± 28 113.0 10.1 93 ± 3 
 
 
 
Activation volume 
Experimental values for relative activity of the naringinase enzymatic complex were 
acquired in the pressure range of 0 – 250 MPa at 40 ºC (Figure 3.8), considering the 
hydrolysis of 4-NGP, 4-NRP and naringin. This flavone rutinoside has both glucose and 
rhamnose residues that can be hydrolysed by naringinase (Vila-Real et al., 2007), while 
4-NRP and 4-NGP possess respectively a rhamnose and a glucose which makes them 
specific for both -L-rhamnosidase and -D-glucosidase, respectively. 
Table 3.6 Estimation of the reaction volumes of -D-glucosidase and -L-rhamnosidase. 
 
Mean value ± SD, n = 3. 
F = ((SSE1-SSE2)/(q2-q1))/(SSE2/(n-q2)), 95% 
Fc = (p2-p1,n-p2) 
 
Figure 3.7 Pressure dependence of the equilibrium constant of -D-glucosidase and -L-rhamnosidase. 
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The -D-glucosidase activity of naringinase decreased with pressures greatly at 50 MPa, 
and at 200 MPa almost reached 50 % inactivation (Figure 3.8). 
Both 4-NRP and naringin hydrolysis rates increased with pressure from 0 to 150 MPa. 
A higher hydrolysis rate occurred on the pressure ranged of 100 150 MPa, followed 
by a decrease of the -L-rhamnosidase and the naringinase activity for the naringin 
bioconversion (Figure 3.8). 
Naringin hydrolysis by naringinase firstly and faster withdraws the rhamnose residue of 
naringin, as favored by pressure increase, and later and slower the glucose residue, as -
D-glucosidase expression is deactivated by pressure (Figure 3.8).  
Pressure effects on rate constants were quantified according to the best fit of 
experimental data to first and second order polynomials relating ln k to P or to P2, 
respectively described by the models of Burris and Laidler (Equation 1.22) (Burris and 
Laidler, 1955) and Golinkin, Laidlaw and Hyne (Equation 1.24) (Golinkin et al., 1966). 
These models were used to fit naringinase activity pressure dependence for the 
substrates: 4-NGP, and 4-NRP and naringin (Table 3.7).  
Pressure affected negatively the reaction rate constant for 4-NGP hydrolysis. The 
experimental results for 4-NGP hydrolysis at different pressure were best fitted to the 
model of Burris and Laidler with a determination coefficient of 0.969. From the slope of 
ln k versus P an activation volume of 6.5 ± 1.9 mL mol1 was obtained. This positive 
activation volume means that 4-NGP hydrolysis rate was not favoured by pressure. 
Regarding the 4-NRP and naringin hydrolysis data were best fitted with Golinkin, 
Laidlaw and Hyne model, with a correlation coefficient of 0.99 and 0.97, respectively. 
The Δ≠V values for 4-NRP and naringin hydrolysis, calculated using Equation 1.25 are 
respectively –7.7 ± 1.5 and –20.0 ± 5.2 mL mol1. These values are related with an 
increase of the reaction rate constants at low pressure values, below 100 MPa. 
In previous work the effect of pressure on naringinase activity was tested in different 
systems (Marques et al., 2007; Pedro et al., 2007; Vila-Real et al., 2007; Ribeiro et al., 
2010). In fact a positive effect of pressure on reaction rates and a Δ≠V of –15.0 ± 1.8 mL 
mol¯1 were found using soluble naringinase for the hydrolysis of naringin (Vila-Real et 
al., 2007). Moreover a negative Δ≠V (−9 ± 2.8 mL mol¯1) was obtained with naringinase 
immobilized within calcium alginate beads (Pedro et al., 2007). 
Solvent contributions may be on the molecular basis of these moderated negative 
activation volumes by the formation of hydrogen bonds in the transition state (Tanaka et 
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al., 1994), which are stabilized by pressure due to the lowering of the inter-atomic 
distance (Mozhaev et al., 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2.2 Temperature dependence 
Both -L-rhamnosidase and -D-glucosidase activities increased with temperature. 
Clearly, the representation of the ln of naringinase specific activity, for the hydrolysis of 
4-NRP, 4-NGP and naringin against the absolute temperatures, resulted in a straight 
line. Indeed, Arrhenius equation (Equation 1.13) fits well to experimental data (Table 
3.8). Thermodynamic activation parameters, ≠H, ≠S and ≠G were evaluated 
according to Equations: 1.14, 1.15 and 1.16. 
Both hydrolysis of 4-NGP and 4-NRP by naringinase were found to be endothermic and 
endergonic reactions (Table 3.8). At constant temperature higher rates results in lower 
Substrate 4-NGP 4-NRP Naringin 
Fitting model Burris and Laidler Golinkin, Laidlaw and Hyne 
Golinkin, Laidlaw and 
Hyne 
R2 0.94 0.99 0.97 
F 0.1 116.9 114.8 
F-test Fc 10.1 10.1 10.1 
≠V (mL mol1) 6.5 ± 1.9 7.7 ± 1.5 20.0 ± 5.2 
≠ (mL mol1 MPa1) - ± 0.01 ±
Table 3.7 Estimation of the activation volumes, for the hydrolysis of 4-NGP, -NRP and naringin. 
 
Mean value ± SD, n = 3. 
95%. 
Figure 3.8 Pressure dependence of: -D-glucosidase, -L-rhamnosidase and naringinase. 
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standard Gibbs energy of activation. According to the results depicted in Table 3.7, the 
hydrolysis of both 4-NGP and 4-NRP occurs faster than the hydrolysis of naringin. This 
was an expected result as the conversion of naringin to final products takes at least two 
reaction steps, first into prunin and rhamnose and later into naringenin and glucose. 
Moreover, the binding energy associated with the specific substrate-enzyme interaction 
is usually a significant factor in lowering the Gibbs energy change required for reaction, 
being the large bonding energies of substrates due mostly to the complementary shape 
of the active site of the enzyme. Same trend occurs in activation enthalpy; in fact it is 
two and a half times higher in naringin bioconversion. For a bimolecular reaction 
transition state is formed when the two molecules old bonds are weakened and new 
bonds begin to form. So, positive and relatively high values for ≠H occur when 
covalent bonds are break.  
In both 4-NGP and 4-NRP hydrolysis reactions the formation of activated complex 
occurred with a higher degree of order, as inferred by the negative entropy of activation 
values (Lonhienne et al., 2000). In fact, activation entropy ≠S will tend to compensate 
≠H. So, the values found for ≠H on 4-NGP and 4-NRP hydrolysis was accompanied 
with a large decline in entropy from reactants to the transition state, resulting into very 
negative values, 133 kJ mol1 K1 and 128 kJ mol1 K1, respectively. 
The effects of pressure and temperature on the equilibrium or kinetics are antagonistic 
in molecular terms. As follows from the principle of microscopic ordering, an increase 
in pressure at constant temperature leads to an ordering of molecules or a decrease in 
the entropy of the system (Balny, 2004).  
 
 
Activity 4-NGP 4-NRP Naringin 
R2 0.97 0.98 0.99 
≠H (kJ mol1) 39.8 ± 9.8 39.6 ± 8.2 105.2 ± 3.8
≠S (kJ mol1K1) 133 ± 32 128 ± 27 46.0 ± 12.5
≠G20 ºC (kJ mol 39.0 37.7 
≠G25 ºC (kJ mol 39.7 38.3 91.5
≠G30 ºC (kJ mol 40.3 39.0 91.1
≠G35 ºC (kJ mol 41.0 39.6 90.9
≠G40 ºC (kJ mol 41.6 40.3 90.9
≠G45 ºC (kJ mol 42.3 40.9 91.6 
 
 
Table 3.8 Temperature activation parameters for the hydrolysis of 4-NGP and 4-NRP, at 0 MPa. 
 
Mean value ± SD, n = 3. 
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3.3.3 Combined effects of pressure and temperature on the kinetic parameters of 
naringin bioconversion 
Naringin hydrolysis by naringinase was preformed under atmospheric pressure as well 
as under pressure conditions of 150 MPa within a temperature range from 25 to 80 ºC 
(Figure 3.9). The range of naringin concentrations increased with temperature, due to its 
increased solubility with temperature. In fact due to naringin solubility limits at lower 
temperatures (25 35 ºC) only a range of 0.2 to 1 mM concentrations could be used; for 
temperatures higher than 55 ºC, solubility of naringin increased, so a range of 0.2 to 7 
mM naringin concentrations were then used (Figure 3.9). The temperature dependence 
of KM, kcat and kcat.KM1 was studied (Figure 3.10 and 3.11).  
The naringinase specific activity increased with temperature till 60 ºC and 70 ºC, 
respectively, at atmospheric and 150 MPa pressure conditions (Figure 3.9). At 
atmospheric pressure the rate of naringin hydrolysis decreased for higher temperatures 
than 70ºC. 
 
 
 
 
 
 
 
 
 
 
 
 
A slight increase in KM was observed with temperatures from 20 to 60 ºC, while for 
higher temperatures (70 and 80 ºC) it almost duplicated, from 2 mM to 4 mM, at 
atmospheric pressure. Under high pressure conditions of 150 MPa, Michaelis-Menten 
constant remained constant at temperatures from 20 to 50 ºC, while for temperatures of 
60 to 80 ºC a slight increase was observed, from 2 to 2.5 mM (Figure 3.10).  
In naringin hydrolysis with naringinase, from Penicillium sp., a KM of 2 mM was 
described for immobilized naringinase by covalent binding to wood material (Puri et al., 
Figure 3.9 Michaelis-Menten kinetics of naringinase, at different temperatures, at 0 MPa (a) and 150 MPa 
(b) (mean value ± SE). 
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2005), while Puri et al. (1996) cited a value of 10 mM for the KM of naringinase (from 
Penicillium sp.) immobilized in calcium alginate beads under pressure. Pedro et al. 
(2007) obtained a KM of 0.303 mM and vmax of 0.0418 mM min−1 with naringinase 
immobilized within calcium alginate beads, at atmospheric pressure. 
An important consequence of pressure application is that the reaction hydrolysis 
acceleration due to temperature increase is more significant under higher pressure 
conditions. The catalytic constant, as well as, the apparent second-order rate constant 
showed an increase till the temperature of 70 ºC was reached, where the enzyme activity 
was highest, decreasing afterwards. Around this temperature both the catalytic constant 
and apparent second-order rate constant showed higher values, respectively 15 mol 
min1 mg1 and 5 L min1 g1 under high pressure than at atmospheric pressure, 
respectively 5 mol min1 mg1 and 1.5 L min1 g1 (Figure 3.11). The kcat and kcat.KM1 
for the naringinase-catalyzed hydrolysis of naringin is not only temperature dependent 
but pressure as well. Under high pressure, at 70 ºC kcat and kcat.KM1 are 3-fold higher 
than at atmospheric pressure (Figure 3.11) and is even higher at 80 ºC, more than 4-fold 
(Figure 3.11a). When these values are compared at 30 ºC a 15-fold increase was 
observed at 70 ºC under 150 MPa. Similar results were obtained with -chymotrypsin at 
50 ºC and 360 MPa, with an activity more than 30-fold higher than the activity 
determined at atmospheric pressure and 20 ºC (Mozhaev et al., 1996). These authors 
assumed that activation volumes values increase with temperature. This stated pressure 
dependence is also in agreement with a pressure stabilization of protein, underlying a 
protecting pressure effect on naringinase native state against inactivation caused by 
heat. 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Temperature dependence of the Michaelis-Menten of naringinase for naringin bioconversion, 
at 0 MPa and 150 MPa (mean value ± SE). 
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Figure 3.11 Temperature dependence of the catalytic constant (kcat) (a) and second order constant 
(kcat.KM1) (b) of naringinase for naringin bioconversion, at 0 MPa and 150 MPa (mean value ± SE). 
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3.4 Conclusions 
 
This study shows how pressure can be turned into a powerful tool in biosynthesis, 
through the reduction of enzymatic inactivation caused by heat. It is shown how 
pressure can protect both -L-rhamnosidase (≠V = 79 ± 7 mL mol1, at 85.0 ºC) and -
D-glucosidase (≠V = 87 ± 8 mL mol1, at 75.0 ºC) activities from inactivation at high 
temperature conditions. In fact an antagonistic behavior between pressure and 
temperature, concerning the stability of proteins was observed. β-D-glucosidase was 30-
fold more resistant against inactivation at 200 MPa than at atmospheric pressure, while 
α-L-rhamnosidase was 32-fold more resistant against inactivation at 250 MPa than at 
atmospheric pressure. The best pressure condition to reduce β-D-glucosidase 
inactivation at 75.0 ºC was 173 MPa; while in the case of α-L-rhamnosidase 
inactivation at 85.0 ºC, the optimal pressure condition was above the maximal 
experimental pressure conditions (> 250 MPa). From another point of view, pressure 
allowed a reaction temperature increment ranging from 5 to 15ºC, according to the 
naringinase activity, -D-glucosidase and -L-rhamnosidase respectively, without 
comprising an increase on the enzyme inactivation rate. 
Pressure effects on equilibrium constants were quantified according to the fit of 
experimental data to Baliga and Whalley model. Positive reaction volumes of 64.3 mL 
mol1 and 93.1 mL mol1 were respectively obtained for the hydrolysis of 4-NGP and 4-
NRP. The decrease in the hydrolysis equilibrium constants for both 4-NGP and 4-NRP 
with pressure was in agreement with the positive reaction volumes, which is a 
consequence of the breaking of the covalent bond between the sugar and p-nitrophenol. 
Pressure effects on rate constants were quantified according to the best fit of 
experimental data to the Burris and Laidler model as well as the Golinkin, Laidlaw and 
Hyne model. The Δ≠V values for 4-NRP and naringin hydrolysis calculated using the 
Golinkin, Laidlaw and Hyne model were respectively –7.7 ± 1.5 and –20.0 ± 5.2 mL 
mol1, which is in agreement with a reaction rate increase with pressure. Moreover a 
positive Δ≠V value for the hydrolysis of 4-NGP (6.5 ± 1.9 mL mol-1) is in agreement 
with a reaction rate decrease with pressure.  
The catalytic constant as well as the apparent second-order rate for the hydrolysis of 
naringin catalyzed by naringinase is not only temperature dependent but pressure as 
well. Under 150 MPa, at 70 ºC the apparent second-order rate is 3-fold higher than 
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atmospheric pressure and is even higher at 80 ºC, 4-fold. This stated pressure 
dependence is in agreement with pressure stabilization of the enzyme native state, at 
high temperatures. In conclusion the effect of amplification of pressure effects on 
reaction rates by temperature could have a pragmatic use for accelerating enzymatic 
reactions. 
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4.1 Introduction 
 
In this work naringinase was subjected to immobilization concerning the general 
advantages of the biocatalyst immobilization technique described on 1.5. Studies 
regarding immobilization of naringinase and its reusability have been reported. 
Covalent binding has been used on glutaraldeyde-coated Bombyx mori silk fibers 
(Ellenrieder and Daz, 1996 and 1998), hen egg white (Puri et al., 2001), woodchips 
(Puri et al., 2005); non-covalent binding was tested on DEAE-Sephadex (Ono et al., 
1977), on Celite (Şekeroğlu et al., 2006) and on XAD, an non-ionic microstructured 
polymer, (Amaro et al., 2009) through adsorption; the entrapment method was 
developed using hallow fibres of cellulose triacetate (Tsen and Yu, 1991), Ca-alginate 
(Puri et al., 1996; Pedro et al., 2007; Ferreira, 2008) K-carrageenan (Ribeiro and 
Ribeiro, 2008a) and also polyvinyl alcohol (Nunes et al., 2010). The low operational 
stability and low activity are important problems to overcome concerning naringinase 
immobilization. 
Naringinase is immobilized, in this work, through an occlusion method within silica 
glasses through sol-gel method. This work is divided into three distinct parts. A first one 
consisting on the optimization of immobilized naringinase using several sol-gel 
precursors and also glycerol as additive. Afterwards the best naringinase immobilizate 
was used in biocatalytic cosolvent systems and ultimately this best immobilizate was 
changed through the addition of several ionic liquids (ILs). 
As an inclusion method, sol-gel glasses share the advantages related to this method as 
well as the inherent advantages of this kind of immobilization material (cf. 1.5). The 
high quantity of different sol-gel precursors and the many tuneable parameters 
underlying sol-gel chemistry turns it into a very challenging method. The pore size 
tuning is a major issue in order to circumvent a disadvantage of the occlusion method, 
which is related to the internal mass transfer effects. 
The main purpose of studying the use of organic solvents is to circumvent the low water 
solubility of the flavone rutinosides substrates caused by the hydrophobic nature of the 
phenolic moiety. Naringin and prunin were studied in this work. Beyond temperature, 
another approach to increase substrate solubility is medium engineering involving the 
substitution of aqueous reaction media by non-conventional media. Enzymes usually 
require aqueous environments in which some organic substrates are poorly soluble and 
in some cases even unstable. A straightforward solution to this problem is the 
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application of biphasic or cosolvent systems (Filho et al., 2003). In biphasic systems, 
the enzyme is dissolved in the aqueous phase, while the hydrophobic substrate is 
present in a high concentration in the organic phase. The occurrence of a liquid–liquid 
interface and presence of residual amounts of organic solvent in water can lead to 
deactivation of the biocatalyst. Different approaches to guide the choice of the proper 
solvent have been proposed, such as that reported by Laane et al. (1987) who suggested 
the use of the polarity of solvents, expressed by the logP value as the main criterion for 
optimizing organic solvents in multi liquid-phase biocatalysis. Cosolvent systems come 
from the addition to the aqueous media of water-miscible solvents such as: acetone, 
ethanol, acetonitrile or dioxane, used to increase the solubility of apolar reactants. 
Usually, the addition of small amounts of a water-miscible solvent has little effect on 
the enzyme activity and stability, in some cases the addition of low concentrations of 
these solvents may even result in an enhanced enzyme activity and stability. However, 
an increase in the concentration of most water-miscible solvents may have an inhibitory 
effect on the biocatalyst (Vermue and Tramper, 1995). This effect is a consequence of 
disturbing the enzyme native state, where non-compatible solvents lead to its 
denaturation (Scharnagl et al., 2005). The occlusion immobilization method within sol-
gel may contribute in some extent for the preservation of the biocatalyst native structure 
by excluding aggressive compounds from the porous matrix due to its partition 
characteristics and also a possible enzyme unfolding physical restriction. 
Focusing on ILs as sol-gel additives, the slow diffusion rate of substrate in silica 
matrices can lower the activity of the immobilized enzymes (Lee et al., 2007a, b). To 
overcome this drawback some additives can be used, such as sugars that act as 
stabilizers (Brennan et al., 2003), polymers that reduce the extent of shrinking during 
the making and drying of the matrix (Wu and Choi, 2004), and other compounds, such 
as amino acids, polyols, surfactants or cyclodextrins (Reetz et al., 2003). The use of ILs 
is another approach recently being developed (Sheldon et al., 2002); as templates to 
make mesoporous silica or as stabilizers to protect some enzymes, e.g. lipases, from the 
inactivation during sol-gel immobilization process (Lee et al., 2007a, b). ILs are very 
promising compounds within the sol-gel chemistry beyond biocatalysis. Despite their 
reported potential as alternative reaction media for biocatalysis through the increase of 
reactivity, selectivity and stability of enzymes (Park and Kazlauskas, 2003), their 
application also as sol-gel additives, acting as templating agents, may lead to the 
enhancement of immobilized biocatalysts activity and stability (Liu et al., 2005a, b; Lee 
  CHAPTER 4 
115 
et al., 2007a, b). On the basis of this application are their versatile tunable properties 
including: polarity, chemical stability, viscosity and solvent capacity; just by combining 
different anions and cations. In this work, ILs are used as templates additives of sol-gel 
glasses in order to improve the activity of immobilized naringinase, towards glycosides 
hydrolysis. The versatile tuneable properties of ILs turn them into challenging 
compounds to circumvent a major disadvantage of the inclusion method related to the 
internal mass transfer effects. Beyond pore size tuning, ILs may also be used for the 
modulation of the partition characteristics of the sol-gel glasses. 
The main goal of this work is the immobilization of naringinase within an inorganic 
silicate material through sol-gel immobilization method. Intrinsically related with this 
goal is the development of a biocatalyst immobilizate with high activity, good 
accessibility to substrate, high resistance against leaching and long-term stability in 
order to use in glycosides hydrolysis. Other goal consists on the use of sol-gel 
immobilization to increase naringinase stability against organic cosolvents that may be 
used to overcome the low solubility of flavone rutinosides in aqueous system and also 
studying naringin hydrolysis by naringinase in aqueous cosolvent systems. Finally, 
concerning the use of ILs, this work aims to study several ILs as sol-gel glasses 
additives, concerning their content and structure in order to increase the activity and 
stability of -L-rhamnosidase and -D-glucosidase from naringinase. Secondarily, the 
study of naringin and prunin hydrolysis by immobilized naringinase within several sol-
gel/IL matrices aims to optimize the flavone glycosides hydrolysis. 
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4.2 Material and methods 
 
4.2.1 Chemicals 
Naringin, naringenin, 3-aminopropyltrimethoxysilane (APS), methyltrimethoxysilane 
(MTS), 4-NRP, 4-NGP, 1-ethyl-3-methylimidazolium dimethylphosphate (Table 4.1) 
and rhamnose were from Sigma-Aldrich; tetramethoxysilane (TMOS), 1-butyl-3-
methylimidazolium 2-(2-methoxyethoxy)ethylsulphate, and 1-butyl-3-
methylimidazolium hexafluorophosphate (Table 4.1) were from Fluka; 1-ethanol-3-
methylimidazolium chloride, 1-butyl-3-methylimidazolium trifluoroacetate, 1-
butylimidazolium tetrafluoroborate, 1-ethanol-3-methylimidazolium tetrafluoroborate, 
1-butyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium 
hexafluorophosphate, 1-ethanol-3-methylimidazolium hexafluorophosphate, 1-octyl-3-
methylimidazolium hexafluorophosphate, 1-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 1-octyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide, 1-ethyl-2-methylpyridinium ethylsulphate and 1-
ethyl-3-methylpyridinium ethylsulphate (Table 4.1) were from Solchemar; glycerol, 
3,5-dinitrosalicylic acid (DNS) and glucose were from Merck while the protein assay 
dye reagent concentrate (cat. nº 500-0006) was from Bio-Rad. Diglycerylsilane (DGS) 
was synthesized by us according to (Brook et al., 2004b). Prunin was biosynthesized 
according to the method described on Chapter 2. Prunin purity was evaluated using 
HPLC-MS. All other chemicals were analytical grade and obtained from various 
sources.  
 
4.2.2 Enzyme solution 
Naringinase (CAS nº. 9068-31-9, cat. nº. 1385) from Penicillium decumbens was 
obtained from Sigma-Aldrich and stored at 20 ºC. The lyophilized naringinase powder 
was dissolved in the appropriate buffer solution 24 hours before experiments and kept at 
4 ºC. For the production of prunin starting from naringin the -D-glucosidase 
expression of naringinase was inactivated as described on Chapter 2. 
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Structure Name Abbreviation 
 
 
 
1-ethanol-3-methylimidazolium 
chloride [C2OHMIM] [Cl] 
 
 
 
1-ethyl-3-methylimidazolium 
dimethylphosphate [EMIM] [DMP] 
 
 
 
1-butyl-3-methylimidazolium 2-(2-
methoxyethoxy)ethylsulphate 
[BMIM] 
[MeOEtOEtOSO3] 
 
 
 
1-butyl-3-methylimidazolium 
trifluoroacetate [BMIM] [TFA] 
 
 
 
1-butylimidazolium tetrafluoroborate [BIM] [BF4] 
 
 
 
1-ethanol-3-methylimidazolium 
tetrafluoroborate [C2OHMIM] [BF4] 
 
 
 
1-butyl-3-methylimidazolium 
tetrafluoroborate [BMIM] [BF4] 
 
 
 
1-ethyl-3-methylimidazolium 
hexafluorophosphate [EMIM] [PF6] 
 
 
 
1-ethanol-3-methylimidazolium 
hexafluorophosphate [C2OHMIM] [PF6] 
 
 
 
1-butyl-3-methylimidazolium 
hexafluorophosphate [BMIM] [PF6] 
 
 
 
1-octyl-3-methylimidazolium 
hexafluorophosphate [OMIM] [PF6] 
 
 
 
1-butyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide [BMIM] [Tf2N] 
 
 
 
1-octyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide [OMIM] [Tf2N] 
 
 
 
1-ethyl-2-methylpyridinium 
ethylsulphate [E2-MPy] [ESO4] 
 
 
 
1-ethyl-3-methylpyridinium 
ethylsulphate [E3-MPy] [ESO4] 
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Table 4.1 Ionic liquids (structure, name and abbreviation) used in sol-gel bio-immobilization. 
CHAPTER 4   
118 
4.2.3 Analytical methods 
The reducing sugars concentration was determined using the DNS microassay on 3.2.3 
(Miller, 1959), absorbance is read at =575 nm (Hitachi 2000, UV-visible 
spectrophotometer), against a glucose or rhamnose calibration curve, according to the 
sugar released during each specific hydrolytic reaction. In the case of the studies 
focusing on the immobilization of naringinase using ILs as additives, the reducing 
sugars concentration was determined using the DNS microassay, measuring the 
absorbance at 595 nm (Zenith 3100 spectrofluorimeter). 
The concentration of p-nitrophenol released after hydrolysis of 4-NRP and 4-NGP was 
evaluated spectrophotometrically at 340 nm (Zenith 3100 spectrofluorimeter), using a 
calibration curve of each compound. 
The protein content was determined using Bradford assay according to the Bio-Rad 
protein microassay procedure using a naringinase calibration curve, at 595 nm (Zenith 
3100 spectrofluorimeter) (Bradford, 1976). 
In order to calculate the partition coefficient, the concentration of the flavanones, 
naringin, prunin, naringenin, was determined by measuring the absorbance at 280 nm 
using a calibration curve of each flavanone; while the compounds 4-NRP, 4-NGP and 
4-nitrophenol were determined at 340 nm (Hitachi 2000, UV-visible 
spectrophotometer). 
 
4.2.4 Naringin solubility 
Due to the low solubility of naringin in water several solvents were tested in order to 
increase substrate solubility. The solvents were chosen according to their dielectric 
constant. The naringin solubility was assessed through the complete dissolution of 10 
mol of naringin in 50, 100, 200, 400 and 800 L of pure solvent at 25ºC. Within 
cosolvent systems, the following solvents were tested: propylene carbonate; dimethyl 
sulfoxide; N,N-dimethylmethanamide; N,N-dimethylacetamide; methanol; acetonitrile; 
ethanol; acetone; 1-propanol; 2-propanol; 1-butanol; 2-butanol; 3-methyl-1-butanol; 2-
butoxyethanol; tetrahydrofuran; 1,2-dimethoxyethane; 2-methyl-2-butanol; 1,4-dioxane. 
 
4.2.5 Immobilization protocol 
Naringinase was immobilized within monolithic and lens-shaped hydrogels. The 
immobilization protocol is divided into two distinct protocols. A first protocol focuses 
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mainly on the use of several sol-gel precursors, while the second one consists on the use 
of ionic liquids as additives of sol-gel. 
 
4.2.5.1 Sol-gel precursors 
Immobilization matrices using several sol-gel precursors were made according to the 
immobilization procedures listed in Table 4.2. The silica sol of matrices A, B, D, E and 
F was prepared in Eppendorf tubes (1.5 mL). The hydrogel matrices were prepared in a 
96 round well plate by mixing the sol (25 L) with the enzyme solution (25 L) (Musa 
et al., 2007). In the case of matrix C the sol was prepared inside the 96 well plate. 
Three aging and drying conditions were tested including open air, closed (with 
parafilm) and half-open (closed with parafilm with a 1 mm hole) at room temperature 
(Table 4.2). 
 
 
4.2.5.2 Ionic liquids as additives of sol-gel 
Three immobilization methods were established to produce lens shape sol-gel/ILs 
matrices, where naringinase was encapsulated. Matrices were made according to the 
immobilization procedures listed in Table 4.3. The silica sol was prepared in an 
Matrix Sol preparation Gel formation Aging 
A 1) water (70 L), H+ (15 L of 40 mM HCl) 
2) TMOS (300 L) 
3) Sonication, 0ºC, 1 min 
 
[naringinase] = 0.250 g.L-1, 
20 mM acetate buffer, pH 6 
Closed 
system 
4 hours  
B 1) water (70 L), H+ (15 L of 40 mM HCl) 
2) glycerol (96 mg) 
3) TMOS (300 L) 
4) Sonication, 0ºC, 20 min 
 
[naringinase] = 0.250 g.L-1, 
20 mM acetate buffer, pH 6 
Open air 
14 hours 
C 1) DGS (55 mg) 
2) [naringinase] = 0.250 g mL-1, 20 mM acetate buffer, pH 6 
3) Sonication, 0ºC, 5 min 
 
Open air 
14 hours 
D 1) water (86 L), H+ (48 L of 40 mM HCl) 
2) DGS (55 mg) 
3) Sonication, 0ºC, 10 min 
4) TMOS (280 L) 
5) Sonication, 0ºC, 5 min 
 
[naringinase] = 0.250 g.L-1, 
20 mM acetate buffer, pH 6 
Open air 
4 hours 
E 1) water (70 L), H+ (15 L of 40 mM HCl) 
2) TMOS (300 L) 
3) Sonication, 0ºC, 1 min 
 
[naringinase] = 0.250 g.L-1, 
20 mM acetate buffer, pH 6, 
0.8% MTS 
Closed 
system 
4 hours 
F 1) water (70 L), H+ (15 L of 40 mM HCl) 
2) TMOS (300 L) 
3) Sonication, 0ºC, 1 min 
[naringinase] = 0.250 g.L-1, 
20 mM acetate buffer, pH 6, 
0.8% APS 
Closed 
system 
4 hours 
Table 4.2 Immobilization protocol using several sol-gel precursors. 
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Eppendorf tube (1.5 mL) and the hydrogel was prepared in a 96 well plate by mixing 
the sol (25 L) with the enzyme solution (25 L). The sol-gel was mixed in a vortex 
and left in an opened 96 well plate, at room temperature in open air for 14 hours. 
 
 
4.2.6 Matrix properties 
The sol-gel matrix adopts the shape of the bottom of the each round well from the 96 
well plates during gel formation period leading to a lens shape. The lens diameter (Dm) 
was determined with a micrometer. The matrix volume (Vm) was determined by 
Equation 4.1: 
 
 
 
where Vt is the total volume of the system (matrices + external solvent), Ves is the 
external solvent volume and nm is the size of the matrices sample; experiments were 
carried out in a volumetric flask containing 8 matrices by adding water to a total volume 
of 1 mL. The matrix density (dm) is the ratio between matrix mass (wm) and matrix 
volume. The internal solvent volume (Vis) was determined through air drying of 8 
matrices to a constant weight. The weight decrease of each matrix, after evaporation, 
corresponded to the internal solvent. 
Method Sol preparation Gel formation 
1 1) IL (30 mg) 
2) water (70 L), H+ (15 L of 40 mM HCl) 
3) glycerol (96 mg) 
4) TMOS (300 L) 
5) Sonication, 0ºC, 20 min 
 
[Naringinase] = 0.250 g.L-1, acetate 
buffer 20 mM, pH 6.0 (25L) 
2 1) IL (30 mg) 
2) water (70 L), H+ (15 L of 80 mM HCl) 
3) glycerol (96 mg) 
4) TMOS (300 L) 
5) Sonication, 0ºC, 20 min 
 
[Naringinase] = 0.250 g.L-1, 20 mM 
acetate buffer, pH 6.0 (25L) 
3 1) IL (30 mg) 
2) water (70 L), H+ (15 L of 80 mM HCl) 
3) glycerol (96 mg) 
4) TMOS (300 L) 
5) Sonication, 0ºC, 20 min 
[Naringinase] = 0.500 g.L-1 , 20 mM 
acetate buffer, pH 6.0 (12.5 L)  
+ IL solution of 12% w/w, 20 mM 
acetate buffer, pH 6.0 (12.5 L) 
Table 4.3 Immobilization protocol within different sol-gel/ILs matrices. 
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The partition coefficient (Pm/s) of substrates and products was the ratio of the compound 
concentration between matrices and external solvent and was estimated according to 
Equation 4.2 (Fukui et al., 1987). 
 
 
 
c0 and c are the initial and final concentration of certain compound. It was calculated the 
Pm/s of the following compounds: naringin, prunin, naringenin, 4-NRP, 4-NGP and 4-
nitrophenol in 40 mM acetate buffer at pH 4.0. In the case of naringenin due to its low 
water solubility a 10% hydroethanol solution was used. The experiments were carried 
out in 96 well plates. A 0.5 mM solution (50 L) of each compound, under study, was 
added to each well with one matrix. After 30 minutes samples were taken and the 
compound concentration was measured.  
 
4.2.7 Scanning electron microscopy (SEM) 
The structure of the matrices was observed using scanning electron microscopy - field 
emission gun (FEG-SEM). Surfaces of the samples were examined using SEM with a 
JEOL JSM-7001F FEG-SEM operating at 5.0 kV. The surfaces were previously sputter-
coated with a gold layer 20 nm thick to avoid charging effects during observation. 
 
4.2.8 Activity measurement 
4.2.8.1 Naringinase immobilized using several so-gel precursors 
During the optimization of naringinase immobilization using several sol-gel precursors, 
the naringinase activity was measured using a 3.91 mM naringin solution (1.00 mL) as 
substrate in 20 mM acetate buffer at pH 4.0. For the free enzyme assay, a 250 mg L-1 
enzyme solution (150 L) in 20 mM acetate buffer pH 4.0 was added to the naringin 
solution; in the immobilized enzyme assay, six matrices were added. The amount of 
either free or immobilized enzyme corresponded to an enzyme content of 37.5 g in the 
reaction mixture. The reaction took place in a 24 well plate that was placed inside an 
agitated thermostatic bath at 45.0 ºC and 200 rpm for 60 min. The enzyme specific 
activity was measured using the DNS assay by determining the concentration of the 
reducing sugars in the collected aliquots during the first 60 min of the reaction. After 
collecting samples the reaction was immediately stopped, lowering the temperature of 
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solutions below 0 ºC. The activity of naringinase for the bioconversion of naringin was 
calculated by linear regression of the first data-points. The hydrolysis of naringin into 
naringenin liberates one molecule of rhamnose followed by one of glucose (both 
reducing sugars). 
 
4.2.8.2 Biocatalysis with immobilized naringinase using organic solvents 
The activities of α-L-rhamnosidase and β-D-glucosidase expressed by naringinase 
enzyme complex were respectively evaluated using 0.20 mM of 4-NRP and 4-NGP, in 
20 mM acetate buffer at pH 4.0. A naringinase concentration of 31.3 mg L-1 was used in 
these experiments. In the immobilized enzyme assay, only one matrix was used per each 
well of a 96 flat well pate (200 L). The amount of either free or immobilized enzyme, 
in the reaction mixture, was 6.25 g. The enzymatic reaction was followed 
spectrophotometrically (Zenith 3100 spectrofluorimeter). Absorbance was measured 
every 1 min, during 30 min at 30.0 ºC. The enzyme activities of -L-rhamnosidase and 
-D-glucosidase expressed by naringinase were calculated by linear regression on the 
first data-points during the initial 30 min reaction time. 
In the case of bioconversion studies within cosolvent systems, naringin bioconversion 
studies were carried out in standard solutions of naringin in 20 mM acetate buffer at pH 
4.0, at 45 ºC, using 250 mg L-1 of free naringinase. The naringin concentration varied 
from 0.30 to 3.0 mM in the aqueous system and to 30 mM in the aqueous cosolvent 
systems. The activity of naringinase for the bioconversion of naringin was calculated by 
first order polynomial regression data fit of the initial data, collected every 1 min during 
10 min. 
 
4.2.8.3 Sol-gel immobilization of enzyme using ILs as additives 
In the studies concerning the use of ILs as additives the activities of -L-rhamnosidase 
and -D-glucosidase expressed by naringinase for the respective hydrolysis of 4-NRP 
and 4-NGP, were determined as described on the previous point (4.2.8.2). 
In the case of bioconversion studies using ILs as additives of sol-gel, the studies were 
carried out using the substrates naringin and prunin. In these experiments naringin was 
hydrolyzed only into prunin, because -D-glucosidase was inactivated according to the 
conditions described on Chapter 2. The naringin hydrolysis was carried out in standard 
solutions in 20 mM citrate buffer at pH 3.3 and prunin hydrolysis in 20 mM acetate 
  CHAPTER 4 
123 
buffer at pH 4.0. The naringin concentration varied from 1.5 to 12.0 mM while prunin 
varied from 0.8 to 6.4 mM. In both cases the hydrolytic reaction took place in a 96 well 
plate (200 L), at 50.0 ºC. A naringinase concentration of 31.3 mg L1 was used in free 
enzyme studies. An enzyme amount of 6.25 g in the reaction mixture was used in both 
free and immobilized system. The activity of -L-rhamnosidase and -D-glucosidase 
for the respective hydrolysis of naringin and prunin was calculated by first order 
polynomial regression data fit of the initial data, collected every 10 min during 90 min. 
The Michaelis-Menten model (Equation 1.1) was used to fit the experimental data, 
concerning the bioconversion of naringin and prunin. The fit was carried out through 
non-linear regression by minimising the residual sum of squares between the 
experimental data points of the initial rate vs. substrate concentration and those 
estimated by the model, using Solver add-in from Microsoft Excel 2003 for Windows 
XP, considering the following options: Newton method; 100 iterations, precision of 
106, 5% of tolerance and 1104 convergence. The kinetic parameters estimated by 
Lineweaver-Burk linear regression (Equation 1.4) were used as initial values of this 
non-linear curve-fit program. The non-linear regression parameters were constricted to 
positive numbers. Following this methodology, the catalytic constants, kcat, were 
determined according to Equation 1.5. 
 
4.2.9 Naringinase biochemical properties 
The influence of pH on the naringinase specific activity can be described by Equation 
1.44. The naringinase activity pH profiles were obtained through non-linear regression 
by minimizing the residual sum of squares between the experimental data points of the 
naringinase specific activity vs. pH and those estimated by the model.  The Solver add-
in from Microsoft Excel 2003 for Windows XP was used with the following options: 
Newton method; 100 iterations, precision of 106, 5% of tolerance and 104 of 
convergence. The optimum experimental pH values were used as initial parameters of 
the non-linear regression and no constraints were used. Optimum pH values were then 
determined from Equation 1.45. 
 
4.2.10 Immobilization yield 
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The immobilization yield, y was determined following Equation 4.3 where wEimm and 
wEt are the amount of enzyme entrapped within sol-gel and the total initial amount of 
enzyme, respectively. 
 
 
 
wEt corresponds to the total amount of enzyme (25 L of a 250 mg L-1 naringinase 
solution, 6.25 g) that was placed inside each well of the microplate to produce each 
biocatalyst. wEimm represents the difference between the total amount of enzyme and the 
enzyme present in the buffer (2x25 L of a 20 mM acetate buffer at pH 4.0) that was 
used to wash each matrix. The 100% yield is defined as if the total amount of 
naringinase is immobilized (no naringinase recovered in the washing buffer). The 
concentration of protein in the enzyme solution was determined before and after 
immobilization in the supernatant and the effluent of the washing steps. The amount of 
protein in solution was evaluated by the Bradford method. Naringinase activity in the 
washing buffer was assessed by adding naringin to the buffer to a final concentration of 
3.91 mM.  
 
4.2.11 Immobilization efficiency 
The efficiency coefficient (was determined according to Equation 4.4 where vimm 
and vfree refer to the rates of the reaction catalyzed by the immobilized and free enzyme, 
respectively (Tischer and Kasche, 1999): 
 
 
 
4.2.12 Operational stability 
To test the stability of immobilized naringinase within the studying conditions, three 
different operational stability protocols were established: a first one covering the 
optimization of the immobilization of naringinase using several sol-gel precursors, a 
second one focused on the biocatalysis with immobilized naringinase using organic 
solvents and a third and last one concerning the use of ILs as additives of sol-gel used to 
immobilized naringinase. 
 
(4.3) 100
Et
Eimm 
w
w
y
free
imm
v
v
 (4.4) 
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4.2.12.1 Naringinase immobilized using several sol-gel precursors 
To test the stability of the encapsulated naringinase, the sol-gel matrices were used 
several times for the hydrolytic reaction, which was conducted in 20 mM acetate buffer 
at pH 4.0. After each run of 1 hour, the matrices were separated and washed with 
acetate buffer pH 4.0. The reaction medium was then replaced with fresh medium. The 
activity of the freshly prepared matrices in the first run was defined as 100% (A0). 
The enzyme inactivation kinetics of naringinase during successive reuses was described 
by both biphasic inactivation (Equation 1.47) and single-step first-order inactivation 
(Equation 1.48). First-order inactivation rate constants (k1 and k2) and the 1 parameter 
were then determined by non-linear regression, minimizing the residual sum of squares 
between the experimental data points of the residual activity vs. runs and those 
estimated by the model.  The Solver add-in from Microsoft Excel 2003 for Windows 
XP was used with the following options: Newton method; 100 iterations, precision of 
106, 5 % tolerance and 1104 of convergence. The first-order inactivation rate 
constant obtained from linear regression of ln Ar vs. t was used as the initial value for 
the non-linear regression k1 parameter. The non-linear regression parameters were 
restricted to positive numbers.  
The reuse half-life (t1/2) of the biocatalyst was determined according to the models fitted 
to the inactivation profiles. When the model used was Equation 1.48, the reuse half-life 
was determined using Equation 1.49. In other cases the reuse half-life was determined 
by interpolation or extrapolation. 
 
4.2.12.2 Biocatalysis with immobilized naringinase using organic solvents 
The activity and stability of -L-rhamnosidase and -D-glucosidase expressed by 
soluble and sol-gel immobilized naringinase were evaluated, in several aqueous 
cosolvent systems using several solvent concentrations. 
Firstly, a primary solvent screening according to the effect over -L-rhamnosidase and 
-D-glucosidase expressed by free naringinase was carried out. An inactivation protocol 
was established in order to study the selective stability of -L-rhamnosidase and -D-
glucosidase expressed by naringinase enzyme complex. Enzyme inactivation assays 
were followed in 20 mM acetate buffer at pH 4.0, using 0, 2.5, 5 and 10 % (v/v) of 
cosolvent, at 65 ºC and 80 ºC, respectively for -D-glucosidase and -L-rhamnosidase 
of soluble naringinase. In this first case an enzyme concentration of 625 mg L-1 were 
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used in 20 mM acetate buffer at pH 4.0, with 5 % (v/v) of cosolvent, during 30 minutes 
at 65 ºC and 80 ºC, respectively, and aliquots were collected during 4 hours. The 
activity of non deactivated soluble naringinase (A0) was used as the reference (100% 
activity).  
In the second case, the immobilized naringinase was used for periods of 30 minutes 
under the above mentioned inactivation conditions during a total of six hours. After 
each inactivation period the matrices were washed and its activity was measured. The 
enzyme activity (A0) of freshly prepared matrices before the first inactivation run was 
defined as 100 %. 
The enzyme inactivation kinetics of both -L-rhamnosidase and -D-glucosidase, 
during successive reuses was described by both biphasic inactivation (Equation 1.47) 
and single-step first-order inactivation (Equation 1.48). The inactivation rate constants 
(k1 and k2) and the 1 parameter, according to the model adjusted, were determined 
through non-linear regression by minimising the residual sum of squares between the 
experimental data points of the residual activity vs. runs and those estimated by the 
model, using Solver add-in from Microsoft Excel 2003 for Windows XP, considering 
the following options: Newton method; 100 iterations, precision of 106, 5 % of 
tolerance and 1x104 convergence. The first-order inactivation rate constant obtained 
from linear regression of ln (Ar) vs. t was used as initial values of the non-linear 
regression k1 parameter. The non-linear regression parameters were constricted to 
positive numbers.  
The reuse half-life time of the biocatalyst was determined according to the models fitted 
to the inactivation profiles. When the model used was Equation 1.48, the reuse half-life 
is determined by Equation 1.49. In other cases the reuse half-life was determined by 
interpolation or extrapolation. 
 
4.2.12.3 Immobilization of naringinase using ILs as additives 
To test the stability of the encapsulated naringinase, the sol-gel/ILs matrices were used 
fifty times for the hydrolytic reaction, in 20 mM acetate buffer at pH 4.0. After each run 
of 20 minutes the matrices were separated and washed with 20 mM acetate buffer at pH 
4.0. The reaction medium was then replaced by fresh medium. The activity and stability 
of -L-rhamnosidase and -D-glucosidase expressed by soluble and sol-gel 
immobilized naringinase were evaluated on the hydrolysis of 4-NRP and 4-NGP. 
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4.2 Results and discussion 
 
The results of this study about the immobilization of naringinase within silica glasses 
through sol-gel method are divided into three main parts: a first one covering the 
optimization of the immobilization of naringinase using several sol-gel precursors, a 
second one focused on the biocatalysis with immobilized naringinase using organic 
solvents and a third and last one concerning the use of ILs as additives of sol-gel used to 
immobilize naringinase. 
 
4.3.1 Optimization of naringinase immobilization using several sol-gel precursors 
Initial immobilization studies were related to sol preparation and gel formation. 
In the sol preparation both the basic and acidic hydrolysis of TMOS were tested using 
HCl and NaOH, respectively. TMOS acid catalysis preformed better than basic catalysis 
for immobilization of naringinase. In the later case, naringinase was easily leached from 
the matrices. Basic catalysis increased the pore diameter via fast condensation, which 
occurred simultaneously with hydrolysis. 
The sonication time period, which is the period needed to form one layer of sol was 
optimized, once the sonication period influences the pore size, with longer periods 
making smaller pores (Roux et al., 1997). 
The monolith size and buffer/sol ratio were also studied. Initially the matrices were 
prepared with a conical shape. These particles had volumes around 0.10, 0.50 or 2.00 
mL. When they were used in naringin bioconversion, we observed an increase in 
naringinase activity with decreasing diameter. In order to increase naringinase activity, 
the monoliths were produced inside 96 round well plates, making lens-shaped monoliths 
with an average volume of 0.05 mL. In this situation a higher naringinase activity was 
recorded, which is consistent with a reduction of mass-transfer impedance due to the 
higher surface-area/volume ratio, as observed by Tischer and Kashe (1999). In order to 
avoid enzyme inactivation by methanol release, various buffer/sol ratios were assayed, 
namely 6:1, 3:1, 2:1 and 1:1. However, the higher ratio matrices were fragile and the 
enzyme was readily released. 
After these initial studies, an optimization process was performed by varying the 
following parameters: aging time, sol-gel precursor, buffer solution pH, enzyme 
concentration and drying conditions during aging. In addition, the performance of the 
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bio-immobilizates was evaluated according to the immobilization yield, efficiency and 
operational stability. 
 
4.3.1.1 Effect of aging time and sol-gel precursors 
The hydrogel aging and drying led to gel densification with increased strength but low 
pore size due to gel shrinking, which was probably responsible for mass transfer 
impedance (Gill and Ballesteros, 2000). During aging the wet silica shrinks up to 85%, 
resulting in a decrease of pore size from 200 nm to 2 – 20 nm depending on the extent 
of drying (Jin and Brennan, 2002). The pore size must be sufficiently large to allow 
molecules and ions to diffuse into the matrix and small enough to prevent entrapped 
biomolecules from leaching (Tischer and Kasche, 1999; Jin and Brennan, 2002; Pollard 
and Woodley, 2007). Therefore aging is critical to control enzyme loss and substrate 
entrance. A 24 h aging period was initially used, but it was excessive leading to the gel 
shrink and cracking. The minimum time needed for the gel formation for all matrices 
was the time of four hours. Following this, two aging times were studied: 4 h and 14 h. 
The TMOS used in matrix A was modified to be a more biocompatible by 
transesterification with glycerol in matrix B and by using DGS in matrix C (Brook et 
al., 2004b) (Figure 4.1). The use of poly(glyceroxysilane) precursors may prevent pore 
collapse due to its low water content, and the slow release of glycerol during aging 
acting as a drying-control additive (Gill and Ballesteros, 2000). Using diglycerylsilane 
as the sol-gel precursor prevented methanol production during the hydrolysis step that 
may be toxic for naringinase. In this work, the buffer/DGS ratio was minimized leading 
to harder matrices when compared to Brook et al. (2004b) work. In matrix D, both DGS 
and TMOS were used (Figure 4.1).  
Alkyl-alkoxysilanes, as methyltrimethoxysilane (MTS) and 3-
aminopropyltrimethoxysilan (APS) , were used in matrices E and F (Figure 4.1), 
respectively, to modulate the ionic environment, surface tension and diameter of the 
pore, focusing on decreasing mass-transfer rates (Gill and Ballesteros, 2000). The 
influence of aging time and sol-gel precursor on the immobilization efficiency was 
studied for five consecutive reutilizations (Figure 4.1). To compare the different sol-gel 
matrices and find the best ones to be used in further optimization studies, we considered 
the immobilization efficiency of naringinase during the fifth run (Figure 4.1). The best 
efficiency was achieved with naringinase immobilized within matrix D (TMOS/DGS) 
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aged for 4 h. A significant statistical difference (p <0.05) between other matrices was 
observed, exception to matrix A (TMOS) aged for 4 h, B (TMOS /glycerol) aged for 14 
h and C (DGS) aged for 14 h. After five consecutive runs matrices B, C and F aged for 
longer periods (14 h) had higher efficiency than those with shorter aging times (4 h). 
These results indicate that the enzyme retention in these matrices was increased with 
aging and may be due to a decrease of pore size. In the case of matrix F, the enzyme 
may have formed a peptide bond via the amino group on APS and a carboxylate moiety 
on naringinase. This may have also reduced enzyme activity. 
On the other hand, matrices A and D showed higher efficiency with less aging. In this 
case, 14 h was probably too long and caused excessive pore shrinkage compromising 
mass transfer. This was consistent with the lower efficiency obtained in the first run of 
A and D aged for 14 hours compared to 4 h (Figure 4.1). 
In conclusion, the best matrices were A (aged for 4 h), B (aged for 14 h), C (aged for 14 
h) and D (aged for 4 h). 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.1.2 Influence of TMOS/DGS ratio in matrix D 
Once matrix C (made from DGS) became too fragile, it was combined with TMOS to 
improve its strength. Matrix D was produced from different ratios of DGS and TMOS. 
Preliminary studies showed different reuse efficiencies among these matrices. The 
influence of the TMOS/DGS ratio on the reuse efficiency was studied (Figure 4.2). The 
Figure 4.1 Influence of the aging time on the immobilization reuse efficiency coefficient of the sol-gel 
matrices, A – F; for five runs (a) (mean value ± SD, n = 3) and after five runs (b) (mean value ± SD, n = 
3, * p < 0.05 vs. matrix D-4h, independent two-tailed Student T-test). 
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TMOS/DGS ratio significantly influenced the naringinase efficiency after the fifth use. 
The optimum ratio of 5:1 (w/w) caused the highest efficiency after the fifth run (Figure 
4.2). In further studies this ratio was used to maximize the efficiency of matrix D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.1.3 Effect of pH on gel formation 
Gel formation occurs due to a pH change after the addition of a buffer solution to the 
sol. This buffer solution must have a pH high enough to ensure gel formation but low 
enough to preserve naringinase activity. Some low pH values were initially tested but a 
consistent gel was only obtained when pH was higher than pH 4.0 using TMOS as the 
only precursor. In bioconversion trials, free naringinase showed activity at pH below 
6.0, so a range of 4.0 – 6.0 was chosen to study the effect of pH. In addition, other 
authors had described a higher gel formation rate between pH 4.0 and 6.0 (Brook et al., 
2004b). 
In Figure 4.3 the influence of pH on naringinase immobilization efficiency is shown. 
Choosing the pH 6.0 value as a reference for gel formation of each matrix, significant 
statistical differences (p < 0.05) were observed between gels formed at pH 6.0 and other 
pH values. The highest efficiency was achieved at pH 6.0. 
 
 
Figure 4.2 Influence of the TMOS/DGS ratio on the immobilization reuse efficiency coefficient of the 
sol-gel matrix D; for five runs (a) (mean value ± SD)  and after five runs (b) (mean value ± SD, n = 3, * p 
< 0.05 vs. 5:1 (w/w), independent two-tailed Student T-test). 
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4.3.1.4 Influence of naringinase concentration 
Immobilization efficiency decreased with increasing naringinase concentration (Figure 
4.4). Internal mass-transfer limitations may have occurred at high naringinase 
concentrations, since the specific activity remained constant within the naringinase 
concentration range used. 
The high efficiency observed with lower naringinase concentrations and the statistical 
analysis in Figure 4.4 led us to choose 0.25 g L1 of naringinase for subsequent studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Influence of pH on the immobilization efficiency coefficient of the sol-gel matrices A – D 
(mean value ± SD, n = 3, * p < 0.05 vs. pH 6.0, independent two-tailed Student T-test).  
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Figure 4.4 Influence of the naringinase concentration on the immobilization efficiency coefficient of the 
sol-gel matrices A – D (mean value ± SD, n = 3, * p < 0.05 vs [E] = 0.25 g L-1, independent two-tailed 
Student T-test). 
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4.3.1.5 Drying conditions during aging 
The drying conditions during aging influence solvent loss and may influence the 
biocatalyst activity. Matrix B showed the highest efficiency (Figure 4.4) and was 
chosen for a further study. In this system three aging/drying conditions were tested, 
namely: open air, closed and half-open. The effect of drying conditions on matrix B 
reuse efficiency is shown on Figure 4.5a. After the second reutilization no protein was 
detected in the liquid phase. The activity data and inactivation models fitted to the data 
points are presented in Figure 4.5a. The inactivation profile of naringinase in the sol-gel 
open air and the half-open system could be well described by a first-order inactivation 
model. A considerably higher operational stability with a half-life of 6.5 h was observed 
for naringinase in the half-open system. This value was more than two folds the value 
obtained for naringinase in the closed system, which has an exponential decay with a 
first-order inactivation constant of 0.19 h1 (Table 4.4).  
The higher naringinase operational stability occurred in the open system, which showed 
the best result. During the 23 consecutive runs, no loss of activity was observed, 
theoretically resulting in an infinite half-life. The matrices produced in the three 
different systems had different diameters (p < 0.05, One Way ANOVA) (Figure 4.5b). 
For matrix B, faster drying conditions caused a reduction in the diameter of the 
monoliths (Table 4.4). Comparison of the diameter of the B matrices with their half-
lives (Table 4.4) indicates that half-life decreases with a monolith diameter increase. To 
better understand this process the structure of the matrices was analyzed using SEM. 
SEM micrographs of TMOS plus glycerol gels made with different drying conditions 
showed similar porosity around 20-30 nm (Figure 4.5c). 
The hydrogel aging process was an efficient method for increasing operational stability. 
After hydrolysis the TMOS solution still contains some methanol that may be 
detrimental to the enzyme activity. The slower the evaporation rate, the longer the 
exposure of the enzyme to the methanol, which would promote protein denaturation and 
may explain the lower half-lives obtained for the matrices that were aged in half-open 
and closed containers. 
Subsequently, matrices were aged in open containers except for matrix A, which 
cracked under these conditions. 
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4.3.1.6 Immobilization characterization 
Matrix properties 
All four matrices (A – D) showed mechanical resistance in buffer solution and did not 
compact during the reutilization assays. According to Figure 4.6a and Table 4.5, a small 
decrease in monolith diameter caused a large decrease in volume. Matrix B had the 
smallest diameter and the highest density and surface area/volume ratio, followed by 
matrix D (Table 4.5). Figure 4.6b demonstrates the lens-shape of the four matrices 
studied. 
Aging system Immobilization 
efficiency
Dm  (mm) t1/2 (h) kinetic parameters R2 
Closed 
 
0.67 ± 0.01 5.44 ± 0.02 3.64 ± 0.11 k1 = 0.19 h-1 0.97 
Half-opened 
 
0.72 ± 0.01 5.19 ± 0.07 6.40 ± 0.20 k1 = 0.11 h-1 0.99 
Opened 0.72 ± 0.01 4.71 ± 0.06 ∞ - - 
Figure 4.5 a) Influence of the aging system (open-air, half-open and closed) on the naringinase residual 
activity of the sol-gel matrix B, after 23 successive runs (mean value ± SD, n = 3) and b) diameter (mean 
value ± SD, n = 3). c) SEM microphotographs of the sol-gel matrices (TMOS/glycerol) obtained under 
different conditions [closed (B1), half-open (B2) and open-air (B3)] for encapsulated naringinase. The bar 
represents 1m.  
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Table 4.4 Characterization of matrix B according to the aging system used. 
 
Mean value ± SD, n = 3. 
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The partition coefficient of the flavanones, naringin and naringenin were determined 
according to Equation 4.2 (Table 4.5). The partition coefficient of naringin increased 
with the efficiency coefficient. Theoretically, matrix A was the less hydrophilic which 
was made from TMOS, comparing to matrix B (TMOS/glycerol) and matrix D 
(TMOS/DGS). According to Brook et al. (2004a), glycerol in matrix B would have 
been washed from the gel, while in matrix D, some diglycerylsilane would have 
remained inside the monolith making it more hydrophilic. These gel characteristics may 
have influenced the partition coefficient of naringin affecting consecutively the 
efficiency of each matrix, leading to the conclusion that a more hydrophilic matrix 
would be more efficient on decreasing internal mass-transfer effects (Tischer and 
Kasche, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Matrix 
 
Dm  (mm) Vm (L) dm (g.mL-1) Pm/s naringin Pm/s naringenin 
A 
 
5.77 ± 0.02 46.0 0.67 0.65 ± 0.06 0.77 ± 0.14 0.66 ± 0.04 
B 
 
4.71 ± 0.02 23.3 0.89 0.68 ± 0.15 0.65 ± 0.08 0.72 ± 0.01 
C 
 
6.02 ± 0.08 60.4 - - - 1.07 ± 0.02 
D 5.51 ± 0.06 31.1 0.86 0.97 ± 0.10 0.80 ± 0.04 0.76 ± 0.01 
Figure 4.6. a) Diameter and volume of matrices: A – D (mean value ± SD, n = 3). b) Photo of matrices: A 
– D. 
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Table 4.5 Properties of matrices A – D and naringinase efficiency. 
 
Mean value ± standard deviation, n = 3. 
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Effects of temperature and pH on naringinase activity 
The naringinase temperature profile was studied between 40.0 and 80.0 ºC and the 
optimum activity was recorded around 70 ºC (Figure 4.7a) for free naringinase as well 
as for immobilized naringinase within the four matrices. According to this, these sol-gel 
monoliths do not seem to protect naringinase against heat-inactivation, which is similar 
to the results obtained by Bernardino et al. (2009) with penicillin acilase immobilized 
onto sol-gel microcapsules; in opposition to dry-aged sol-gels where the optimum 
temperature is shifted towards higher temperatures (Jin and Brennan, 2002). In this last 
case, the enzyme native state is favoured in dry-aged gels due to gel restriction, 
increasing its thermal stability (Jin and Brennan, 2002). 
The optimum temperature around 70 ºC for the hydrolysis of naringin into naringenin 
by naringinase in sol-gel matrices increases the potential for immobilized naringinase to 
be used on an industrial scale where higher temperatures are used to reduce the viscosity 
of the bioreaction medium and also improving naringin solubility. 
The pH profile was studied between 3.5 and 6.0 (Figure 4.7b) and the optimum pH was 
found to be 4.3 (Table 4.6) for free naringinase. 
The student T-test showed that there was no statistical difference between the optimum 
pH values for free naringinase and naringinase immobilized in the four matrices A – D 
(Table 4.6). This may have been due to the small matrix size or the high buffer capacity 
(Tischer and Kasche, 1999). A maximum naringinase specific activity of 0.86 mol 
min-1 mg1 was obtained for naringinase immobilized within matrices A and D, with 
similar pK1 and pK2 at an optimum pH of 4.3 ± 0.1(Table 4.6). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 a) Temperature profile of free and immobilized naringinase in sol-gel matrices: A – D (mean 
value ± SD, n = 3). b) pH profile of free naringinase and naringinase immobilized within sol-gel matrices: 
A – D (mean value ± SD, n = 3). 
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Immobilization yield and efficiency 
During the immobilization procedure a very low naringinase loss occurred in all the 
four matrices tested, leading to an immobilization yield higher than 82% for all of them 
(Figure 4.8), calculated according to Equation 4.1. The best immobilization yield was 
92% in the case of matrix D, although there was no statistical difference between each 
matrix (p > 0.05, One Way ANOVA). 
The naringinase immobilization efficiency coefficients of the four matrices A – D were 
high (> 0.70), which is consistent with reduced mass transfer effects (Figure 4.8). A 
significant statistical difference existed between the efficiency coefficients of these 
matrices. Matrix C showed a very high efficiency compared to the other three matrices, 
possibly because naringinase native state is better preserved in matrix C, which was 
produced without alcohol formation during gel formation. 
 
 
 
 
 
 
 
 
 
 
 
pHopt Non-linear parameters R2 
Matrix    
A 4.4 ± 0.1 Amax = 0.82, pK1 = 3.1,  pK2 = 5.7 0.84 
B 4.4 ± 0.2 Amax = 0.68, pK1 = 2.8,  pK2 = 5.9 0.91 
C 4.3 ± 0.1 Amax = 0.85, pK1 = 2.9,  pK2 = 5.7 0.91 
D 4.3 ± 0.1 Amax = 0.86, pK1 = 2.9,  pK2 = 5.7 0.95 
Free enzyme 4.3 ± 0.1 Amax = 1.11, pK1 = 2.9,  pK2 = 5.7 0.93 
Table 4.6 Optimum pH values of the sol-gel matrices A – D. 
 
Mean value ± SD; n = 3; * p < 0.05 vs. free enzyme; independent two-tailed Student T-test 
 
Figure 4.8 Yield and efficiency of immobilized naringinase within matrices: A – D (mean value ± SD, n = 
3). 
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4.3.1.7 Operational stability 
All matrices tested (A – D) were able to retain naringinase activity over repeated uses 
(Figure 4.9a). The structure of these matrices was observed using SEM. Figure 4.9b 
shows SEM micrographs of matrices A (TMOS), B (TMOS/glycerol), C (DGS) and D 
(TMOS/DGS). Matrices A and C showed a coarser structure with a porosity around 100 
nm, while the structure of matrices B and D was finer showing a porosity of 20-30 nm.  
The inactivation model of Henley and Sadana (1985) (Equation 1.47) fits well to the 
experimental data in the case of matrices A, C and D (Figure 4.9a, Table 4.7). Among 
these matrices, D was by far the best matrix, showing a reduced loss of activity with a 
half-life time of 115 h (Table 4.7).  
Matrix B had no detectable loss of activity after 50 successive reutilizations, 
theoretically showing an infinite half-life time (Table 4.7). In fact, matrix B seemed to 
protect naringinase from heat inactivation to some extent, since the thermal inactivation 
of free naringinase under these reaction conditions had a half-life of 169 h. This 
operational stability study showed outstanding behaviours of matrices D and especially 
B, with very long half-life times, high efficiency (72% and 76%, respectively) and high 
immobilization yields around 90% (Table 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 a) Residual activity of naringinase after several reutilization runs of the sol-gel matrices: A – 
D (mean value ± SD, n = 3). b) SEM micrographs of the sol–gel matrices: A D with encapsulated 
naringinase. The bar represents 1 m. 
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4.3.2 Biocatalysis with immobilized naringinase using organic solvents 
In order to overcome the low solubility of naringin in aqueous media (0.50g L1 at 20 
ºC; Pulley, 1936) which limits the productivity and yield of the enzymatic 
bioconversion, several approaches based on biphasic and cosolvent systems were 
studied.  
 
4.3.2.1 Biphasic systems 
Towards the use of liquid–liquid biphasic conditions for naringin biocatalysis, a 
selection of different solvents was carried out according to their logP values and 
functionality. The following solvents were tested with the purpose to increase naringin 
solubility: octane and n-hexane were representative of unbranched alkanes; cyclohexane 
of cyclic alkanes; 1-octanol, 2-octanol and 1-hexanol of alcohols; toluene and anisole of 
aromatic compounds; ethylic ether of ethers; ethyl acetate of esters; carbon tetrachloride 
and chloroform of halogenated solvents. Unsatisfactory results were afforded due to the 
low solubility of naringin in these non-polar solvents, despite its low solubility in water. 
The biphasic design system was excluded from the bioprocessing of naringin. 
 
4.3.2.2 Aqueous cosolvent systems 
Another approach to enhance naringin concentration is the use of water cosolvent 
systems, which were tested according to solvents relative permittivity. The main goal 
consists on maximizing naringin dissolution in the aqueous system, keeping naringinase 
with a high retention activity and stability. 
Table 4.8 presents several organic solvents tested, the respective dielectric constant and 
naringin solubility. Naringin showed a low solubility (< 12.5 mM) in the following 
Matrix y (%)  t1/2 (h) kinetic parameters R2 
A 
 
82 ± 8 0.66 ± 0.04 26.4 ± 7.1 1 = 1.81, k1 = 0.0314 h1, k2 = 0.46 h1 0.97
B 
 
89 ± 2 0.72 ± 0.01 ∞ - - 
C 
 
85 ± 6 1.07 ± 0.02 0.62 ± 0.12 1 = 0.52, k1 = 14.0 h1, k2 = 0.085 h1 0.99 
D 92 ± 2 0.76 ± 0.01 115 ± 9 1 = 60, k1 = 0.0069 h1, k2 = 3.88 h1 0.91 
Table 4.7 Yield, efficiencyand operational stability characterization of sol-gel matrices, A–D. 
Mean value ± SD, n = 3. 
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organic solvents: acetonitrile, 3-methyl-1-butanol and 2-methyl-2-butanol. Propylene 
carbonate, 1 and 2-propanol, 1and 2-butanol slightly improved naringin dissolution. 
Acetone; dimethyl sulfoxide; N,N-dimethylmethanamide; N,N-dimethylacetamide; 
methanol; ethanol; tetrahydrofuran; 1,2-dimethoxyethane and 1,4- dioxane showed to be 
the best organic solvents, allowing a naringin dissolution higher than 100 mM. 
Afterwards, the effect of these solvents (5 %) was tested over the activity of -L-
rhamnosidase and -D-glucosidase, through the hydrolysis of specific substrates: 4-
NRP and 4-NGP respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As it is shown on Table 4.9, -D-glucosidase shows a high (> 50 %) residual activity in 
the presence of 1,4-dioxane, 1,2 dimethoxyethane, tetrahydrofuran, acetone, ethanol, 
methanol and acetonitrile, while -L-rhamnosidase shows high activities (> 50 %) with 
almost all the solvent tested, except to 1-butanol, 3-methyl-1-butanol and 2-
butoxyethanol.  
According to this preliminary studies, considering the naringin solubility together with 
the residual activity of -L-rhamnosidase and -D-glucosidase, eight solvents (dimethyl 
sulfoxide; N,N-dimethylmethanamide; methanol; ethanol; acetone; tetrahydrofuran; 1,2-
Solvent Dielectric constant [Naringin] (mM) 
water 80.10 < 12.5 
Propylene carbonate 65.00 [12.5 – 25[ 
Dimethyl sulfoxide 47.20 [100 – 200[ 
N,N-dimethylmethanamide 40.10 > 200 
N,N-Dimethylacetamide 38.80 > 200 
Methanol 36.60 > 200 
Acetonitrile 36.60 < 12.5 
Ethanol 25.30 [100 – 200[ 
Acetone 21.01 > 200 
1-propanol 20.80 [25 – 50[ 
2-propanol 20.18 [25 – 50[ 
1-butanol 17.84 [12.5 – 25[ 
2-butanol 17.26 [12.5 – 25[ 
3-methyl-1-butanol 15.63 < 12.5 
2-Butoxyethanol 9.57 [50 – 100[ 
Tetrahydrofuran 7.60 > 200 
1,2-Dimethoxyethane 7.40 > 200 
2-Methyl-2-butanol 5.97 < 12.5 
1,4-Dioxane 2.22 [100 – 200[ 
Table 4.8 Naringin solubility in several organic solvents, at 25 ºC. 
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dimethoxyethane and 1,4-dioxane) were chosen to be used in further stability and 
activity studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.2.3 Cosolvent stability studies 
In this work, stability studies with -L-rhamnosidase and -D-glucosidase expressed by 
soluble and immobilized naringinase were performed in aqueous cosolvent systems, at 
0, 2.5, 5 and 10 % (v/v), of dimethyl sulfoxide, acetone, N,N-dimethylacetamide, 
methanol, 1,2-dimethoxyethane, ethanol, tetrahydrofuran, 1,4-dioxane. Naringinase was 
immobilized within sol-gel matrices of TMOS and glycerol (Matrix B). In these 
aqueous cosolvent systems, the use of naringinase immobilized onto sol-gel matrices 
allowed higher residual activities of -L-rhamnosidase and -D-glucosidase with 
respect to the corresponding soluble enzyme. At the lowest cosolvent concentration, the 
immobilized biocatalyst was always more stable than the soluble one (Figure 4.10 and 
4.11). In the case of -D-glucosidase a residual activity greater than 100 % was attained 
with all cosolvents, even at higher concentrations (10 %), with the exception to 
dimethyl sulfoxide (Figure 4.11). A 1.5 increase in -D-glucosidase residual activity 
was observed with the cosolvent 1,2-dimethoxyethane. 
These results showed a protective effect of sol-gel matrices within cosolvents systems, 
in the three concentrations tested, being this effect more pronounced for -D-
Residual Activity 
Cosolvent 
-D-glucosidase -L-rhamnosidase 
Propylene carbonate 0.34 ± 0.04 0.57 ± 0.03 
Dimethyl sulfoxide 0.85 ± 0.06 1.01 ± 0.01 
N,N-dimethylmethanamide 0.52 ± 0.04 0.78 ± 0.05 
N,N-Dimethylacetamide 0.54 ± 0.01 0.80 ± 0.04 
Methanol 0.80 ± 0.06 0.92 ± 0.07 
Acetonitrile 0.73 ± 0.04 0.90 ± 0.01 
Ethanol 0.73 ± 0.01 0.83 ± 0.04 
Acetone 0.64 ± 0.01 0.81 ± 0.02 
1-propanol 0.50 ± 0.02 0.52 ± 0.06 
2-propanol 0.72 ± 0.03 0.83 ± 0.08 
1-buthanol 0.10 ± 0.01 0.40 ± 0.04 
2-buthanol 0.48 ± 0.02 0.77 ± 0.04 
3-methyl-1-buthanol 0.41 ± 0.01 0.08 ± 0.03 
2-Butoxyethanol 0.26 ± 0.02 0.26 ± 0.02 
Tetrahydrofuran 0.70 ± 0.02 0.65 ± 0.02 
1,2-Dimethoxyethane 0.80 ± 0.04 0.81 ± 0.06 
2-Methyl-2-butanol 0.46 ± 0.04 0.93 ± 0.06 
1,4-Dioxane 0.58 ± 0.01 0.83 ± 0.06 
Table 4.9 Residual activity of -D-glucosidase and -L-rhamnosidase expressed by soluble naringinase. 
 
Mean value ± SE, n = 3. 
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glucosidase (Figure 4.11) than for -L-rhamnosidase (Figure 4.10), when comparing 
with soluble enzyme. There was a good fit between experimental inactivation kinetics 
of -L-rhamnosidase and -D-glucosidase of soluble naringinase and a simple 
exponential decay model was adjusted, allowing the calculation of k1 and the half-life 
time, except in the case of soluble -D-glucosidase without cosolvent, where a biphasic 
system was fitted (Tables 4.10 and 4.11). In all the cosolvent systems tested an increase 
in the inactivation parameters k1 with a correspondent decrease of half-life times were 
observed for soluble naringinase (Table 4.10 and 4.11). An activity increase was seen 
whenever the sol-gel immobilized naringinase was reused for the first time. This fact 
may be explained by some glycerol release from the sol-gel matrix (a precursor used 
during the immobilization procedure). This glycerol release may lead to a better 
substrate access to the immobilized enzyme, increasing enzyme activity after the first 
run. The inactivation of -L-rhamnosidase and -D-glucosidase from the immobilized 
naringinase was well described by a biphasic inactivation (Equation 2.7). The 
parameters k1, k2, 1 and the half-life time of the biocatalysts were calculated (Table 
4.10 and 4.11). Improved enzyme stability is associated to a decrease in the inactivation 
parameters k1 or k2 with a corresponding increase in half-life time or an increase in 
enzyme residual activity, 1. 
The results reported on Table 4.10 and 4.11 support an improved stabilization of 
naringinase for the hydrolysis of 4-NRP and 4-NGP, for all cosolvent systems tested; 
which are easily supported by the increased half-life times of sol-gel immobilized 
naringinase (Table 4.10 and 4.11), when compared with soluble naringinase. The 
stabilization of -L-rhamnosidase activity by sol-gel immobilized can be highlighted in 
the case use of tetrahydrofuran using concentrations of 2.5, 5.0 and 10.0 %, which 
originated an increase of 7, 13 and 21-fold, on the half-life time, respectively, with 
respect to the corresponding soluble enzyme (Table 4.10). This is an example of the 
high protective effect of the sol-gel (Matrix B) to the enzyme naringinase over different 
cosolvent concentrations. In the case of -D-glucosidase activity, expressed by sol-gel 
immobilized naringinase, almost a 60-fold increase in the half-life time was observed, 
respectively from 0.33 (soluble enzyme) to 19.2 hours, concerning as well a 
tetrahydrofuran cosolvent system (10%) (Table 4.11). For all the aqueous cosolvents 
systems an half-life time increase greater than 3 fold with immobilized enzyme was 
observed, comparing to soluble enzyme (Table 4.10 and 4.11). At the higher cosolvent 
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concentration used (10 %) the sol-gel protective effect was much more pronounced, as 
shown by increased half-life times, e.g. 11-fold with ethanol, 13-fold with 1,4 dioxane, 
14-fold with 1,2 dimethoxyethane, 18-fold with acetone, 24-fold with N,N-
dimethylacetamide and the best one 59-fold with tetrahydrofuran, in the case of the 
hydrolysis of 4-NGP, by -D-glucosidase. 
The immobilization of naringinase through sol-gel technique improved both -L-
rhamnosidase and -D-glucosidase resistance against inactivation in the presence of 
organic cosolvents. Enhanced biocatalyst stabilization, in all solvent range tested, was 
achieved through immobilization. The different stability behaviours in certain solvent 
conditions, using soluble and immobilized enzyme, may arise from distinct mechanisms 
of inactivation. The role of glycerol as compensatory cosolvent must not be forgotten, 
which stabilizes the folded form against denaturation under external stress (Scharnagl et 
al., 2005). In this case, of naringinase immobilization onto sol-gel (TMOS/glycerol), 
glycerol may prevent unfolding at high concentrations of organic cosolvents. 
According with these findings, Brena et al., 2003 also reports an enzymatic stabilization 
through immobilization. Brena showed a half-life time increase from 8 to 100 h after 
immobilization of E. coli -galactosidase onto glutaraldehyde-agarose, in 18 % (v/v) 
dioxane, also in 36 (%) dimethylformamide, a half-life time increase from 0.3 to 1 h 
was reported (Brena et al., 2003). Some authors stabilized -glucosidase by 
immobilization onto macroporous poly(GMA-co-EGDMA) (Radivoje et al., 2006). The 
immobilized enzyme had 4 and 10-fold higher half-life times than the soluble one in 
dimethyl sulfoxide and methanol, respectively (Radivoje et al., 2006). In other work, 
water miscible cosolvents, like dimethyl sulfoxide, were used to increase substrate 
solubility (Roccatano et al., 2006); however, the catalytic activity of P450 was 
significantly lower. The effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile 
on the catalytic activities of nine human cDNA-expressed cytochrome P-450s in 
aqueous cosolvent systems was also tested (Busby et al., 1999). 
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Figure 4.10 Stability of -L-rhamnosidase expressed by soluble and immobilized naringinase in 
cosolvent systems. 0%, 2.5%, 5% and 10% (v/v) are cosolvent percentages used with soluble (  ,  ,   ,  ) 
and immobilized ( ,   ,   ,  ) naringinase, respectively. 
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Figure 4.11 Stability of -D-glucosidase expressed by soluble and immobilized naringinase in cosolvent 
systems. 0%, 2.5%, 5% and 10% (v/v) are cosolvent percentages used with soluble (  ,  ,  ,  ) and 
immobilized (   ,   ,   ,   ) naringinase, respectively. 
  CHAPTER 4 
145 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

-L
-r
ha
m
no
si
da
se
 
C
os
ol
ve
nt
 [%
 (V
/V
)]
 
(E
xp
re
ss
ed
 b
y 
so
lu
bl
e 
na
rin
gi
na
se
) 
(E
xp
re
ss
ed
 b
y 
so
l-g
el
 im
m
ob
ili
ze
d 
na
rin
gi
na
se
) 
 
k 1
 (h
-1
) 
t 1/
2 
so
l (
h)
   
   
   
   
   
R2
 
 
a 1
 
k 1
 (h
-1
) 
k 2
 (h
-1
) 
t 1/
2 
im
m
 (h
) 
R2
 
t 1/
2 
im
m
 . 
t 1/
2 
so
l-1
 
D
im
et
hy
l s
ul
fo
xi
de
 
 
 
 
 
 
 
 
 
 
0 
0.
19
 ±
 0
.0
1 
3.
63
 ±
 0
.3
1 
0.
96
 
1.
29
 ±
 0
.0
2 
2.
18
 ±
 0
.2
9 
0.
21
 ±
 0
.0
5 
5.
22
 ±
 0
.5
7 
0.
96
 
1 
2.
5 
0.
32
 ±
 0
.0
2 
2.
20
 ±
 0
.1
6 
0.
91
 
1.
58
 ±
 0
.0
1 
0.
72
 ±
 0
.1
3 
0.
20
 ±
 0
.0
1 
7.
30
 ±
 0
.2
6 
0.
95
 
3 
5 
0.
32
 ±
 0
.0
 
2.
30
 ±
 0
.0
5 
0.
94
 
1.
39
 ±
 0
.2
1 
0.
82
 ±
 0
.2
6 
0.
12
 ±
 0
.0
5 
6.
67
 ±
 0
.9
9 
0.
99
 
3 
10
 
0.
33
 ±
 0
.0
2 
2.
10
 ±
 0
.1
2 
0.
87
 
1.
17
 ±
 0
.0
5 
0.
21
 ±
 0
.0
9 
0.
13
 ±
 0
.0
1 
6.
33
 ±
 0
.1
2 
0.
94
 
3 
N,
N-
D
im
et
hy
la
ce
ta
m
id
e 
 
 
 
 
 
 
 
 
 
2.
5 
0.
40
 ±
 0
.0
2 
1.
75
 ±
 0
.0
7 
0.
90
 
1.
26
 ±
 0
.3
9 
1.
87
 ±
 0
.1
0 
0.
13
 ±
 0
.0
1 
7.
97
 ±
 0
.5
8 
0.
93
 
5 
5 
0.
52
 ±
 0
.0
1 
1.
33
 ±
 0
.0
4 
0.
94
 
1.
11
 ±
 0
.0
5 
4.
00
 ±
 0
.3
4 
0.
12
 ±
 0
.1
0 
5.
00
 ±
 1
.1
5 
0.
96
 
4 
10
 
0.
82
 ±
 0
.0
2 
0.
84
 ±
 0
.0
2 
0.
98
 
- 
0.
16
 ±
 0
.0
2 
- 
4.
23
 ±
 0
.5
0 
0.
88
 
5 
M
et
ha
no
l 
 
 
 
 
 
 
 
 
 
2.
5 
0.
43
 ±
 0
.0
1 
1.
60
 ±
 0
.0
2 
0.
94
 
1.
54
 ±
 0
.2
2 
5.
00
 ±
 0
.3
3 
0.
14
 ±
 0
.0
3 
8.
53
 ±
 1
.5
4 
0.
94
 
5 
5 
0.
47
 ±
 0
.0
2 
1.
47
 ±
 0
.0
8 
0.
93
 
1.
41
 ±
 0
.1
3 
2.
00
 ±
 0
.3
7 
0.
18
 ±
 0
.0
6 
5.
77
 ±
 0
.3
5 
0.
91
 
4 
10
 
0.
66
 ±
 0
.0
2 
1.
05
 ±
 0
.0
3 
0.
98
 
1.
43
 ±
 0
.0
9 
3.
23
 ±
 0
.3
4 
0.
17
 ±
 0
.0
1 
6.
57
 ±
 0
.2
3 
0.
99
 
6 
Et
ha
no
l 
 
 
 
 
 
 
 
 
 
2.
5 
0.
37
 ±
 0
.0
2 
1.
87
 ±
 0
.1
0 
0.
88
 
1.
67
 ±
 0
.0
9 
1.
68
 ±
 0
.3
8 
0.
20
 ±
 0
.0
5 
6.
77
 ±
 0
.9
5 
0.
96
 
4 
5 
0.
53
 ±
 0
.0
1 
1.
31
 ±
 0
.0
4 
0.
87
 
1.
48
 ±
 0
.1
8 
2.
50
 ±
 0
.1
6 
0.
23
 ±
 0
.0
4 
4.
67
 ±
 0
.3
7 
0.
97
 
4 
10
 
1.
16
 ±
 0
.0
1 
0.
60
 ±
 0
.0
3 
0.
96
 
- 
0.
13
 ±
 0
.0
1 
- 
5.
00
 ±
 0
.5
7 
0.
94
 
8 
A
ce
to
ne
 
 
 
 
 
 
 
 
 
 
2.
5 
0.
45
 ±
 0
.0
1 
1.
55
 ±
 0
.0
3 
0.
94
 
1.
42
 ±
 0
.1
9 
2.
90
 ±
 0
.7
4 
0.
19
 ±
 0
.0
5 
5.
83
 ±
 1
.5
3 
0.
95
 
4 
5 
0.
47
 ±
 0
.0
2 
1.
47
 ±
 0
.0
6 
0.
93
 
1.
22
 ±
 0
.1
2 
3.
20
 ±
 0
.4
4 
0.
17
 ±
 0
.0
6 
5.
37
 ±
 0
.7
7 
0.
95
 
4 
10
 
0.
86
 ±
 0
.0
2 
0.
81
 ±
 0
.0
2 
0.
96
 
1.
27
 ±
 0
.0
2 
4.
50
 ±
 0
.4
2 
0.
17
 ±
 0
.0
4 
6.
03
 ±
1.
13
 
0.
95
 
7 
Te
tra
hy
dr
of
ur
an
 
 
 
 
 
 
 
 
 
 
2.
5 
1.
02
 ±
 0
.0
2 
0.
68
 ±
 0
.0
1 
0.
99
 
1.
47
 ±
 0
.3
4 
3.
50
 ±
 0
.3
6 
0.
20
 ±
 0
.0
2 
5.
00
 ±
 0
.7
0 
0.
97
 
7 
5 
1.
57
 ±
 0
.0
2 
0.
44
 ±
 0
.0
1 
0.
99
 
1.
13
 ±
 0
.0
6 
11
.8
0 
± 
0.
12
 
0.
15
 ±
 0
.0
1 
5.
53
 ±
 0
.2
2 
0.
95
 
13
 
10
 
5.
33
 ±
 0
.0
2 
0.
13
 ±
 0
.0
1 
0.
99
 
- 
0.
25
 ±
 0
.0
1 
- 
2.
77
 ±
 0
.1
2 
0.
93
 
21
 
1,
2-
D
im
et
ho
xy
et
ha
ne
 
 
 
 
 
 
 
 
 
 
2.
5 
0.
82
 ±
 0
.0
2 
0.
85
 ±
 0
.0
2 
0.
99
 
1.
17
 ±
 0
.0
8 
3.
70
 ±
 0
.7
9 
0.
23
 ±
 0
.0
8 
4.
03
 ±
 0
.7
9 
0.
96
 
5 
5 
0.
89
 ±
 0
.0
2 
0.
78
 ±
 0
.0
2 
0.
99
 
- 
0.
17
 ±
 0
.0
1 
- 
4.
20
 ±
 0
.1
5 
0.
93
 
5 
10
 
1.
21
 ±
 0
.0
2 
0.
57
 ±
 0
.0
1 
0.
99
 
- 
0.
24
 ±
 0
.0
2 
- 
2.
87
 ±
 0
.1
8 
0.
97
 
5 
1,
4-
D
io
xa
ne
 
 
 
 
 
 
 
 
 
 
2.
5 
0.
31
 ±
 0
.0
2 
2.
20
 ±
 0
.0
6 
0.
85
 
1.
38
 ±
 0
.0
9 
2.
90
 ±
 0
.4
0 
0.
19
 ±
 0
.0
2 
5.
27
 ±
 0
.3
5 
0.
98
 
2 
5 
0.
48
 ±
 0
.0
2 
1.
43
 ±
 0
.0
7 
0.
94
 
1.
16
 ±
 0
.0
7 
4.
00
 ±
 0
.1
2 
0.
20
 ±
 0
.0
2 
4.
30
 ±
 0
.1
0 
0.
98
 
3 
10
 
1.
00
 ±
 0
.0
2 
0.
69
 ±
 0
.0
5 
0.
99
 
- 
0.
24
 ±
 0
.0
1 
- 
2.
97
 ±
 0
.1
8 
0.
86
 
4 
 M
ea
n 
va
lu
e 
± 
SE
, n
 =
 3
. 
 
 
T
ab
le
 4
.1
0 
In
ac
tiv
at
io
n 
pa
ra
m
et
er
s o
f 
-L
-r
ha
m
no
si
da
se
 e
xp
re
ss
ed
 b
y 
so
lu
bl
e 
an
d 
im
m
ob
ili
ze
d 
na
rin
gi
na
se
 w
ith
in
 c
os
ol
ve
nt
 sy
ste
m
s. 
CHAPTER 4   
146 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

-D
-G
lu
co
si
da
se
 
C
os
ol
ve
nt
   
 [%
 (V
/V
)]
 
(E
xp
re
ss
ed
 b
y 
so
lu
bl
e 
na
rin
gi
na
se
) 
(E
xp
re
ss
ed
 b
y 
so
l-g
el
 im
m
ob
ili
ze
d 
na
rin
gi
na
se
) 
 

1 
k 1
 (h
-1
) 
k 2
 (h
-1
) 
t 1/
2 
so
l (
h)
   
   
   
   
 R
2  
 

1 
k 1
 (h
-1
) 
k 2
 (h
-1
) 
t 1/
2 
im
m
 (h
) 
R2
 
t 1/
2 
im
m
 . 
t 1/
2 
so
l-1
 
D
im
et
hy
l s
ul
fo
xi
de
 
 
 
 
 
 
 
 
 
 
 
 
0 
0.
76
± 
0.
03
 
2.
84
 ±
 0
.8
4 
 0
.0
74
± 
0.
01
 
6.
18
 ±
 0
.5
5 
0.
99
 
1.
29
 ±
 0
.0
1 
2.
18
 ±
 0
.7
9 
  0
.2
1 
± 
0.
00
 
33
.6
 ±
 4
.0
 
0.
99
 
5 
2.
5 
 - 
0.
19
 ±
 0
.0
1 
- 
3.
72
 ±
 0
.1
2 
0.
89
 
1.
15
 ±
 0
.0
6 
26
.3
 ±
 8
.2
 
0.
03
7 
± 
0.
02
 
20
.7
 ±
 3
.7
 
0.
91
 
6 
5 
 - 
0.
20
 ±
 0
.0
1 
- 
3.
10
 ±
 0
.1
4 
0.
95
 
1.
15
 ±
 0
.0
3 
3.
16
 ±
 0
.1
0 
0.
05
3 
± 
0.
01
 
13
.8
 ±
 1
.0
 
0.
91
 
4 
10
 
 - 
0.
32
 ±
 0
.0
0 
- 
2.
16
 ±
 0
.0
3 
0.
95
 
1.
16
 ±
 0
.1
0 
0.
65
 ±
 0
.0
8 
0.
07
1 
± 
0.
02
 
12
.9
 ±
 0
.5
 
0.
88
 
6 
N
,N
-D
im
et
hy
la
ce
ta
m
id
e 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
 - 
0.
25
 ±
 0
.0
1 
- 
2.
72
 ±
 0
.0
8 
0.
89
 
1.
34
 ±
 0
.2
4 
24
.9
 ±
 7
.5
 
0.
03
9 
± 
0.
01
 
25
.4
 ±
 2
.6
 
0.
88
 
9 
5 
 - 
0.
42
 ±
 0
.0
1 
- 
1.
84
 ±
 0
.0
5 
0.
93
 
1.
30
 ±
 0
.0
5 
2.
70
 ±
 0
.7
8 
0.
05
6 
± 
0.
01
 
15
.3
 ±
 1
.4
 
0.
97
 
8 
10
 
 - 
1.
40
 ±
 0
.0
9 
- 
0.
49
 ±
 0
.0
3 
0.
96
 
1.
43
 ±
 0
.4
3 
0.
93
 ±
 0
.0
8 
0.
10
4 
± 
0.
08
 
11
.7
 ±
 1
.6
 
0.
99
 
24
 
M
et
ha
no
l 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
27
 ±
 0
.0
1 
- 
2.
54
 ±
 0
.0
6 
0.
90
 
1.
43
 ±
 0
.1
7 
30
.8
 ±
 9
.5
 
0.
05
9 
± 
0.
01
 
17
.4
 ±
 1
.5
 
0.
92
 
7 
5 
- 
0.
30
 ±
 0
.0
2 
- 
2.
33
 ±
 0
.1
6 
0.
92
 
1.
38
 ±
 0
.0
2 
3.
37
 ±
 0
.1
8 
0.
05
6 
± 
0.
00
 
18
.0
 ±
 2
.1
 
0.
84
 
8 
10
 
- 
0.
44
 ±
 0
.0
3 
- 
1.
56
 ±
 0
.0
9 
0.
85
 
1.
11
 ±
 0
.1
0 
1.
77
 ±
 0
.5
3 
0.
04
7 
± 
0.
01
 
17
.5
 ±
 2
.2
 
0.
99
 
11
 
Et
ha
no
l 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
28
 ±
 0
.0
1 
- 
2.
47
 ±
 0
.0
6 
0.
89
 
1.
40
 ±
 0
.1
3 
23
.2
 ±
 2
.3
 
0.
06
3 
± 
0.
01
 
17
.3
 ±
 2
.1
 
0.
87
 
7 
5 
- 
0.
31
 ±
 0
.0
1 
- 
2.
25
 ±
 0
.1
1 
0.
86
 
1.
37
 ±
 0
.0
3 
30
.0
 ±
 9
.7
 
0.
05
0 
± 
0.
01
 
18
.3
 ±
 1
.5
 
0.
87
 
8 
10
 
- 
0.
94
 ±
 0
.0
1 
- 
0.
74
 ±
 0
.0
2 
0.
94
 
1.
27
 ±
 0
.0
7 
3.
43
 ±
 0
.6
7 
0.
05
1 
± 
0.
00
 
18
.0
 ±
 1
.0
 
0.
97
 
24
 
A
ce
to
ne
 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
32
 ±
 0
.0
2 
- 
2.
14
 ±
 0
.0
7 
0.
92
 
1.
27
 ±
 0
.0
6 
26
.5
 ±
 8
.5
 
0.
02
7 
± 
0.
00
 
31
.7
 ±
 2
.2
 
0.
93
 
15
 
5 
- 
0.
38
 ±
 0
.0
1 
- 
1.
80
 ±
 0
.0
6 
0.
93
 
1.
35
 ±
 0
.1
0 
0.
87
 ±
 0
.0
5 
0.
05
8 
± 
0.
02
 
20
.9
 ±
 4
.5
 
0.
92
 
12
 
10
 
- 
0.
95
 ±
 0
.0
3 
- 
0.
73
 ±
 0
.0
3 
0.
98
 
1.
61
 ±
 0
.0
8 
0.
18
 ±
 0
.4
3 
0.
14
8 
± 
0.
01
 
13
.4
 ±
 2
.4
 
0.
80
 
18
 
Te
tra
hy
dr
of
ur
an
 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
30
 ±
 0
.0
1 
- 
2.
31
 ±
 0
.1
0 
0.
95
 
1.
34
 ±
 0
.0
1 
20
.8
 ±
 0
.8
 
0.
04
6 
± 
0.
01
 
24
.7
 ±
 5
.0
 
0.
96
 
11
 
5 
- 
0.
41
 ±
 0
.0
2 
- 
1.
69
 ±
 0
.1
0 
0.
83
 
1.
45
 ±
 0
.0
2 
2.
07
 ±
 0
.7
4 
0.
06
9 
± 
0.
00
 
16
.1
 ±
 1
.2
 
0.
97
 
10
 
10
 
- 
2.
12
 ±
 0
.0
4 
- 
0.
33
 ±
 0
.0
1 
0.
97
 
1.
29
 ±
 0
.0
2 
3.
43
 ±
 0
.1
7 
0.
05
0 
± 
0.
00
 
19
.2
 ±
 1
.0
 
0.
90
 
59
 
1,
2-
D
im
et
ho
xy
et
ha
ne
 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
25
 ±
 0
.0
0 
- 
2.
77
 ±
 0
.0
4 
0.
92
 
1.
56
 ±
 0
.0
2 
2.
58
 ±
 0
.9
7 
0.
06
3 
± 
0.
00
 
17
.8
 ±
 0
.9
 
0.
98
 
6 
5 
- 
0.
33
 ±
 0
.0
0 
- 
2.
06
 ±
 0
.0
2 
0.
98
 
1.
46
 ±
 0
.1
0 
4.
51
 ±
 0
.7
7 
0.
06
6 
± 
0.
01
 
16
.5
 ±
 2
.3
 
0.
97
 
8 
10
 
- 
0.
53
 ±
 0
.0
4 
- 
1.
30
 ±
 0
.0
8 
0.
92
 
1.
36
 ±
 0
.0
4 
5.
16
 ±
 0
.9
6 
0.
05
2 
± 
0.
01
 
17
.7
 ±
 2
.9
 
0.
96
 
14
 
1,
4-
D
io
xa
ne
 
 
 
 
 
 
 
 
 
 
 
 
2.
5 
- 
0.
21
 ±
 0
.0
2 
- 
3.
36
 ±
 0
.3
3 
0.
92
 
1.
37
 ±
 0
.0
3 
3.
46
 ±
 0
.7
4 
0.
04
7 
± 
0.
00
 
21
.3
 ±
2.
2 
0.
99
 
6 
5 
- 
0.
28
 ±
 0
.0
0 
- 
2.
50
 ±
 0
.0
3 
0.
85
 
1.
20
 ±
 0
.0
2 
30
.1
 ±
 0
.8
 
0.
04
3 
± 
0.
00
 
20
.2
 ±
 0
.5
 
0.
91
 
8 
10
 
- 
0.
47
 ±
 0
.0
1 
- 
1.
46
 ±
 0
.0
4 
0.
94
 
1.
19
 ±
 0
.0
2 
20
.2
 ±
 0
.1
 
0.
08
4 
± 
0.
01
 
19
.2
 ±
 3
.7
 
0.
89
 
13
 
 M
ea
n 
va
lu
e 
± 
SE
, n
 =
 3
. 
 
 T
ab
le
 4
.1
1 
In
ac
tiv
at
io
n 
pa
ra
m
et
er
s o
f 
-D
-g
lu
co
si
da
se
 e
xp
re
ss
ed
 b
y 
so
lu
bl
e 
an
d 
im
m
ob
ili
ze
d 
na
rin
gi
na
se
 w
ith
in
 c
os
ol
ve
nt
 s
ys
te
m
s. 
 
  CHAPTER 4 
147 
4.3.2.4 Kinetic study of naringin bioconversion 
A kinetic study of naringin hydrolysis was carried out in free cosolvent and 10 % 
aqueous cosolvent systems of 1,2-dimethoxyethane; 1,4- dioxane and tetrahydrofuran. 
A maximum naringin concentration of 2.5 mM was dissolved in the free cosolvent 
aqueous system, while increased naringin concentrations were used in the 10 % aqueous 
cosolvent systems, with a maximum concentration, of 5 mM in 1,2-dimethoxyethane 
and 15 mM in 1,4- dioxane and tetrahydrofuran, respectively, (Figure 4.12). The less 
toxic cosolvents were respectively, 1,2-dimethoxyethane, 1,4-dioxane, and 
tetrahydrofuran. Kinetic constants were evaluated on naringin hydrolysis by naringinase 
within these aqueous cosolvent systems. 1,4-dioxane and 1,2-dimethoxyethane showed 
a higher naringinase specific activity, being considered the most favourable (Figure 
4.12). Naringin shows a higher solubility in 1,4-dioxane (Table 4.8), but a higher kcat 
and a lower KM was observed with 1,2-dimethoxyethane (Table 4.12).  
Different concentrations of 1,2-imethoxyethane (1, 2 and 3 %) were tested using 
different naringin concentrations, allowing kinetic constant evaluation (Figure 4.13). 
According to the results reported on Figure 4.13 and Table 4.13, the presence of 1,2-
dimethoxyethane in aqueous systems led to a slight increase in kcat and higher KM. The 
kcat was much less affected with the presence of the cosolvent, than the apparent KM, 
also a sharp decrease of the catalytic efficiency (kcat.KM1) was observed. 
An increase in the Michaelis-Menten constant, KM for the hydrolysis of naringin in the 
aqueous cosolvent system of 1,2-dimethoxyethane in water reflects changes in the 
affinity of the enzyme for the substrate, which is common in reactions involving 
hydrophobic interactions during the enzyme-substrate complex formation. Similar 
results were obtained in other works, showing increased Michaelis-Menten constant for 
the hydrolytic activity of -chymotrypsin (Kise and Tomiuchi, 1991) in cosolvent 
systems.  
 
 
 
Cosolvent kcat (mol min─1 mg─1) KM (mM) kcat KM
─1 (L min─1 g─1) R2 
Without 2.05 ± 0.14 1.92 ± 0.27 1.07 0.99 
1,2-Dimethoxyethane 2.52 ± 0.09 4.26 ± 0.30 0.59 0.99 
1,4-Dioxane 1.91± 0.17 5.15 ± 0.22 0.37 0.99 
Tetrahydrofuran 1.46 ± 0.18 8.00 ± 2.72 0.18 0.97 
Table 4.12 Kinetic parameters of soluble naringinase, in 10 % (v/v) aqueous cosolvent systems. 
 
Mean value ± SE, n = 3. 
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1,2-Dimethoxyethane (%) kcat (mol.min─1 mg─1) KM (mM) kcat.KM─1 (L min─1 g─1) R2 
0 2.40 ± 0.18 2.21 ± 0.33 1.08 0.99 
1 2.45 ± 0.12 3.03 ± 0.42 0.81 0.98 
2 2.54 ± 0.10 3.58 ± 0.53 0.71 0.98 
3 2.60 ± 0.08 4.41 ± 0.59 0.59 0.98 
Table 4.13 Kinetic parameters of soluble naringinase, in aqueous cosolvent system composed of 1,2-
dimethoxyethane. 
 
Mean values ± SE, n = 3. 
Figure 4.12 Michaelis-Menten kinetics of soluble naringinase, in several aqueous cosolvent systems (10 %). 
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Figure 4.13 Michaelis-Menten kinetics of naringinase, in aqueous cosolvent system composed of 
different concentrations of 1,2-dimethoxyethane (1, 2 and 3 %). 
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4.3.3 Sol-gel immobilization of naringinase using ILs as additives 
In preliminary studies, the ILs: [EMIM][DMP], [C2OHMIM][BF4], 
[BMIM][MeOEtOEtOSO3] and [E2-MPy][ESO4] were tested in the production of the 
sol-gel matrices as additives with TMOS and in combination with glycerol. In these 
experiments, ILs were added during the sol formation leading to a homogenous silica 
colloid. They were tested in 3% (w/w) relative proportion to the gel mass. This value 
(3%) was selected after preliminary assays using different ILs proportions (w/w) relative 
to the gel mass before aging (data not shown). The hydrolytic reactions of the substrates 
4-NRP and 4-NGP, with respectively -L-rhamnosidase and -D-glucosidase, were 
used as reaction models to study the effects of the different ILs on sol-gel matrices.  
Figure 4.14 presents the results obtained for -L-rhamnosidase and -D-glucosidase 
activities immobilized within sol-gel matrices of TMOS/ILs and TMOS/Glycerol/ILs, 
during 19 consecutive reutilizations. In both cases the enzyme activity was higher for 
immobilized enzyme within sol-gel matrices of TMOS/Glycerol/ILs, than for matrices 
made of TMOS/ILs. In fact, the presence of glycerol, showed to be important in all 
matrices produced with ILs, resulting in higher -L-rhamnosidase (Figure 4.14a) and -
D-glucosidase (Figure 4.14b) efficiencies, respectively, of about ~60% and ~75%. 
Moreover, the use of glycerol with [E2-MPy][ESO4], as additives, led to an increase on 
the efficiency of -L-rhamnosidase from 11 to 62% and a -D-glucosidase efficiency 
increase from 21% to 78%. Also, the efficiency of -D-glucosidase of naringinase 
encapsulated on TMOS/Glycerol/ILs was higher compared with those obtained (72%) 
with sol-gel matrices of TMOS/Glycerol (matrix B). 
 
 
 
 
 
 
 
 
 
 
 Figure 4.14 Influence of ILs on the efficiency of -L-rhamnosidase (a) and -D-glucosidase (b) 
immobilized in TMOS sol-gel matrices with and without glycerol, after 19 consecutive runs (bars: 1st, 4th, 
7th, 10th, 13th, 16th and 19th runs) (mean value ± SE, n = 8). 
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The addition of ILs on sol-gel matrices can be performed in the sol preparation 
incorporated in the silica sol (Liu et al., 2005a, b; Lee et al., 2007b) or during the gel 
formation, dissolved in the enzymatic solution (Zarcula et al., 2009). After 19 
consecutive reutilizations, no significant differences (Figure 4.15) were observed on the 
efficiency of -L-rhamnosidase (~65%) and -D-glucosidase (~80%) immobilized 
within sol-gel matrices of TMOS/Glycerol with ILs incorporated in the silica sol 
(Figure 4.15a) or in the enzymatic solution (Figure 4.15b). The exception was the 
incorporation of the IL, [E2-MPy][ESO4], on silica sol that allowed higher efficiencies 
of -L-rhamnosidase (17% to 62%) and -D-glucosidase (50% to 78%) of naringinase. 
Lee et al. (2007b) found a higher activity for immobilized lipase when ILs and TEOS 
were hydrolyzed before lipase addition. In further studies, the ILs were added to the 
silica sol, unless stated otherwise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3.1 Influence of ILs structure on sol-gel naringinase immobilization efficiency 
As indicated in 4.2.5.2 (method 1), the silica sol–gel materials were obtained through a 
sol-gel method using TMOS/Glycerol and the following ILs: [C2OHMIM][Cl], 
[EMIM][DMP], [BMIM][MeOEtOEtOSO3], [C2OHMIM][BF4], [EMIM][PF6], 
[BMIM][PF6], [OMIM][Tf2N], [E2-MPy][ESO4] and [E3-MPy][ESO4]. When method 1 
was used for the ILs [C2OHMIM][PF6], [OMIM][PF6] and [BMIM][Tf2N], a colloid 
system wasn’t formed even after one hour of sonication. So, a higher concentration of 
catalyst was needed to obtain one layer of silica sol, leading to the development of 
Figure 4.15 Influence of the incorporation of ILs in silica sol (TMOS/Glycerol) and in the enzymatic 
solution, on the efficiency of -L-rhamnosidase (a) and -D-glucosidase (b), after 19 consecutive 
reutilizations (bars: 1st, 4th, 7th, 10th, 13th, 16th and 19th runs) (mean value ± SE, n = 8). 
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method 2, as described in 4.2.5.2. The ILs [BMIM][TFA], [BIM][BF4] and 
[BMIM][BF4] added to the silica sol formed an unstable colloid gel in a very fast way, 
turning it impossible to make the gel. On the basis of this of this colloid instability is the 
Derjaguin-Landau-Verwey-Overbeek (DLVO) theory (Ueno et al., 2008); therefore a 
third method (method 3) was established for these ILs, by mixing them with the solution 
of enzyme, as described in 4.2.5.2. Besides the previous mentioned ILs, 1-butyl-3-
methylimidazolium tetrafluoroborate was also tested as sol-gel additive but it led to a 
very fast gel formation when added to the silica sol and as it isn’t miscible with water it 
couldn’t have been studied even using method 3. 
Immobilized -L-rhamnosidase (Figure 4.16) and -D-glucosidase (Figure 4.17) were 
greatly influenced by ILs (3% w/w) used as templates of sol-gel (TMOS/Glycerol). 
Stability was measured through the average retention of enzyme activity over fifty 
reutilizations (Table 4.14). The most striking feature concerning Figure 4.16 and 4.17 is 
the positive impact of ILs present on TMOS/Glycerol matrices over the enzyme activity 
and stability. The efficiency of -L-rhamnosidase within TMOS/Glycerol/ILs matrices 
(Figure 4.16) is dependent on the structure of the IL cation as follows: [OMIM] > 
[BMIM] > [EMIM] > [C2OHMIM] > [BIM] and [OMIM] ≈ [E2-MPy] >> [E3MPy]. 
Considering these series, the hydrophobic nature of the ILs cation appears to be 
fundamental for -L-rhamnosidase activity and stability. Regarding the imidazolium 
family, the efficiency of -L-rhamnosidase is influenced by the hydrophobic nature of 
the cation. Indeed, an increase in the cation hydrophobicity lead to higher -L-
rhamnosidase efficiencies: [BIM]BF4 << [C2OHMIM] BF4 << [BMIM]BF4. Also, the 
structure of the cation is essential for enzyme activity and stability. Small differences in 
the IL cation structure led to important differences in the enzyme activity and stability, 
for instance, when using [E3-MPy] and [E2-MPy] an impressive difference in the -L-
rhamnosidase activity and stability of almost 150% was observed (Figure 4.16). 
Comparing the anions used in this study, similarly to what happened with the 
hydrophobic nature of the cation, an increase in the anion hydrophobicity led to an 
increase in -L-rhamnosidase efficiency. In the BMIM series the more hydrophobic 
anions (PF6, BF4 and Tf2N) led to higher activities than TFA (Figure 4.16).  
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The positive impact of [BMIM][BF4], [E2-MPy][ESO4], [OMIM][PF6] and 
[OMIM][Tf2N] on TMOS/Glycerol matrices, was also observed on the high -L-
rhamnosidase reuse efficiency average (Table 4.14). The TMOS/Glycerol matrices 
produced without IL, after fifty runs, led to a 40% -L-rhamnosidase inactivation 40% 
(1st run 0.58 and 50th 0.37), while matrices with incorporated ILs, as [E2-MPy][ESO4], 
[BMIM][BF4] and [OMIM][Tf2N] allowed an increase in the average reuse efficiency, 
respectively, of 29%, 31% and 35% (Figure 4.16 and Table 4.14), comparing with sol-
gel matrices without ILs.  
In the case of -D-glucosidase activity almost all TMOS/Glycerol/ILs matrices led to 
average efficiencies around 70-75%, with the exception of [E3-MPy][SO4] (Figure 4.17 
and Table 4.14). [C2OHMIM][PF6] allowed the best average reuse efficiency (0.82) 
which was 12% higher than the matrix without IL. 
 
4.3.3.2 Influence of ILs on the sol-gel matrices structure and properties 
The sol-gel matrices that showed the best average reuse efficiency for each enzymatic 
activity were chosen for further studies, which includes the matrices produced with 
TMOS/Glycerol/[OMIM][Tf2N] in the case of -L-rhamnosidase activity and 
TMOS/Glycerol/[C2OHMIM][PF6] in the case of -D-glucosidase. The macroscopic 
structure of these hydrogel matrices was translucent without cracking, except for 
[OMIM][Tf2N] sol-gel matrices that showed some opacity (Figure 4.18). Indeed after 
several reutilizations the lens became also translucent; showing an increase on -L-
rhamnosidase (Figure 4.16) and -D-glucosidase (Figure 4.17) activities. Figure 4.18, 
also highlights the higher mechanical resistance against cracking after fifty runs of the 
matrix produced with [OMIM][Tf2N] (III50) when comparing with the other two 
matrices: I50 (TMOS/Glycerol) and II50 (TMOS/Glycerol/[C2OHMIM][PF6]), which 
show a markedly cracked structure after fifty reutilizations. The matrix integrity is a 
crucial criterion in a bioprocess implementation, namely at large scale, in order to avoid 
enzyme loss between batches. 
Figure 4.19 shows SEM micrographs of matrices produced with TMOS/Glycerol, 
TMOS/Glycerol/[C2OHMIM][PF6] and TMOS/Glycerol/[OMIM][Tf2N]. The porosity 
of TMOS/Glycerol matrices, in the first use and after 50 consecutive reutilizations, 
respectively, I and I50, showed a finer structure with porosity (average dimension of the 
pores) of 20  30 nm (Figure 4.19). The SEM micrographs of 
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TMOS/Glycerol/[C2OHMIM][PF6] matrices, before and after 50 reutilizations (II1 and 
II50), showed matrices of the same type, porous, in which the structure after successive 
uses II50 is finer than II1. The matrices of TMOS/Glycerol/[OMIM][Tf2N] (III1 and 
III50) showed a sandwich like structure where two films (one in each side) and the inside 
with a porous structure can be observed (Figure 4.20). The interior of matrix 
TMOS/Glycerol/[OMIM][Tf2N] (in the first use) (I1) is a compact material with a 
dispersion of closed bubbles, of IL ([OMIM][Tf2N]) with non-uniform size. The 
bubbles show a spherical inner aspect. Apparently there is a surface film. The same 
matrix, but after successive reutilizations, III50, has a similar structure, with some large 
bubbles, but with regions of bubbles of smaller and more uniform size. The wall 
thickness of the bubbles in matrix III50 varies between 0.5 to 1 m. From the first use 
(III1) to the fifth (III50) there was a refinement of the structure, becoming more uniform. 
This behaviour is characteristic of the dispersion of a hydrophobic compound (e.g. IL, 
[OMIM][Tf2N]) in a hydrophilic matrix (e.g. TMOS/Glycerol). In conclusion, clearly 
the matrices III1 and III50 presented a microstructure with closed bubbles but with 
different sizes. This modification of the matrix may play an important role on enzyme 
efficiency, as well as on the enzyme/matrix interactions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 Macroscopic structure of matrices before use: I (TMOS/Glycerol), II 
(TMOS/Glycerol/[C2OHMIM][PF6]) and III (TMOS/Glycerol/[OMIM][Tf2N]); and matrices reused over 
50 runs: I50 (TMOS/Glycerol), II50 (TMOS/Glycerol/[C2OHMIM][PF6]) and III50 
(TMOS/Glycerol/[OMIM][Tf2N]). 
 
 
 
B1  A1  C1 
A50 B50 C50 
   I   II    III
III50   I50  II  
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Figure 4.19 SEM microphotographs of matrices before use: I (TMOS/Glycerol), II 
(TMOS/Glycerol/[C2OHMIM][PF6]) and III (TMOS/Glycerol/[OMIM][Tf2N]); and matrices reused over 
50 runs: I50 (TMOS/Glycerol), II50 (TMOS/Glycerol/[C2OHMIM][PF6]) and III50 
(TMOS/Glycerol/[OMIM][Tf2N]). 
 
Figure 4.20 SEM structure detail of the sol-gel matrix III (TMOS/Glycerol/[OMIM][Tf2N]). IIIS 
corresponds to the surface of the lens while IIII is the inner part of the matrix. 
 
  C C2 
C3 
1    III 
    IIII 
   IIIS 
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SEM analysis showed that matrices (I, II and III) are shaped lens with a film structure 
which varies within the lens, depending on the nature of ILs. The microstructure of the 
lens varies from granular to porous, depending on the material type. Additionally, some 
physical properties of the matrices, like partition coefficients (Table 4.15), diameter, 
volume, density were evaluated (Table 4.16). 
 
 
 
 
 
 
 
The substrate concentration achieved inside the matrix is important for enzyme activity 
once the enzyme movement is restricted within the semi-solid structure. The partition 
coefficient (Pm/s) of 4-NRP and 4-NGP using the TMOS/Glycerol, 
TMOS/Glycerol/[C2OHMIM][PF6] and TMOS/Glycerol/[OMIM][Tf2N] matrices were 
determined according to Equation 4.2 (Table 4.15). A slight increase in the partition 
coefficients of TMOS/Glycerol/[C2OHMIM][PF6] matrices were obtained, comparing 
with TMOS/Glycerol matrices. As both matrices have hydrophilic characteristics, this 
difference may be due to the presence of a nitro group in 4-nitrophenol derived 
substrates, which is a strong electron-attracting group that may interact through 
electrostatic interactions (Liu et al., 2005a, b) with the IL present within the matrix. 
Pm/s 
Sol-gel matrices 
Naringin Prunin Naringenin 4-NRP 4-NGP 4-Nitrophenol 
TMOS/Glycerol 0.57 ± 0.04 0.53 ± 0.03 0.56 ± 0.03 0.74 ± 0.05 0.82 ± 0.04 0.87 ± 0.04 
TMOS/Glycerol/ 
 [C2OHMIM][PF6] 
0.47 ± 0.03 0.48 ± 0.03 0.53 ± 0.03 0.86 ± 0.04 0.92 ± 0.05 1.04 ± 0.02 
TMOS/Glycerol/ 
 [OMIM][Tf2N] 
0.42 ± 0.02 0.42 ± 0.05 0.49 ± 0.02 0.41 ± 0.04 0.47 ± 0.04 0.68 ± 0.05 
Sol-gel matrix Dm (mm) Vm (L) wm (mg) dm (g mL1) Vis (L) 
TMOS/Glycerol 5.34 ± 0.05 19.3 ± 0.7 19.6 ± 0.5 1.02 ± 0.05 13.0 ± 0.4 
TMOS/Glycerol/[C2OHMIM][PF6] 5.36 ± 0.05 20.8 ± 0.7 21.4 ± 0.8 1.03 ± 0.03 14.9 ± 0.5 
TMOS/Glycerol/[OMIM][Tf2N] 4.60 ± 0.02 17.2 ± 0.9 18.1 ± 0.2 1.06 ± 0.06 10.7 ± 0.2 
Table 4.15. Partition coefficients between matrix and 20 mM acetate buffer, pH 4, of the substrates and 
products used in this study. 
 
Mean value ± SE, n = 6. 
 
Table 4.16 Physical properties of TMOS/Glycerol/[OMIM][Tf2N], TMOS/Glycerol/[C2OHMIM][PF6] 
and TMOS/Glycerol matrices. 
 
Mean value ± SE, n = 6. 
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According to this a substrate concentration increase inside the matrix is expected (Table 
4.15). Moreover, lower partition coefficients were accomplished with 
TMOS/Glycerol/[OMIM][Tf2N] than with TMOS/Glycerol matrices; which is in 
agreement with the hydrophobic characteristics of [OMIM][Tf2N] (Table 4.15). 
The TMOS/Glycerol and TMOS/Glycerol/[C2OHMIM][PF6] matrices, the more 
hydrophylic matrices, showed similar properties (Table 4.16). A small decrease in 
TMOS/Glycerol/[OMIM][Tf2N] matrix diameter caused a decrease in matrix volume 
(Figure 4.18, Table 4.15). Moreover, the three matrices showed similar densities.  
In conclusion, the ILs as additives of TMOS/Glycerol sol-gel matrices had a higher 
impact on the activity and stability of -L-rhamnosidase than on -D-glucosidase 
expressed by naringinase. Regarding the higher efficiencies of the sol-gel matrices 
produced with [OMIM][Tf2N] and [C2OHMIM][PF6], they were chosen for the 
hydrolysis of flavone glycosides including naringin and prunin. 
 
4.3.3.3 Kinetic study of naringin and prunin bioconversion 
Naringin was bioconverted into prunin, using -L-rhamnosidase activity, expressed by 
naringinase immobilized, within sol-gel matrices of TMOS/Glycerol/[OMIM][Tf2N] 
and TMOS/Glycerol (Figure 4.21a). Its kinetic parameters were determined. Moreover, 
kinetic parameters of prunin hydrolysis into naringenin by means of -D-glucosidase, 
expressed by naringinase, immobilized within sol-gel matrices of 
TMOS/Glycerol/[C2OHMIM][PF6] and TMOS/Glycerol were also evaluated (Figure 
4.21b). The kinetic profile of both naringin and prunin hydrolysis using free and 
immobilized naringinase obeys to the Michaelis-Menten model. According to the results 
shown on Figure 4.21a and Table 4.17 a slight increase in KM, similar kcat and a sharp 
decrease of the catalytic efficiency (kcat.KM1) was obtained for -L-rhamnosidase 
encapsulated within TMOS/Glycerol/[OMIM][Tf2N], when comparing with 
TMOS/Glycerol matrix. The increase of KM reflects changes in the affinity of 
enzymefor naringin, which supports hydrophobic interactions involved in the enzyme-
substrate complex formation, due to the more hydrophobic characteristics of this IL. In 
addition, the partition coefficient of naringin, prunin and naringenin decreased with the 
addition of [OMIM][Tf2N] to TMOS/Glycerol matrices (Table 4.15), which, is also 
supported by the hydrophobic characteristic of [OMIM][Tf2N]. 
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Prunin hydrolysis, by -D-glucosidase immobilized within 
TMOS/Glycerol/[C2OHMIM][PF6] and TMOS/Glycerol led to similar KM, kcat and 
catalytic efficiency (kcat.KM1). The prunin partition coefficient of 
TMOS/Glycerol/[C2OHMIM][PF6] and TMOS/Glycerol matrices (Table 4.15) almost 
did not change (0.48 ± 0.03 and 0.53 ± 0.03). Indeed the 
TMOS/Glycerol/[C2OHMIM][PF6] matrix shows hydrophilic characteristics as 
TMOS/Glycerol matrix. 
Substrate Naringinase 
kcat   
(mol min1 mg1) 
KM  
(mM) 
kcat.KM1  
(L min1 g1) 
y  
(%) R
2 
Free 0.84 ± 0.03 1.51 ± 0.14 0.56 - 0.999 
TMOS/Glycerol 0.62 ± 0.02 3.06 ± 0.26 0.20 92 0.995 Naringin 
TMOS/Glycerol/ 
[OMIM] [Tf2N] 
0.61 ± 0.05 3.97 ± 0.60 0.15 92 0.997 
Free 0.63 ± 0.02 0.81 ± 0.10 0.78 - 0.999 
TMOS/Glycerol 0.55 ± 0.03 1.42 ± 0.24 0.38 92 0.999 Prunin 
TMOS/Glycerol/ 
[C2OHNIN] [PF6] 
0.53 ± 0.02 1.38 ± 0.09 0.38 100 0.997 
Figure 4.21 a) Michaelis-Menten kinetics of naringin hydrolysis into prunin by -L-rhamnosidase b) 
Michaelis-Menten kinetics of prunin hydrolysis into naringenin by -D-glucosidase (mean value ± SE, n 
= 3). 
 
0
0.2
0.4
0.6
0.8
0 2 4 6 8
[Prunin] (mM)
A
 ( m
m
ol
.m
in
-
1 .m
g-
1 )
free enzyme
immobilized enzyme (without IL)
immobilized enzyme ([C2OHM IM ] [PF6])
0.0
0.3
0.5
0.8
1.0
0 5 10 15
[Naringin] (mM)
A
 ( m
m
ol
.m
in
-
1 .m
g-
1 )
free enzyme
immobilized enzyme (without IL)
immobilized enzyme ([OM IM ] [Tf2N])
 a) b) 
Table 4.17 Kinetic parameters of the hydrolysis of naringin and prunin by -L-rhamnosidase and -D-
glucosidase using free and immobilized naringinase within sol-gel matrices. 
Mean value ± SE, n = 3. 
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When the kinetic parameters of encapsulated naringinase are compared to those 
obtained with soluble enzyme, mass transfer effects seem to occur in all cases of 
immobilized enzyme, resulting in lower kcat and kcat.KM-1.  
The high immobilization yield (> 90%) for all three sol-gel matrices (TMOS + Glycerol 
without IL, with [OMIM][Tf2N] and with [C2OHMIM][PF6]) indicates a small loss of 
enzyme during the immobilization procedure.  
 
4.3.3.4 Pressure influence on the stability of immobilized naringinase 
Preliminary assays were made, concerning the influence of pressure on the stability of 
immobilized naringinase. A pressure magnitude of 150 MPa was used to accomplish 
these assays. The matrices studied were made of TMOS/Glycerol, 
TMOS/Glycerol/[OMIM][Tf2N] and TMOS/Glycerol/[C2OHMIM][PF6]. In the case of 
the matrix made of TMOS/Glycerol both the stabilities of -L-rhamnosidase and -D-
glucosidase activities were investigated (Figure 4.22). Both activities show a similar 
behaviour. The matrices submitted to 150 MPa, as well as the matrices kept at 
atmospheric pressure show a constant residual activity along the six hour study. In the 
case of the pressurized matrices the residual activity was slightly lower than non-
pressurized matrices. This fact is however not much relevant attending to the above 
mentioned fact of residual activity constancy during the assay. In addition the matrices 
showed to be mechanical resistant against such a high pressure magnitude of 150 MPa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22 Residual activity of -L-rhamnosidase (a) and -D-glucosidase (b), from immobilized 
naringinase entrapped within a TMOS/Glycerol matrix, under 0 or 150 MPa, at 50.0 ºC. 
 
a) b) 
0.00
0.50
1.00
1.50
1 2 3 4 5 6
t (h)
A
r
0 MPa
150 MPa
0.00
0.50
1.00
1.50
1 2 3 4 5 6
t  (h)
A
r
0 MPa
150 MPa
CHAPTER 4   
162 
Considering the good results of -L-rhamnosidase activity inside a matrix made of 
TMOS/Glycerol/[OMIM][Tf2N], the influence of pressure on its residual activity was 
also investigated. Interestingly, regarding Figure 4.23 it seems that in this case 
pressurized matrices not only show a constant residual activity along the 4 hours assay, 
but also have a higher residual activity than non-pressurized matrices. In addition in the 
case of matrices kept at atmospheric pressure seems to occur a decrease of the residual 
activity. An eventual protecting effect of pressure against inactivation may have 
occurred. 
In the case of matrices made of TMOS/Glycerol/[C2OHMIM][PF6], it happened that 
they were crashed by pressure at a magnitude of 150 MPa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23 Residual activity of -L-rhamnosidase, from immobilized naringinase entrapped within a 
TMOS/Glycerol/[OMIM][Tf2N] matrix, under 0 or 150 MPa, at 50.0 ºC. 
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4.4. Conclusions 
 
Glycerol and DGS respectively present on matrices B (TMOS/glycerol) and D 
(TMOS/DGS), were able to improve immobilization using TMOS. Aging time was an 
important parameter for improving sol-gel encapsulated naringinase activity. The best 
results were obtained with TMOS and TMOS/DGS after 4 h and TMOS/glycerol and 
DGS at 14 h aging time. Also the immobilization conditions of matrices B and D made 
them the best matrices, with very high immobilization yields (89% and 92%, 
respectively) and efficiency (72% and 76%, respectively). At an optimum pH of 4.3, a 
maximum naringinase specific activity of 0.86 mol min1 mg1 was obtained with the 
enzyme immobilized within matrices A (TMOS) and D (TMOS/DGS). 
Matrix B remained without any activity loss and 100% residual activity after 50 
successive reutilizations. Both matrix B and D showed outstanding naringinase 
operational stability due to a long-term activity and resistance to leaching, which are 
two major requirements for bio-immobilization, contributing to the importance and 
innovation of this work. 
Naringinase improved stability was achieved against several organic cosolvents studied. 
Aqueous cosolvent systems were developed, possessing a high enzyme retention 
activity. In all cosolvent systems tested a decrease in the inactivation parameters k1 and 
k2 occurred along with a correspondent increase of the half-life time in the case of sol-
gel immobilized naringinase, reflecting an improved stabilization. Beyond the possible 
restriction effect against protein unfolding caused by the immobilization method itself, 
the presence of glycerol within de sol-gel glasses, known to be a stabilizer of the protein 
structure, is certainly behind the stabilization effect of this sol-gel glasses 
(TMOS/glycerol). 
For all the aqueous cosolvents systems studied a half-life time increase, greater than 3 
fold, was observed for the immobilized naringinase, comparing with the soluble 
enzyme. The sol-gel protective effect was very pronounced at the highest cosolvent 
concentrations tested (10 %), as shown by the half-life times increase of the 
immobilized -D-glucosidase activity, respectively, 13, 14, 24 and 59-fold for 1,4 
dioxane; 1,2 dimethoxyethane; N,N-dimethylacetamide and tetrahydrofuran. 
Furthermore, the cosolvent system consisting of 1,2 dimethoxyethane showed to be a 
very interesting system for the hydrolysis of flavone rutinosides, such as naringin. 
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This study also showed that an IL content of 3% w/w can influence the enzymatic reuse 
efficiency; being mainly incorporated in the silica sol. The addition of the ILs: 
[OMIM][Tf2N] and [C2OHMIM][PF6] to the sol-gel matrices increased not only the 
efficiency of respectively 4-NRP and 4-NGP hydrolysis, but reduced the enzyme 
inactivation that occurred in TMOS/Glycerol matrices. In addition, the presence of the 
IL [OMIM][Tf2N] within the sol-gel matrices led to a higher mechanical resistance 
against cracking, which is important for industrial purposes. The macroscopic 
evaluation and SEM analysis showed that [OMIM][Tf2N] greatly influence the 
characteristics of the matrices, more robust and with regions of bubbles of smaller and 
more uniform size after several reutilizations, characteristic of a hydrophobic compound 
dispersion in a hydrophilic matrix. Moreover, ILs were also important to modulate the 
substrate and products partition between solvent and matrix acting as partition 
controlling agents. 
ILs as well as glycerol, used as template agents to produce nanostructured sol-gel 
matrices, improved the immobilization efficiency and stability of -L-rhamnosidase and 
-D-glucosidase expressed by naringinase. ILs influenced the structural characteristics 
of the sol-gel matrix suggesting that they play an important role in enzyme performance 
and on the high efficiency and stability achieved; which highlights the potential of this 
strategy for the finer tuning of the encapsulated enzymes properties within sol-gel/ILs 
matrices.  
In addition, considering the study of immobilized naringinase under pressure is 
important to point out the mechanical resistance and good stability profile of 
naringinase immobilized within TMOS/Glycerol and TMOS/Glycerol/[OMIM][Tf2N] 
matrices, under high-pressure conditions. 
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5.1 Introduction 
 
Inflammation is present in AD pathology and some anti-inflammatory approaches have 
been proposed to treat AD (cf. 1.2.2.3). Also, as described on 1.3.2, anti-inflammatory 
activity is a common pharmacological activity shared by flavonoids. Both naringin (cf. 
1.3.2.1) and naringenin (cf. 1.3.2.3) are reported to possess anti-inflammatory activity. 
In line with this, is important to evaluate their activity in CNS cells.  
The anti-inflammatory activity of a certain compound can be evaluated through the 
reduction of TNF- secretion after stimulation with lipopolysaccharide (LPS). TNF-is 
among the best characterized early response cytokines (Saliba and Henrot, 2001), 
produced by cells of the central nervous system responsible for proinflammatory action 
(Quan et al., 1999). LPS induces the release of TNF- in nerve cells such as astrocytes 
(Fernandes et al., 2004) and indomethacin was pointed to abrogate this effect (Repovic 
and Benveniste, 2002). The aim of this study, concerning this cell culture model, is to 
determine the efficacy of the anti-inflammatory properties of both naringin and 
naringenin in LPS-stimulated astrocytes and to establish the efficiency of each 
compound relatively to that of indomethacin. 
From another point of view, it’s important to study whether the flavanones: naringin, 
prunin and naringenin or some of their metabolites can cross the BBB and reach the 
brain. The analysis of their distribution in plasma and brain may elucidate the potential 
role of these compounds to reach and act on a brain disease, such as AD.  
The route of administration of a certain compound may decisively influence the therapy 
success. Concerning these compounds regardless of the oral administration of naringin, 
prunin or naringenin the observed circulating metabolites are glucuronoconjugates, 
sulfates and glucuronosulfoconjugated of naringenin (Felgines et al., 2000; Wang et al., 
2006b); naringenin glycosides, naringin and prunin, are not detected in plasma nor in 
urine (Felgines et al., 2000). In the case of naringin is suggested that it is hydrolyzed to 
its corresponding aglycone by glycosidases produced by intestinal bacteria (Felgines et 
al., 2000). Also, Hsiu et al. (2002) found that after oral administration of naringin an 
extensive glucuronidation and sulfation must occur during the first pass in the gut wall. 
In the case of prunin, both human cytosolic -glucosidase (hCBG) and lactase-phlorizin 
hydrolase (LPH) may be responsible for its hydrolysis. hCBG is located intracellularly 
(Nemeth et al., 2003) and is a xenobiotic metabolizing enzyme that shows high 
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specificity for 4- and 7-glucosides of isoflavones, flavonols, flavones and flavanones 
and is present in the liver, kidney, intestine and spleen of humans (Glew et al., 1993). 
LPH is anchored in the mucosal membrane in the brush-border of the small intestine 
(Zecca et al., 1998; Hollox et al., 2001). LPH is also a human -glucosidase that 
hydrolyses a broad range of flavonoid glucosides, including flavonols, flavones, 
flavanones, and isoflavones (Nemeth et al., 2003).  
Following this, intraperitoneal administration was used in the animal model, in order to 
avoid the reported first pass metabolization that may occur in the gut wall. After 
intraperitoneal administration, each flavanone: naringin, prunin and naringenin, is 
quickly absorbed into the bloodstream. Within the bloodstream, it is then possible to 
study the influence of the structural differences of these flavanones on their distribution 
into the brain. The aim of this study, concerning the animal model, is to show the 
advantage of using aglycones and glucosides to cross the BBB, instead of rutinosides, in 
order to treat AD. On the basis of this idea is a possible passive diffusion of 
hydrophobic aglycones across the BBB and also an eventual transport of glucosides, 
through receptors recognition, as described on 1.3.4. In preliminary studies the 
flavanones naringin, prunin and naringenin were studied. The administration of these 
compounds to the animal model, and their determination as well as possible metabolites 
in plasma and brain may be helpful to determine weather these hypothesis are correct. 
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5.3 Material and methods 
 
5.2.1 Chemicals 
Naringin, naringenin and daidzein were purchased from Sigma-Aldrich. Prunin was 
biosynthesized according to the method described on Chapter 2. Dulbecco’s modified 
Eagle’s medium (DMEM) and fetal calf serum (FCS) were purchased from Biochrom 
AG (Berlin, Germany). Antibiotic antimycotic solution and rabbit antibody anti-glial 
fibrillary acidic protein (GFAP) were acquired from Sigma (St. Louis, MO, USA). The 
monoclonal antibody against the CR3 complement receptor of microglia (OX-42) was 
obtained from Serotec (Raleigh, NC, USA). Recombinant TNF-was purchased from 
R&D Systems (Minneapolis, MN, USA). Escherichia coli O111:B4 (LPS) was 
purchased from Calbiochem (La Jolla, CA, USA), dissolved at 1 mg mL1 in phosphate 
buffered saline (PBS) at pH 7.4 and kept at 4 ºC. 
All other chemicals were analytical grade and obtained from various sources. 
 
5.2.2 Cell cultures 
Astrocytes were isolated from 2-day-old rats according to Blondeau et al. (1993) and 
Silva et al. (1999). The brains of decapitated rats were collected in DMEM containing 
11 mM sodium bicarbonate, 71 mM glucose and 1% antibiotic antimycotic solution. 
Following this, meninges, blood vessels and white matter were removed. The 
neocortices were homogenized by mechanical fragmentation and the cells collected by 
centrifugation at 700 g for 10 min. Finally, cells were resuspended in culture medium 
supplemented with 10% FCS, plated (2.0 × 105 cells cm2) on 12-well tissue culture 
plates (Corning Costar, Cambridge, MA, USA) and cultured for 10 days. Microglial 
contamination was assessed by immunocytochemical staining using primary antibodies 
raised against OX-42 (mouse) (Liu et al., 2002) and GFAP (rabbit), followed by a 
species-specific fluorescent-labeled secondary antibody, and was inferior to 2.5%. Thus, 
the high purity level of astrocyte cultures excludes interference of contaminant 
microglial cells that would account for the released cytokines (Hanisch, 2002; 
Nakamura et al., 2003; Fernandes et al., 2004). 
Primary cultures of rat cortical astrocytes were incubated for 4, 8 and 24 h with 100 ng 
mL1 LPS, 100 g mL1 indomethacin, 3.2 µg mL1 naringin or 10 µg mL1 naringenin, 
at 37ºC. In sister cultures cells were incubated with LPS + naringin, LPS + 
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indomethacin or LPS + naringenin. In addition both naringin and naringenin were 
studied in a 1/10 dilution. Cytokine release was assessed by ELISA. 
 
5.2.3 Animals 
Male mice (n = 32, 8 – 12 weeks, weighing 25 – 35 g) were purchased from Harlan 
Ibérica, Barcelona, Spain. All animals received a standard diet and water ad libitum. 
Experiments were conducted according to the Home Office Guidance in the Operation 
of Animals (Scientific Procedures) Act 1986, published by Her Majesty’s Stationary 
Office, London, UK and the Institutional Animal Research Commit- tee Guide for the 
Care and Use of Laboratory Animals published by the US National Institutes of Health 
(NIH Publication No. 85-23, revised 1996), as well as to the EC regulations (O.J. of 
E.C. L 358/1 18/12/1986). 
Before experiments animals fasted for 24h. A solution of saline/DMSO (9:1, v/v) was 
used for the preparation of all solutions. Naringin, prunin and naringenin were 
intraperitoneally (i.p.) injected at a dose of 40 mol kg1 mM.  
 
5.2.4 Distribution studies 
Eight mice were used to study each of the three substances (naringin, prunin and 
naringenin). Experiments were done in duplicate. Mice were sacrificed at 0.25, 0.5, 1 
and 4 hours after dosing and were previously anesthetized with sodium pentobarbital (6 
mg kg1 i.p.) for collection of blood by cardiac puncture and brain tissue was perfused 
by intraventricular injection of 5 mL of chilled saline solution to remove residual blood. 
 
5.2.5 Blood sample preparation 
Serum was isolated from the blood samples by centrifugation at 657 g for 10 min, at 
4ºC (Li et al., 2007). Serum was stored at –20ºC prior to extraction. 10 L of the 
internal standard solution, daidzein, (10 g mL1) were added to 100 L of serum 
sample and also 10 L of an acetic acid/water (1:2) (v/v) solution (Li et al., 2004). 400 
L of acetone were added to serum sample, and samples were shaken using vortex 
(15’’). The homogenate was centrifuged at 1500 g for 5 min at 4ºC (Mullen et al., 
2009). The supernatants were evaporated under a flow of nitrogen gas 30ºC till 
approximately 50 L. The aqueous phase was extracted with 400 L of ethyl acetate. 
  CHAPTER 5 
171 
Extraction was performed by mixing the tubes for 1.5 min, followed by centrifugation 
for 2 min at 16000 g. The organic layer was transferred into a clean tube and dried 
under a flow of nitrogen gas 30ºC. Samples were stored at –20ºC prior analysis. 
 
5.2.6 Brain sample preparation 
Brain was promptly removed and washed with saline (PBS) and blotted dry. Meninges 
were removed. Brain was weighted (Mullen et al., 2009). Brain samples were stored at 
–20ºC prior to extraction. The brain was diluted with 2 volumes (V/w) of phosphate 
buffer solution containing 0.1% EDTA and the internal standard, daidzein, (1 g mL1) 
(pH 7.4) (Mullen et al., 2009), and was homogenized using firstly a pestle and then a 
pipette and finally a sonicator. 600 L of acetone were added to the homogenate, and 
extraction occurred through shaking using vortex. The homogenate was centrifuged at 
1500 g for 5 min at 4ºC (Mullen et al., 2009). The supernatants were evaporated under a 
flow of nitrogen gas 30ºC till approximately 150 L. The aqueous extract was acidified 
with 15 L of acetic acid/water (1:2) (v/v) (Li et al., 2004). The aqueous phase was 
extracted with 600 L of ethyl acetate. Extraction was performed by mixing the tubes 
for 1.5 min, followed by centrifugation for 2 min at 16000 g. The organic layer was 
transferred into a clean tube and dried under a flow of nitrogen gas 30ºC. Samples were 
stored at –20ºC prior analysis. 
 
5.2.7 HPLC-MS analysis 
The sample residues were reconstituted in 80 L of acetonitrile plus 20 L of formic 
acid solution (0.25%). The samples were centrifuged at 12000 rpm during 5 minutes 
(Biofuge). 
The HPLC-DAD-ESI-MS/MS experiments used to identify the compounds (naringin, 
prunin, naringenin and their metabolites) were performed with a liquid chromatograph 
(Alliance, Waters 2695 Separation Module) system with a photodiode array detector 
(DAD, Waters 2996) set at 280 nm (for monitoring) in tandem with a mass spectrometer 
(Micromass Quattro Micro API) with a Triple Quadrupole (TQ) and an electrospray ion 
source (ESI) operating in negative mode. Chromatographic conditions were as follow: 
column C18 (Synergi, Phenomenex) 100 mm  2.0 mm, 2.5 m; eluent (A) water-
formic acid (99.5:0.5, v/v), (B) acetonitrile (LC-MS grade, Merck). The linear gradient 
was at initial time 95 % eluent A, at 30 min 60 % eluent A, at 45 min 10 % eluent A. 
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The flow rate was 0.25 mL min1 and the column temperature 35 ºC. Mass range was 
measured from 100-1000 amu. The ESI source conditions were adjusted as follows: 
source capillary operating at 2.5 kV and the extraction cone at 30 V: the source 
temperature was 150 ºC and the desolvation temperature was 350 ºC. 
The sample analysis in order to detect naringin, prunin and naringenin as well as its 
metabolites it was used the SIR method in negative mode for the molecular ions [M-
H+]- of each compound in analysis. The metabolites studied corresponded to 
glucorunoconjugates, sulfates and glucuronosulfoconjugated of the administered 
compounds.  
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5.3 Results and discussion 
 
5.3.1 In vitro anti-inflammatory effect of naringin and naringenin 
LPS induced a 10-fold maximum increase in the release of TNF- at 24 h (p < 0.05). 
Naringin, as well as naringenin did not induce any increase in the cytokine secretion by 
astrocytes at 4, 8 and 24 h incubation, except in the case of naringin (2.3 g L1) and 
naringenin (1 mg mL1). When astrocytes were co-incubated for 24 h, but not at 4 or 8 
h, with LPS and naringin (0.23 g mL1) a 2.5-fold decrease (p < 0.10) was noticed, 
while a 3.7-fold decrease (p < 0.05) was obtained for naringenin (10 g mL1).  
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Figure 5.1 Determination of TNF- concentration, after an incubation time period of 4h with: LPS, 
naringin, indomethacin and naringenin; as well as co-incubation of LPS with naringin, indomethacin and 
naringenin. 
0
250
500
750
1000
Co
ntr
ol
LP
S
Na
rin
gin
LP
S+
Na
rin
gin
Na
rin
gin
 (1
/10
)
LP
S+
Na
rin
gin
 (1
/10
)
Ind
om
eth
ac
in
LP
S+
Ind
om
eth
ac
in
Na
rin
ge
nin
LP
S+
Na
rin
ge
nin
Na
rin
ge
nin
 (1
/10
)
LP
S+
Na
rin
ge
nin
 (1
/10
)
[T
NF
- a
]  (
pg
 m
L-
1
)
8 h
Figure 5.2 Determination of TNF- concentration, after an incubation time period of 8h with: LPS, 
naringin, indomethacin and naringenin; as well as co-incubation of LPS with naringin, indomethacin and 
naringenin. 
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These anti-inflammatory effects were similar to those obtained in an in vivo model 
(Ribeiro et al., 2008b) and reinforce a higher protection after 24 h of interaction. 
Interestingly, the levels of secreted TNF- achieved in both conditions are not different 
from control values, what also agrees with the previous mentioned study. In addition, it 
is worthwhile to mention that the protection achieved by naringin (0.23 g mL1) was at 
the same level as that produced by indomethacin at 100 g mL1, and that obtained by 
naringenin (10 g mL1) was even better (40% increase). 
 
5.3.2 Preliminary studies concerning the distribution of the flavanones: naringin, 
prunin and naringenin in plasma and brain of mice after intraperitoneal administration. 
Naringin, prunin and naringenin were detected in plasma thirty minutes after 
intraperitoneal administration, but only prunin and naringenin were found in brain after 
this period (Annex 2). These preliminary results clearly demonstrate the capacity of 
both prunin and naringenin to cross the BBB, in opposition to naringin that wasn’t 
found in brain. Comparing both prunin and naringin, it can be concluded that the 
glucose moiety of prunin plays an important role during the crossing of BBB, in 
opposition to the terminal rhamnose sugar moiety of naringin. One hypothetical 
scenario for the transport of prunin across the BBB is its active transportation by means 
of SLGT 1. Concerning naringenin, a possible way to cross the BBB is through passive 
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Figure 5.3 Determination of TNF- concentration, after an incubation time period of 24h with: LPS, 
naringin, indomethacin and naringenin; as well as co-incubation of LPS with naringin, indomethacin and 
naringenin. 
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diffusion. 
All the possible metabolites were analysed including: glucuronoconjugates, sulfates and 
glucuronosulfoconjugated and also the metabolites that result from the hydrolysis of the 
sugar moiety. The glucuronide of naringenin was found in all samples including both 
plasma and brain, which supports a metabolization of the flavanones into the aglycone 
naringenin which suffers glucuronidation afterwards. In the case of prunin 
administration, the glucuronide of naringenin, which was found in brain, supports 
hypothetical sequential steps of deglycosylation followed by glucuronidation of prunin. 
Glucocerebrosidase is a human -glucosidase present in the brain that eventually may 
be responsible for the hydrolysis of the glucose moiety of prunin. Gee et al. (2000) 
reported a process for the intestinal epithelium passage of quercetin-3-glucoside that can 
be similar to what happens to prunin, where it is rapidly deglycosylated and then 
glucuronidated (Gee et al., 2000). 
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5.4 Conclusions 
 
In conclusion, although naringin and naringenin revealed to be effective anti-
inflammatory agents on astrocyte reactivity to LPS, naringenin demonstrated a higher 
efficacy that even surpassed that of indomethacin, after an incubation period of 24 
hours. 
Preliminary studies focusing on the distribution of the studied flavanones in plasma and 
brain of mice support the hypothesis of using the glucoside prunin as well as the 
aglycone naringenin in a way to cross the BBB. In addition, the eventual transformation 
of prunin into naringenin inside the brain makes it a prodrug of naringenin. 
These findings, together with those reported for the activity of naringenin against AD 
(cf. 1.3.2), place prunin and naringenin as potential useful drugs against AD. 
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This thesis reports several major biotechnological achievements in order to produce 
potential active drugs against AD. These achievements are mainly guided by a 
bioprocess optimization, consisting on the enzymatic deglycosylation of natural flavone 
glycosides, including naringin and rutin. An exception to this kind of achievements is 
found on Chaper 5, whose main purpose consists on filling the gap between research 
and therapeutics. 
Focusing on bioprocess optimization, the achievements can be divided into three 
conducting wires that include: the design of a biocatalytic process to produce the 
flavone glucosides (prunin and isoquercetin) and aglycones (naringenin and quercetin); 
the enzymatic biocatalysis using naringinase under pressure; and the immobilization of 
naringinase within silica glasses through sol-gel method. 
a) The flavone glucosides (prunin and isoquercetin) and aglycones (naringenin and 
quercetin) were produced, starting from the natural occurring rutinosides (naringin 
and rutin) (Chapter 2). The products were obtained in high purity and good yield 
attending to the high cost of these products, mainly the flavone glucosides: prunin 
and isoquercetin. Focusing on the production of the glucosides, a cheap 
production method was developed, based on a selective inactivation of -D-
glucosidase from naringinase by means of optimal deactivation conditions of 
temperature and pH, determined by means of RSM (81.5 ºC and pH 3.9). This 
achievement comprised simultaneously a high remaining -L-rhamnosidase 
activity. Some expensive methods have been described to accomplish this task, 
including chromatographic purification procedures of either -L-rhamnosidase 
from naringinase or the final products mixture (glucoside + aglycone); some even 
have used specific inhibitors of -D-glucosidase in order to stop the reaction just 
after the rhamnose release. More than this economical advantage, this method can 
be generalized for obtaining others also expensive flavone glucosides starting 
from their rutinosides. 
b) On the enzymatic biocatalysis using naringinase under pressure (Chapter 3), two 
different approaches were studied in order to increase the overall bioprocess 
efficiency. 
A first one, consisted on increasing the stability of enzymes against heat using 
pressure, based on the elliptic phase protein denaturing diagram (Figure 1.12). On 
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Chapter 3 it is shown how pressure can be used as a tool to protect naringinase, 
from inactivation caused by heat. At high temperature conditions, pressure 
decreased the inactivation proneness of both -L-rhamnosidase (32-fold at 250 
MPa and 85.0 ºC) and -D-glucosidase (30-fold at 200 MPa and 75.0 ºC) 
activities, when compared with atmospheric pressure. This protecting effect was 
dependent on the pressure magnitude and is supported by the antagonistic 
behavior between pressure and temperature, concerning the stability of proteins. 
This pressure protecting effect is very useful to rise the temperature condition of 
the biocatalytic reaction, which not only leads to an increased reaction rate, but 
also helps on the dissolution of the flavone substrates (naringin and rutin), whose 
solubility increases with temperature. 
A second potential application of pressure aimed to increase the reaction rate 
constants of both -L-rhamnosidase and -D-glucosidase from naringinase. From 
this study it was found that while -L-rhamnosidase activity increased with 
pressure (≠V = 7.7 ± 1.5 mL mol1), -D-glucosidase activity decreased (≠V = 
 ± 1.9 mL mol1). According to these results pressure seemed to be only 
adequate to increase the deglycosylation rate of rutinosides into glucosides. A 
study concerning the naringin hydrolysis into the aglycone naringenin showed that 
this affirmation is not necessarily true. In the case of the production of aglycones 
from rutinosides, both -L-rhamnosidase and -D-glucosidase activities are 
needed and the final activity under pressure is dependent on both activities. Indeed 
the naringin hydrolysis into naringenin was favored by pressure (≠V = 20.0 ± 
5.2 mL mol1), eventually driven by a first hydrolytic step involving -L-
rhamnosidase, which is favored by pressure. In addition, the naringin hydrolysis 
into naringenin under several temperature conditions, at atmospheric pressure and 
150 MPa supports the pressure stabilization of naringinase native state, at high 
temperature conditions. At 70.0 ºC and 80.0 ºC the kcat.KM is respectively 3 and 4-
fold higher at 150 MPa than at atmospheric pressure. Finally, concerning the 
equilibrium constants, despite the decrease in the hydrolysis equilibrium constants 
of both -L-rhamnosidase and -D-glucosidase caused by pressure the hydrolysis 
degree is still high (> 75%) in both cases at the highest pressure studied (200 
MPa). 
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Following this, pressure showed to be a powerful tool in order to increase the 
overall process efficiency. 
c) Naringinase immobilization within silica glasses through sol-gel method was 
successfully achieved (Chapter 4). The combination of the sol-gel precursors DGS 
and TMOS, as well as the combination of glycerol and TMOS led to the 
production of two interesting sol-gel matrices where naringinase was entrapped. 
Both these matrices showed outstanding operational stability coupled with high 
immobilization yields and efficiency. The best matrix, produced from TMOS and 
glycerol was used in further studies (89% yield, 72% efficiency and 100% residual 
activity after 50 successive reutilizations), involving the stability of immobilized 
naringinase against organic cosolvent systems as well as in a final study involving 
the use of ILs in order to increase the immobilized naringinase efficiency. 
The study of the stability of immobilized naringinase within organic cosolvent 
systems showed that the immobilization within sol-gel matrices protects 
naringinase from inactivation. The cosolvents used in these stabilization studies 
were firstly tested for the dissolution of naringin, and only the best were chosen. 
The stability of immobilized naringinase against organic cosolvents was 
dependent on the organic cosolvent tested, but for all the aqueous cosolvents 
systems studied at least a 3 fold stability increase was observed for immobilized 
naringinase when compared with soluble naringinase. The interesting results of 
naringin hydrolysis within a cosolvent system consisting of 1,2 dimethoxyethane, 
corroborate the advantage of using of organic cosolvents to increase the solubility 
of natural flavone substrates during biocatalytic reaction. 
ILs were used as templating additives of sol-gel matrices. From the huge amount 
of ILs studied, [OMIM][Tf2N] and [C2OHMIM][PF6] led to an efficiency increase 
of -L-rhamnosidase and -D-glucosidase, and in the case of -L-rhamnosidase 
an operational stability increase was also observed. In addition, sol-gel matrices 
produced with [OMIM][Tf2N], showed a robust mechanical resistance against 
cracking. The good performance showed by these matrices was supported by an 
interesting microscopic structure, through SEM analysis. The production of prunin 
and naringenin was preformed using sol-gel matrices produced with ILs.  
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Also, the relevancy of the results of immobilized naringinase under pressure is 
high in order to build a process that combines both the advantages of the 
immobilization of biocatalysts and pressurized reactions. 
 
Considering a potential application of the produced drugs on the therapeutics of AD, 
preliminary studies (Chapter 5) support the hypothesis of using the glucoside prunin as 
well as the aglycone naringenin in a way to cross the BBB. This fact may be a striking 
advantage to target AD, when comparing with the rutinoside naringin that doesn’t seem 
to be able to cross the BBB. As for prunin, evidences were shown to be metabolized 
into naringenin, meaning that acts as a prodrug of naringenin. Naringenin has been 
pointed out as potential active drug against AD as reported on 1.3.2, acting as a 
chemopreventive agent against AD, by reducing the micromolecular A-induced 
oxidative cell stress (Heo et al., 2004) and a possible molecular mechanism has been 
proposed by Tedeschi et al. (2010). Also naringenin is reported to inhibit NF-B which 
is responsible for triggering pro-inflammatory molecules (Kanno et al., 2006; Shi et al., 
2009) leading to a reduction of the redox imbalance and the consecutive chronic 
inflammation which is pointed out as one of the AD progression mechanisms. 
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This thesis work encloses achievements both focusing on bioprocess design and 
potential therapeutics against AD. 
Considering bioprocess design, the achievements are divided in three: 
a) The aglycones: quercetin and naringenin and the glucosides: isoquercetin and 
prunin were produced starting from the natural occurring rutinosides: rutin and 
naringin, by means of naringinase and partially inactivated naringinase 
respectively; 
b) Pressure was found to increase naringinase stability against heat and also the -
L-rhamnosidase activity from naringinase. The naringin hydrolysis under 
pressure (150 MPa) was faster than at atmospheric pressure. 
c) Naringinase entrapped within silica glasses through sol-gel method coupled with 
glycerol and ionic liquids showed a very high performance and resistance 
against cosolvent inactivation. Some matrices with immobilized naringinase 
showed mechanical resistance and good stability profile of naringinase under 
pressure (150 MPa). 
Regarding the potential application of the produced drugs on the therapeutics of AD, 
preliminary studies support the hypothesis of using the glucoside prunin as well as the 
aglycone naringenin in a way to cross the BBB, which is a striking advantage to target 
AD, when comparing with the rutinoside naringin that doesn’t seem to be able to cross 
the BBB. 
 
Due to experimental time restriction the flavonols rutin, isoquercetin and quercetin were 
placed in second level comparing to the flavanones naringin, prunin and naringenin. 
Only in Chapter 2, that describes the production of the glucosides and aglycones from 
the substrates rutinosides, it was possible to study together all these flavones.  
The aglycone quercetin and the glucoside isoquercetin weren’t studied on Chapter 5. 
But in an analogous way, future experiments may show evidence of an identical 
behaviour to naringenin (aglycone) and prunin (glucoside). Several findings also report 
quercetin as a potential active drug against AD. As stated on 1.3.2, quercetin inhibits A 
aggregation and destabilizes pre-formed A fibrils (Ono et al., 2003) and shows 
protective effects of neuronal cells from oxidative stress-induced by A peptide (Ansari 
et al., 2009). Even more interesting is the possible inhibition of -secretase by quercetin 
(Shimmyo et al., 2008). Future studies should focus on using the studied flavones in 
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mice models of AD in order to achieve robust scientific evidence that may launch some 
of these compounds into clinical trials, against AD. At this time a biotechnological 
method shall be set up, considering the compound of interest and all the achievements 
reported on this thesis in order to maximize its production. 
A study that may arise from this thesis work is the glycosylation of some good BACE1 
inhibitors that hardly penetrate the BBB, though a reverse reaction, and expecting a 
recognition followed by transportation through SLGT1 receptors on the BBB. 
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ANNEX 1: Demonstrations 
 
 
 
1. Demonstration of Equation 1.44  
(Dependence of the enzyme specific activity with pH): 
 
 
 
 
 
a) Development of Equation 1.41: 
 
 
 
 
 
b) Development of Equation 1.42: 
 
 
 
 
 
 
c) Substitution of the species: EH2+ and E on the Equation 1.43 by the developed 
cases on a) and b): 
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2. Demonstration of Equation 1.45  
(Determination of the optimum pH value): 
 
a) First derivative of Equation 1.44: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) Calculation of the zeros of the first derivative Equation 1.44: 
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ANNEX 2: LC-MS chromatograms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I Chromatogram of the ion extracted for the controls (57 and 60) and extract brain samples (63 
and 66) after naringin administration (w/z 579; retention time = 11.91 min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II Chromatogram of the ion extracted for the controls (56 and 59) and extract brain samples (68 
and 71) after prunin administration (w/z 433; retention time = 12.10 min). 
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Figure III Chromatogram of the ion extracted for the control (61) and extract brain samples (76 and 79) 
after naringenin administration (w/z 271); retention time = 15.69 min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV Chromatogram of the ion extracted for the control (61) and extract brain samples (70 and 73) 
after prunin administration. Naringenin glucuronide (w/z 447). 
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Figure V Chromatogram of the ion extracted for the control (61) and extract brain samples (76 and 79) 
after naringenin administration. Naringenin glucuronide (w/z 447). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure VI Fragmentation spectrum of ion w/z 447 (retention time = 12.39) in extract blood samples after 
prunin administration. Naringenin (w/z 271). 
 
